Barcelona, Spain

Transcription

Barcelona, Spain

Twenty-third Meeting of the
European Neurological Society
8 – 11 June 2013
Final Programme
Barcelona, Spain
www.ensinfo.org
of the
rd Meeting
iety
Twenty-thi
rological Soc
European Neu
2013
8 – 11 June
me
Final Program
Barcelona, Spain
fo.org
www.ensin
© Jan Engel - Fotolia.com
DOWNLOAD THE
ENS 2013 APP!
 Navigate through the programme
 Locate exhibitors
 Synchronise sessions with your personal calendar
 Access interactive map and more
Scan the QR code:
Android
supported by
iOS
Committees
2
Welcome
3
Important Addresses
4
Sponsor Acknowledgements
5
Educational Grants 2014
6
CME Accreditation / Certificates
7
Subcommittee Meetings
9
Programme Overview
Saturday, 8 June 2013
Sunday, 9 June 2013
Monday, 10 June 2013
Tuesday, 11 June 2013
10 – 11
12 – 13
14 – 15
16 – 17
Scientific Programme
Sunday, 9 June 2013
19 – 25
26 – 34
35 – 40
40 – 45
Oral Sessions
Overview
Sunday, 9 June 2013
46
47 – 54
55 – 66
67 – 69
Posters
Overview
Sunday, 9 June 2013
70 – 71
72 – 88
90 – 121
122 – 133
List of Chairpersons
134
List of Speakers and Authors
135 – 153
Instructions for Speakers and Authors
154 – 155
General Information
156 – 159
Registration Information
160 – 161
Networking Events
163
Useful Information about Barcelona
164 – 165
Travel to and within Barcelona
166 – 167
Venue Floor Plan
169
List of Exhibitors and Exhibition Floor Plan
170 – 171
Satellite Symposia
172 – 173
Imprint
Editor ENS 2013 c/o Congrex Switzerland Ltd.
Publisher & Layout Wecom Gesellschaft für Kommunikation mbH & Co. KG, Hildesheim / Germany, [email protected]
All contents valid at the time of printing. For amendments there can be given no limit or warranty by editor and publisher.
© Cover pictures fazon - Fotolia.com, PeterPunk - Fotolia.com, DZ-Media Verlag GmbH - Fotolia.com,
bbourdages - Fotolia.com
3
Introduction
Contents
© fazon - Fotolia.com
Committees
ENS Executive Committee
President: C.L. Bassetti, CH
Past President: H. Reichmann, DE
Secretary: G. Moonen, BE
Members
K. Bhatia, UK
H. Cock, UK
(Teaching Course Director)
M. Dieterich, DE
F. Fazekas, AT
L. Kappos, CH (Treasurer)
D. Pareyson, IT
E. Ruzicka, CZ
A. Siva, TR
G. Stoll, DE
(Scientific Programme Director)
J. Valls-Solé, ES
A. Verdelho, PT
Journal of Neurology
Official Journal of the
European Neurological Society
Joint Chief Editors:
R.A. Barker, UK
M. Filippi, IT
M. Strupp, DE
4
Local Organising Committee
M. Carreño
O. Fernández
M.T. Gómez-Isla
F. Graus
I. Illa
J. Kulisevsky
C. Molina
A. Rodríguez-Antiguedad
J. Sastre-Garriga
M. Tintoré
Chairperson of the
23rd ENS Meeting
Prof. Xavier Montalban
Hospital Vall d‘Hebron
Neuroscience
Passeig Vall d‘Hebron 119 – 129
08035 Barcelona / Spain
Welcome
Dear ENS colleagues
On behalf of the European Neurological Society, its Executive Committee and
the Local Organising Committee it is my pleasure to welcome you to the 23rd
Meeting of the ENS in Barcelona (8 – 11 June 2013).
In-depth knowledge of disease mechanisms and new evidence both for diagnosis
and treatment of many neurological diseases largely gained momentum in the
1990s after a couple of centuries had been spent on defining clinical entities
and drawing the anatomical and pathology blueprints. The aggregation of the
neurosciences in the past decade has favoured the consolidation of Neurology
as a medical specialty. Of note are the successful partnerships with imaging,
immunology, genetics and epidemiology amongst others which have greatly
contributed to remarkable developments such as those attained in Alzheimer’s
Disease, Epilepsy, Parkinson’s Disease and Multiple Sclerosis to mention but a
few. Translational research in Neurology has been a mainstay since the early
days in the 18th Century and is today’s flagship toward better quality of living
for persons with neurological diseases.
Barcelona in mid June is always a cozy and fun Mediterranean city with plenty
of light and life.
We look forward to welcoming you so that you can get the best of this worldclass scientific meeting on Neurology.
Prof. Xavier Montalban, M.D. PhD
Chairman of the 23rd ENS Meeting
5
Introduction
We are delighted to meet our peers in our beautiful city for a comprehensive
scientific meeting that will offer plenty of learning opportunities in every
subspecialty of Neurology by way of teaching courses, plenary talks as well as
updates as to the latest available evidence delivered through oral and poster
communications, together with industry sponsored symposia. This yearly
meeting is also a great time to upkeep existing connections or create new
ones, find opportunities for collaboration and delve into those topics that
might be not so close to our daily practice.
© Jan S. - Fotolia.com
Important Addresses
ENS Secretariat
European Neurological Society (ENS)
Peter Merian-Strasse 80
4002 Basel / Switzerland
Tel: +41 61 691 51 11
Fax: +41 61 686 77 88
Email:[email protected]
www.ensinfo.org
Congress Organiser
ENS 2013
c/o Congrex Switzerland Ltd.
Tel: +41 61 686 77 77
Fax: +41 61 686 77 88
www.congrex.com
Phone onsite: +34 932 334 575
Accommodation
and Travel Agency
Congrex Travel Ltd.
Tel: +41 61 690 94 11
Fax: +41 61 690 94 14
Phone onsite:+34 932 334 574
Fax onsite: +34 932 334 300
6
Congress Venue
Fira de Barcelona – Recinto Gran Via
Pabellon 8 (North Entrance)
Av. Joan Carles I, 64
08908 L’Hospitalet de Llobregat
Barcelona / Spain
www.firabcn.es
Sponsor Acknowledgements
The ENS wishes to express its gratitude to the following companies who,
through their generosity, have helped to make this congress possible:
Silver Medal Sponsors
Introduction
Bronze Medal Sponsors
Sponsor
7
Educational Grants 2014
DEPARTMENT-DEPARTMENT CO-OPERATION PROGRAMME 2014
40 grants each amounting to a maximum of € 1,800.– in order to make
it possible to stay at a foreign department for 6 weeks.
APPLICATION DEADLINE: 30 November 2013
FELLOWSHIP 2014
Up to 5 Scientific Grants & 3 Educational Grants
each amounting to a maximum of € 2,000.– per month
DURATION: up to 12 months
APPLICATION DEADLINE: 31 December 2013
SPRING SCHOOL FOR YOUNG NEUROLOGISTS – MAY 8-11, 2014
This annual meeting offers lectures and workshops for up to 120 young
neurologists. Participants pay for their travel only.
APPLICATION DEADLINE: 31 January 2014
CME ARTICLES
Each month a CME article is published in the European Journal of Neurology
and on the EFNS website. Answer 5 article-related questions correctly and
receive a certificate recommending one hour of CME.
APPLICATION: Please register on the EFNS website for free-of-charge access.
eBRAIN – www.ebrainjnc.com
This e-learning programme consists of more than 500 sessions and is
free-of-charge for EFNS and ENS members.
Please contact [email protected] to get your access token.
All application forms and detailed information can be found on the website.
WWW.EFNS.ORG  AWARDS & GRANTS
Introduction
© rnl - Fotolia.com
CME Accreditation / Certificates
CME Credits
The quality of continuing education will be rated by the CME
system of the European Accreditation Council for Continuing
Medical Education. European Accreditation is granted in order
to allow participants to validate the credits obtained at the ENS
in their European home country. EACCME credits are recognised
by the American Medical Association towards the Physicians’
Recognition Award (PRA). To convert EACCME credit to AMA
PRA category 1 credit, contact AMA (www.ama-assn.org).
Rating of the ENS Meeting: 6 points/day, 3 points/half-day
The accreditation is valid for the main congress programme
only and does not cover the company-sponsored symposia.
CME
Certificates
To claim your CME credits, please fill in the online evaluation
form at the congress website www.congrex.ch/ens2013 after
the meeting. Please use your personal access code, which is
given to you on a voucher with your badge. After completing a
questionnaire you can print the certificate indicating the CME
credits.
CME Credits for Teaching Courses: please note that the
teaching course handouts include a certificate for each course.
Certificates are only available during the course and cannot be
issued afterwards.
Attendance
Certificates
Attendance certificates will be available from Monday
afternoon onwards at the Self-Service Stations. Changes of
certificates will be charged € 10.–
9
Satellite Symposium
Saturday 8 June 2013 | 11:50–13:20
Auditorium: Room A
Re-evaluating the treatment algorithm
Programme
Chairs: Alex Rovira (Spain)
Peter Rieckmann (Germany)
Multiple sclerosis: Changing concepts,
new targets
Frederik Barkhof (the Netherlands)
Treatment sequencing or treatment selection:
Time to re-evaluate our approach?
Patrick Vermersch (France)
Older, but wiser? Current therapeutic options
and the new treatment algorithm
Óscar Fernández (Spain)
HQ/CPX/13/0002
Subcommittee Meetings
The Executive Committee has set up a series of subcommittees
in order to increase involvement in policy decisions,
representative of the diversity within the neurological
field. The subcommittees aim to promote and advance the
continuing education within their neurological specialties. The
subcommittees also serve as a place to exchange ideas and to
network. Ideas and suggestions for the scientific programme
for 2015 will be collected during the subcommittee meetings
in Barcelona.
We are looking forward to see you at one of the meetings!
Coordinator
Day & Time
Lüder Deecke
Saturday, 8 June 2013, 11:45 – 12:45
Room F
Child Neurology
Daniela Pohl
Saturday, 8 June 2013, 11:50 – 12:50
ENS booth
Neuro-otology /
Neuro-ophtalmology
Marianne Dieterich
Saturday, 8 June 2013, 12:30 – 13:30
ENS booth
Neurorehabilitation
Volker Dietz
Saturday, 8 June 2013, 17:00 – 18:00
ENS booth
Sunday, 9 June 2013, 09:30 – 10:30
ENS booth
Multiple sclerosis /
Giancarlo Comi
Demyelinating diseases of CNS
Room
General neurology
Aksel Siva
Sunday, 9 June 2013, 10:30 – 11:15
ENS booth
Neuroimaging
Massimo Filippi
Sunday, 9 June 2013, 11:15 – 12:15
ENS booth
ENS booth
Pain
Pedro Schestatsky
Sunday, 9 June 2013, 11:00 – 12:00
Headache
Fabio Antonaci
Sunday, 9 June 2013, 12:00 – 13:00
ENS booth
Coma and chronic disorders
of consciousness
Steven Laureys
Sunday, 9 June 2013, 12:00 – 13:00
Room C
Muscle and neuromuscular
junction disorders
Corrado Angelini
Sunday, 9 June 2013, 12:00 – 13:00
Room F
ENS booth
Peripheral neuropathy
Claudia Sommer
Sunday, 9 June 2013, 12:30 – 13:30
Movement disorders
Kailash Bhatia
Sunday, 9 June 2013, 17:00 – 18:00
ENS booth
Epilepsy
Paul Boon
Sunday, 9 June 2013, 17:30 – 18:30
ENS booth
Basic / Preclinical neuroscience Pasquale Annunziata
Monday, 10 June 2013, 11:00 – 12:00
ENS booth
Motor neuron disease
Monday, 10 June 2013, 12:00 – 13:00
Room E
Vincenzo Silani
Clinical neurophysiology
Josep Valls-Solé
Monday, 10 June 2013, 12:00 – 13:00
ENS booth
Dementia
Daniela Galimberti
Monday, 10 June 2013, 12:30 – 13:30
ENS booth
Sleep disorders
Joan Santamaria
Monday, 10 June 2013, 15:00 – 16:00
ENS booth
Clinical neurogenetics
Davide Pareyson
Monday, 10 June 2013, 16:30 – 17:30
ENS booth
Cerebrovascular disorders
Franz Fazekas
Monday, 10 June 2013, 17:00 – 18:00
ENS booth
Infectious disorders
Erich Schmutzhard
Tuesday, 11 June 2013, 11:30 – 12:30
ENS booth
Neuro-oncology
Riccardo Soffietti
Tuesday, 11 June 2013, 12:00 – 13:00
ENS booth
11
Introduction
Subcommittee
Higher cortical functions
Plenary Hall
08:30
09:00
09:30
Room A
Room B
Room C
08:30 – 10:00
08:30 – 10:00
08:30 – 10:00
Interactive Case
Presentation 1
Interactive Case
Presentation 2
Interactive Case
Presentation 3
Clinical pitfalls
Imaging pitfalls
p. 19
Unusual
movement
disorders p. 19
p. 19
10:00
10:10 – 11:40
Workshop 1
Epilepsy and
metabolic
disorders:
diagnosis you
don’t want to miss
10:30
11:00
11:30
p. 19
12:00
11:50 – 13:20
12:30
Satellite
Symposium
Workshop 2
Recognition
and treatment
of headache as
symptoms p. 19
10:10 – 11:40
Workshop 3
From poison to
treatment: the
contribution of
Botulinum toxin to
Neurology over the
last 25 years p. 20
12:00 – 13:30 Lunch Break
Teva
13:00
10:10 – 11:40
p. 21
13:30
14:00
14:30
15:00
13:30 – 17:00
13:30 – 17:00
13:30 – 17:00
Teaching Course 1
Teaching Course 2
Teaching Course 3
Update on movement disorders
in childhood and
adolescence
Age and
gender issues in
headache
Management of
the dizzy patient
15:00 – 15:30 Coffee Break
15:30
TC Continuation
16:00
TC Continuation
TC Continuation
16:30
p. 22
p. 23
p. 23
17:00
17:30
18:00
18:30
19:00
19:30
17:15 – 19:15
Presidential
Symposium
Sleep for the
brain, by the
brain
p. 25
19:30 – approx. 21:00 Opening Ceremony: Fira Gran Via (Hall 8), 2nd Floor
p. 163
12:00 – 16:00 Exhibition opening hours
12
Room D
Room E
Room F
08:30
08:30 – 10:00
Interactive Case
Presentation 4
09:00
Paroxysmal events
09:30
p. 19
10:00
10:10 – 11:40
10:10 – 11:40
10:10 – 11:40
Workshop 4
Workshop 5
Special Session
10:30
The daily-life application
In a case of
Neurology & Arts:
of the revised 2010
mononeuropathy, what the processing of music
McDonald criteria for
to do to define better
in the brain
patients suspecting of
having MS
the lesion? p. 20
p. 20
p. 21
11:30
12:00
12:30
12:00 – 13:30 Lunch Break
13:00
13:30
13:30 – 17:00
13:30 – 17:00
13:30 – 17:00
Teaching Course 4
Teaching Course 5
Teaching Course 6
Rehabilitation
after stroke
Longitudinal
monitoring with
neuroimaging
techniques
Approach to
peripheral neuropathy
14:00
14:30
15:00
15:30
TC Continuation
TC Continuation
TC Continuation
16:00
16:30
p. 24
p. 24
p. 25
17:00
17:30
18:00
18:30
19:00
19:30 – approx. 21:00 Opening Ceremony: Fira Gran Via (Hall 8), 2nd Floor
19:30
p. 163
13
Programme Overview
12:00 – 13:00
Joint ENS-Indian Symposium
Management of
neurological disorders
p. 22
in India
11:00
Sunday, 9 June 2013
Plenary Hall
08:00
08:30
09:00
09:30
Room A
Room B
Room C
08:00 – 11:30
Teaching Course 8
Essential
contribution
of clinical
neurophysiology
to syndromic
diagnosis
08:00 – 11:30
08:00 – 11:30
Teaching Course 12
Teaching Course 7
Current and future
treatments in
neurology I
(full day)
Stroke in
children and
young adults
10:00
TC Continuation
10:30
TC Continuation
TC Continuation
11:00
p. 28
11:30
12:00
12:30
13:00
p. 26
p. 26
11:30 – 12:30 Lunch & Coffee Break
12:00 – 13:30
12:00 – 13:30
Satellite
Symposium
Satellite
Symposium
Biogen Idec
SSIF
p. 29
p. 30
13:30
13:45 – 17:15
Teaching Course 12
Current and future
treatments in
neurology II
(full day)
14:00
14:30
15:00
13:45 – 17:15
Teaching Course 13
Tourette’s
syndrome and
related disorders
13:45 – 15:15
Oral Session 1
Neurogenetics
p. 47
15:15 – 15:45 Coffe Break
15:30
16:00
16:30
17:00
17:30
18:00
18:30
15:45 – 17:15
Oral Session 6
15:45 – 17:15
TC Continuation
TC Continuation
Motor neuron
disease
pp. 51 – 52
p. 29
p. 32
p. 51
17:30 – 19:00
17:30 – 19:00
Satellite
Symposium
Satellite
Symposium
Merck Serono
Eisai Europe Ltd.
p. 33
p. 34
19:00
14
Oral Session 5
Infection and
inflammation
Sunday, 9 June 2013
Room D
08:00 – 11:30
Teaching Course 9
A practical
approach to
the complex
neurogenetic
syndromes
Room E
Room F
Poster Area
08:00 – 11:30
08:00 – 11:30
08:00
Teaching Course 10 Teaching Course 11
Brain computer
interfaces
08:30
Diagnosis and
treatment
of muscle
syndromes
09:00
09:30
10:00
TC Continuation
TC Continuation
TC Continuation
10:30
11:00
p. 27
p. 27
p. 28
11:30 – 12:30
11:30 – 12:30 Lunch & Coffee Break
Poster Session 1
12:00 – 13:30
11:30
12:00
Satellite
Symposium
12:30
12:30 – 13:30
Actelion
EAYNT
Session
p. 31
13:00
p. 31
13:30
13:45 – 15:15
13:45 – 15:15
13:45 – 15:15
Oral Session 2
Oral Session 3
Oral Session 4
Multiple
sclerosis I:
therapeutics
Neurophysiology
Pain and
headache
pp. 48 – 49
p. 49
14:00
14:30
p. 50
15:00
15:15 – 15:45 Coffe Break
15:30
15:45 – 17:15
15:45 – 17:15
15:45 – 17:15
Joint ENS-SEN
Symposium
Oral Session 7
Oral Session 8
Neurooncology and
miscellaneous
General neurology I:
neuro-otology
and neuro
ophthalmology
Role of
antibodies in MS
p. 32
pp. 52 – 53
pp. 53 – 54
16:00
16:30
17:00
17:30
18:00
18:30
19:00
15
Programme Overview
pp. 72 – 88
Plenary Hall
Room A
Room B
09:00 – 11:00
09:00 – 11:00
Room C
07:30
08:00
08:30
09:00
09:30
10:00
Symposium
Symposium
Advances in stroke
prevention and
treatment
Parkinson and
Parkinsonism
p. 35
p. 35
09:30 – 11:00
09:30 – 11:00
Oral Session 9
Oral Session 10
Epilepsy I
Neuroimaging
10:30
pp. 55 – 56
p. 55
11:00
11:00 – 12:00 Lunch and Coffee Break
11:30
12:00
12:30
13:00
13:30
14:00
14:30
11:45 – 13:15
Satellite
Symposium
Novartis
p. 36
13:30 – 15:00
Oral Session 12
Cerebrovascular
disorders I
pp. 57 – 58
15:00
15:30
16:00
16:30
13:30 – 15:00
Oral Session 13
Multiple
sclerosis II:
pathogy and
patogenesis
pp. 58 – 59
13:30 – 15:00
13:30 – 15:00
Oral Session 14
Oral Session 15
Dementia I
Muscle disorders
pp. 59 – 60
pp. 60 – 61
15:30 – 17:00
15:30 – 17:00
15:30 – 17:00
15:30 – 17:00
Oral Session 17
Oral Session 18
Oral Session 19
Oral Session 20
Cerebrovascular
disorders II
Multiple
sclerosis III:
other
Dementia II
Peripheral
neuropathies
pp. 62 – 63
pp. 63 – 64
pp. 64 – 65
pp. 65 – 66
17:00
17:30
17:30 – 19:00
18:00
Satellite
Symposium
18:30
Genzyme
p. 39
19:00
19:30
20:00
20:00 ENS Farewell Networking Event in the "Casa Battló"; City Centre
16
p. 163
Room D
Room E
Room F
Poster Area
07:45 – 08:45
1st Assembly of
Delegates (ENS)
07:30 – 09:00
Practical Session 1
Conventional
needle electromyography
07:30
08:00
08:30
p. 35
09:00
09:30 – 11:00
09:30 – 11:00
09:30 – 11:00
Oral Session 11
Workshop 6
Workshop 7
Paediatric
neurology
How to deal with
ICU acquired
weakness
Complex
regional pain
syndrome
pp. 56 – 57
p. 36
09:30
10:00
10:30
p. 36
11:00
11:30 – 12:30
Poster Session 2
12:15 – 13:15
Special Session
ENS-EAYNT
Translational
Neurology p. 37
13:30 – 17:00
13:30 – 17:00
Teaching Course 14 Teaching Course 15
Brain endothelium
Practical
as therapeutic tarmovement
get in neurological
disorders
disorders
12:30
13:00
13:30
13:30 – 15:00
Oral Session 16
14:00
Sleep disorders
14:30
p. 61
15:00
15:30
15:30 – 17:00
TC Continuation
Oral Session 21
16:00
Neuro
rehabilitation
p. 37
p. 38
12:00
pp. 90 – 105
TC Continuation
11:30
16:30
p. 66
17:00
17:15 – 18:45
Practical Session 2
17:30 – 18:30
Single fibre
electro
myography
Poster Session 3
17:30
18:00
pp. 106 – 121
18:30
p. 38
19:00
19:30
20:00 ENS Farewell Networking Event in the "Casa Battló"; City Centre
20:00
p. 163
17
Programme Overview
Plenary Hall
Room A
Room B
09:00 – 11:00
09:00 – 11:00
Room C
07:30
08:00
08:30
09:00
09:30
10:00
Symposium
Symposium
Personalised
treatment in MS
Recent advances
in Alzheimer and
other dementias
09:30 – 11:00
09:30 – 11:00
Oral Session 22
Oral Session 23
Epilepsy II
Extrapyramidal
disorders
10:30
p. 40
p. 67
p. 40
p. 68
11:00
11:30
11:45 – 13:15
12:00
Satellite
Symposium
12:30
Bayer
HealthCare
13:00
13:30
14:00
14:30
p. 41
13:30 – 17:00
13:30 – 17:00
13:30 – 17:00
13:30 – 17:00
Teaching Course 16 Teaching Course 17 Teaching Course 18 Teaching Course 19
Dementia: tools
for early diagnosis and progression monitoring
15:00
Measuring
heterogeneity
in MS: the MRI
perspective
Challenges in
neurodegenerative diseases:
ALS and FTD
Epilepsy,
diagnostic
advances
15:30
16:00
TC Continuation
TC Continuation
TC Continuation
TC Continuation
16:30
p. 42
p. 43
p. 43
17:00
17:30
18
p. 44
Room D
Room E
Room F
Poster Area
07:30
07:30 – 09:00
Practical Session 3
08:00
Nerve
conduction
studies
08:30
p. 40
09:00
09:30 – 11:00
09:30 – 11:00
Oral Session 24
Workshop 8
Workshop 9
Cerebrovascular
disorders III
Muscle biopsy
and molecular
diagnosis
Diagnostic
procedures in
CNS infections
p. 69
11:00 – 12:00
ENS Business
Meeting
p. 41
09:30
10:00
10:30
p. 41
11:00
11:30 – 12:30
11:45 – 13:15
p. 157
Poster Session 4
Practical Session 4
Reflexes and
long latency
responses
p. 42
13:30 – 17:00
13:30 – 17:00
13:30 – 17:00
Teaching Course 20 Teaching Course 21 Teaching Course 22
Emerging
infections of the
nervous system
Hot spots in
neuro-oncology
Genetics
of pain
11:30
12:00
pp. 122 – 133
12:30
13:00
13:30
14:00
14:30
15:00
15:30
TC Continuation
TC Continuation
TC Continuation
16:00
16:30
p. 44
p. 45
p. 45
17:00
17:30
19
Programme Overview
09:30 – 11:00
Merck Serono is a
division of Merck
08:30 – 10:00
Interactive Case Presentations
Room A
1
Clinical pitfalls
C.L. Bassetti, G. Moonen (Berne, CH; Liège, BE)
Room B
2
Imaging pitfalls
M. Filippi (Milan, IT)
Room C
3
Unusual movement disorders
K. Bhatia (London, UK)
Room D
4
Paroxysmal events
H. Cock (London, UK)
10:10 – 11:40
Room A
Workshop 1
Epilepsy and metabolic disorders:
diagnosis you don't want to miss
Chairperson: B. Plecko (Zurich, CH)
5Hands-on
metabolic work-up for neonatal and
infantile seizures
B. Plecko (Zurich, CH)
and metabolic disorders in adolescents
and adults: a practical diagnostic approach
F. Sedel (Paris, FR)
10:10 – 11:40
Room B
T his workshop is based on the input of the
ENS Subcommittee Child Neurology
(Chair: D. Pohl (Ottawa, CA))
Workshop 2
Recognition and treatment of headache as
symptoms
Chairperson: A. Siva (Istanbul, TR)
7
Headache in the emergency room
A. Siva (Istanbul, TR)
8Intracranial
pressure changes and headache –
diagnosis and management
F. Antonaci (Pavia, IT)
This workshop is based on the input of the
ENS Subcommittee Headache
(Chair: A. Siva (Istanbul, TR))
21
6Epilepsy
10:10 – 11:40
Room C
Workshop 3
From poison to treatment: the contribution of
Botulinum toxin to Neurology over the last 25 years
Chairperson: M.H. Marion (London, UK)
9The
contribution of Botulinum toxin treatment in
dystonia over the last 25 years
M.H. Marion (London, UK)
10The
contribution of Botulinum toxin treatment in
spasticity
R. Jech (Prague, CZ)
ENS Subcommittee Movement Disorders
(Chair: K. Bhatia (London, UK))
10:10 – 11:40
Room D
Workshop 4
The daily-life application of the revised
2010 McDonald criteria for patients suspecting
of having MS
Chairperson: M.A. Rocca (Milan, IT)
11
The neurologist's perspective
L. Kappos (Basel, CH)
12
The radiologist's perspective
M.A. Rocca (Milan, IT)
ENS Subcommittee Neuroimaging
(Chair: M. Filippi (Milan, IT))
10:10 – 11:40
Room E
Workshop 5
In a case of mononeuropathy, what to do
to define better the lesion?
Chairperson: R. Liguori (Bologna, IT)
13
Nerve conduction studies
R. Liguori (Bologna, IT)
14Ultrasound
as completion to assess site, cause
and possible therapy
L. Padua (Rome, IT)
ENS Subcommittee Clinical Neurophysiology
(Chair: J. Valls-Solé (Barcelona, ES))
22
10:10 – 11:40
Room F
Special Session
Neurology & Arts: the processing of
music in the brain
Chairpersons:L. Deecke (Vienna, AT)
I. Peretz (Montreal, CA)
15What
do we learn about music processing when
studying brain lesioned patients?
I. Peretz (Montreal, CA)
16Functional
neuroimaging of music processing in
the brain
R. Beisteiner (Vienna, AT)
17Apollo's
gift and curse: motor learning and
un-learning in musicians
E. Altenmüller (Hannover, DE)
11:50 – 13:20
Room A
Emerging insights in multiple sclerosis:
Re-evaluating the treatment algorithm
Chairpersons:A. Rovira (Barcelona, ES)
P. Rieckmann (Bamberg, DE)
11:50
11:55
18Multiple
12:15
19
Treatment
12:35
20
Older,
12:55
Panel discussion
13:15
Closing remarks
A. Rovira (Barcelona, ES)
Welcome and introduction
Sclerosis: changing concepts, new
targets
F. Barkhof (Amsterdam, NL)
sequencing or treatment selection:
Time to re-evaluate our approach?
P. Vermersch (Lille, FR)
but wiser? Current therapeutic options
and the new treatment algorithm
O. Fernández (Malaga, ES)
Satellite Symposium organised by 23
12:00 – 13:00
Room D
Joint ENS-Indian Symposium
2nd Meeting of ENS with Indian Speakers on the
management of neurological disorders in India
Chairpersons:H. Cock (London, UK)
H. Reichmann (Dresden, DE)
R. Patankar (Mumbai, IN)
21
Epilepsy in the Indian scenario
B. Sharma (Jaipur, IN)
22
Treatment of acute ischaemic stroke-beyond
window period
R. Patankar (Mumbai, IN)
13:30 – 17:00
Room A
Teaching Course 1
Update on movement disorders
in childhood and adolescence
Chairpersons:K. Bhatia (London, UK)
A. Vincent (Oxford, UK)
13:30
29
Dystonia
14:15
30Movement
15:00
15:30
31Movement
16:15
32Psychogenic
– Clinical, genetic and
neuropathological features
H. Houlden (London, UK)
disorders in treatable neurometabolic
diseases
M. Willemsen (Nijmegen, NL)
Coffee break
disorders in paraneoplastic and
autoimmune diseases
movement disorders: diagnostic
hints and pitfalls
T his teaching course is based on the input of the
ENS Subcommittee Child Neurology
(Chair: D. Pohl (Ottawa, CA))
24
13:30 – 17:00
Room B
Teaching Course 2
Age and gender issues in headache
Chairpersons:F. Antonaci (Pavia, IT)
R. Nappi (Pavia, IT)
13:30
33
Diagnostic errors in primary headache
F. Antonaci (Pavia, IT)
14:15
34
Headache in children and adolescents
S. Kuhn Natriashvili (Vienna, AT)
15:00
Coffee break
15:30
35
Headache in women
R. Nappi (Pavia, IT)
16:15
36
Headache in the elderly
M.G. Buzzi (Rome, IT)
13:30 – 17:00
Room C
Teaching Course 3
Management of the dizzy patient
Chairpersons:M. Dieterich (Munich, DE)
A.M. Bronstein (London, UK)
13:30
37Differential
14:15
38Differential
15:00
Coffee break
15:30
39
Chronic dizziness and dysequilibrium
A.M. Bronstein (London, UK)
16:15
40
Physical therapy of the dizzy patient
C. Helmchen (Lübeck, DE)
ENS Subcommittee Headache
(Chair: F. Antonaci (Pavia, IT))
diagnostics of peripheral vertigo
syndromes
D. Straumann (Zurich, CH)
diagnoses of central vertigo
syndromes
M. Dieterich (Munich, DE)
ENS Subcommittee Neuro-otology & Neuroophtalmology (Chair: M. Dieterich (Munich, DE))
25
13:30 – 17:00
Room D
Teaching Course 4
Rehabilitation after stroke
Chairpersons:V. Dietz (Zurich, CH)
J. Rothwell (London, UK)
13:30
41Swallowing
14:15
42
Spasticity and locomotion
V. Dietz (Zurich, CH)
15:00
Coffee break
15:30
43Direct
16:15
44
and speech rehabilitation after
stroke: new approaches
J. Rothwell (London, UK)
current brain stimulation: significance in
stroke rehabilitation
W. Paulus (Göttingen, DE)
Cognitive rehabilitation after stroke
E. Altenmüller (Hannover, DE)
ENS Subcommittee Neurorehabilitation
(Chair: V. Dietz (Zurich, CH))
13:30 – 17:00
Room E
Teaching Course 5
Longitudinal monitoring with
neuroimaging techniques
Chairpersons:M. Filippi (Milan, IT)
F. Fazekas (Graz, AT)
13:30
45
14:15
46Dementia
Multiple Sclerosis
15:00
Coffee break
15:30
47
Imaging progression of Parkinson's disease
D. Brooks (London, UK)
16:15
48
F. Agosta (Milan, IT)
ENS Subcommittee Neuroimaging
(Chair: M. Filippi (Milan, IT))
26
13:30 – 17:00
Room F
Teaching Course 6
Approach to peripheral neuropathy
Chairpersons:C. Sommer (Würzburg, DE)
G. Llewelyn (Cardiff, UK)
13:30
49
Diagnostic approach to peripheral neuropathy
C. Sommer (Würzburg, DE)
14:15
50
Diabetic neuropathy
G. Llewelyn (Cardiff, UK)
15:00
Coffee break
15:30
51
Acute neuropathies
B. Jacobs (Rotterdam, NL)
16:15
52
Hereditary neuropathies
D. Pareyson (Milan, IT)
17:15 – 19:15
Plenary Hall
Presidential Symposium
Sleep for the brain, by the brain
Chairperson: C.L. Bassetti (Berne, CH)
17:15
53Neuronal
17:45
54Reciprocal
18:15
55Sleep-wake
18:45
56
Sleep-wake
networks and mechanisms responsible
for sleep and their dysfunctions in pathologies
P.-H. Luppi (Lyon, FR)
interactions between wakefulness
and sleep
P. Maquet (Liège, BE)
disorders as first/main manifestation
of a neurological disorder
J. Santamaria (Barcelona, ES)
disorders as modulators of the
outcome of neurological disorders
C.L. Bassetti (Berne, CH)
27
ENS Subcommittee Peripheral Neuropathy
(Chair: C. Sommer (Würzburg, DE))
Sunday, 9 June 2013
08:00 – 11:30
Room B
Teaching Course 7
Stroke in children and young adults
Chairpersons:P. Berlit (Essen, DE)
A.C. Fonseca (Lisbon, PT)
08:00
57Coagulation
08:45
58
Genetic disorders
M. Dichgans (Munich, DE)
09:30
Coffee break
10:00
59Vasculopathies
disorders as the cause of stroke in
the young
A.C. Fonseca (Lisbon, PT)
P. Berlit (Essen, DE)
10:45
60
Vasospasm and migraine
C. Stapf (Paris, FR)
This teaching course is based on the input of the
ENS Subcommittee Cerebrovascular Disorders
(Chair: P. Berlit (Essen, DE))
08:00 – 11:30
Room C
Teaching Course 8
Essential contribution of clinical neurophysiology
to syndromic diagnosis
Chairpersons:J. Valls-Solé (Barcelona, ES)
C. Krarup (Copenhagen, DK)
08:00
61Generalised
08:45
62Tetraparesis
09:30
10:00
63
Facial
10:45
64How
weakness. Is it motor neuron disease,
myopathy, myasthenia or chronic fatigue?
in the UCI. Is it neuropathy or
myopathy?
R. Dengler (Hannover, DE)
Coffee break
pain. Is it the nerve, the joint or the
muscle?
S.K. Jääskeläinen (Turku, FI)
neurophysiology might help in case of a
suspected psychogenic disorder
J. Valls-Solé (Barcelona, ES)
ENS Subcommittee Clinical Neurophysiology
(Chair: J. Valls-Solé (Barcelona, ES))
28
Sunday, 9 June 2013
08:00 – 11:30
Room D
Teaching Course 9
A practical approach to the complex
neurogenetic syndromes
Chairpersons:D. Pareyson (Milan, IT)
T. Klopstock (Munich, DE)
08:00
65
The clinical approach
N. Wood (London, UK)
08:45
66
The contribution of the laboratory tests
T. Klopstock (Munich, DE)
09:30
Coffee break
10:00
67
The contribution of MRI
C. Uggetti (Milan, IT)
10:45
68
Illustrative clinical cases
ENS Subcommittee Clinical Neurogenetics
(Chair: D. Pareyson (Milan, IT))
Teaching Course 10
Brain computer interfaces
Chairpersons:S. Laureys (Liège, BE)
Q. Noirhomme (Liège, BE)
08:00 – 11:30
Room E
ENS-AAN joint teaching course
08:00
69
Why do we need BCI?
S. Laureys (Liège, BE)
08:45
70
How do brain-computer interfaces work?
Q. Noirhomme (Liège, BE)
09:30
Coffee break
10:00
71
BCI in disorders of consciousness
D. Mattia (Rome, IT)
10:45
72
Future challenges of BCI
D. McFarland (Albany, US)
ENS Subcommittee Coma and Chronic Disorders of
Consciousness (Chair: S. Laureys (Liège, BE))
29
08:00 – 11:30
Room F
Sunday, 9 June 2013
Teaching Course 11
Diagnosis and treatment of muscle syndromes
Chairpersons:C. Angelini (Venice/Padua, IT)
H. Lochmüller (Newcastle, UK)
ENS-AAN joint teaching course
08:00
73
Ophthalmoplegia: one sign, many diseases
A. Toscano (Messina, IT)
08:45
74The
09:30
09:30
75Approach
10:45
76Inflammatory
approach to children with myasthenic
syndromes
H. Lochmüller (Newcastle, UK)
Coffee break
to Scapuloperoneal syndromes
S. Iyadurai (St. Louis, US)
myopathies: clinical clues for
diagnosis and treatment
C. Angelini (Venice/Padua, IT)
ENS Subcommittee Muscle and Neuromuscular
Junction Disorders (Chair: C. Angelini (Venice/Padua, IT))
08:00 – 11:30
Room A
Teaching Course 12
Current and future treatments in neurology I
(Full day course)
Chairpersons:Z. Argov (Jerusalem, IL)
08:00
77
Acute myelitis
H.-P. Hartung (Düsseldorf, DE)
08:45
78
Stroke and cervical artery dissection
S. Debette (Lille, FR)
09:30
Coffee break
10:00
79
Myasthenic crisis
Z. Argov (Jerusalem, IL)
10:45
80
The patient with advanced Parkinson‘s disease
30
Sunday, 9 June 2013
13:45 – 17:15
Room A
Teaching Course 12
Current and future treatments in neurology II
(Full-day course)
13:45
81Mild
14:30
82Treatment
15:15
Coffee break
15:45
83
Epilepsy treatment beyond medications
P. Boon (Ghent, BE)
16:30
84Stem
12:00 – 13:30
Plenary Hall
Moving the treatment of MS forward
Chairpersons:X. Montalban (Barcelona, ES)
R. Gold (Bochum, DE)
12:00
85Tailoring
12:10
86Oral
12:35
87Natalizumab:
12:50
88Pegylation:
13:10
89PR-Fampridine:
13:25
cognitive impairment and early Alzheimer‘s
disease
E. Scarpini (Milan, IT)
of common neurological diseases
during pregnancy
B. Schmitz (Berlin, DE)
cell therapy in neurology: promise and
hype
A. Uccelli (Genoa, IT)
choice: a drug for each patient at the
right time
X. Montalban (Barcelona, ES)
dimethyl fumarate: a new effective choice
for patients
R. Gold (Bochum, DE)
early and effective use for the right
patient
M. Linnebank (Zurich, CH)
a new ADVANCE after 20 years of
interferon beta-1a evolution
B. Kieseier (Düsseldorf, DE)
a first look at quality of life
through ENABLE data
P. Soelberg Sørensen (Copenhagen, DK)
Question and answer and closing remarks
Sunday, 9 June 2013
12:00 – 13:30
Room B
Amyotrophic Lateral Sclerosis: where do we stand?
Chairpersons:G. Comi (Milan, IT)
V. Silani (Milan, IT)
12:00
12:10
98L1:
12:30
Discussion
12:35
99
L2: MND spectrum: MRI features
F. Agosta (Milan, IT)
12:55
Discussion
13:00
100
L3: Therapy: state of the art and unmet needs
O. Hardiman (Dublin, IE)
13:20
Discussion and concluding remarks
SSIF Opening
G. Comi (Milan, IT)
Patho-physyological updates on amyotrophic
lateral sclerosis
A.C. Ludolph (Ulm, DE)
Sunday, 9 June 2013
12:00 – 13:30
Room D
From neurological anomalies to diagnosis of
treatable conditions: lessons from Niemann-Pick
disease Type C
Chairperson: A. Burlina (Bassano del Grappa, IT)
12:00
12:10
94Relevance
12:25
95
A clinical
12:40
96
From
12:55
97
Treating
13:10
Question and answer session
All
13:25
Summary and conclusions
A. Burlina (Bassano del Grappa, IT)
A. Burlina (Bassano del Grappa, IT)
of neurological manifestations in
differential diagnosis of ataxias
M. Mancuso (Pisa, IT)
approach to differential diagnosis of
central ocular motor disorders
M. Strupp (Munich, DE)
developmental delay to adult cognitive
impairment: differential diagnosis
S. Nia (Vienna, AT)
neurological progression:
disease-specific treatment for NP-C
F. Sedel (Paris, FR)
Satellite Symposium organised by 12:30 – 13:30
Room E
EAYNT Session
Emerging clinical and career prospects for
junior neurologists
Chairpersons:A. Macerollo (Bari, IT)
X. Kobeleva (Hannover, DE)
12:30
101
12:50
102Neurogenetics
13:10
103Superspecialization
Career tips – what I would do if I were you
– an indispensable proficiency for
junior neurologists
M.J. Molnar (Budapest, HU)
in neurology – to be or not to
be for Gen Y
E.T. Varga (Szeged, HU)
33
Sunday, 9 June 2013
13:45 – 17:15
Room B
Teaching Course 13
Tourette‘s syndrome and related disorders
Chairpersons:M. Vidailhet (Paris, FR)
D. Martino (London, UK)
13:45
104
14:30
105OCD
15:15
15:45
106
Pathophysiology
16:30
107
Tourette's syndrome and related disorders
M. Vidailhet (Paris, FR)
and ADHD in relation to tic disorders and
tourette syndrome
M. Robertson (London, UK)
Coffee break
of Gilles de la Tourette
syndrome
Y. Worbe (Paris, FR)
Management of Tourette syndrome
D. Martino (London, UK)
15:45 – 17:15
Room D
Joint ENS-SEN Symposium
Role of antibodies in Multiple Sclerosis
Chairpersons:O. Fernández (Malaga, ES)
15:45
116
Anti-NMO antibodies: clinical value and caveats
J. Palace (Oxford, UK)
16:05
117
Antibodies in the pathogenesis of MS
O. Fernández (Malaga, ES)
16:25
118
Anti_B cell therapy in MS
J. Sastre-Garriga (Barcelona, ES)
16:45
119Antibodies
17:05
Discussion
34
in the risk stratification and
management of MS
Sunday, 9 June 2013
17:30 – 19:00
Plenary Hall
Supporting patient engagement for optimized
treatment management in MS
Chairpersons: D. Bates (Newcastle upon Tyne, UK)
Patient advocate:N. Blanc (Geneva, CH)
17:30
Introduction
17:35
108
17:50
Discussion: Patient perceptions of treatment
goals and success
led by chairpersons and N. Blanc (Geneva, CH)
17:55
109
Understanding
18:10
Discussion: Patient perspectives of the
physician-patient conversation
18:15
110Engaging
18:30
111
The
18:45
Discussion: Patient perspectives on barriers to
engagement with treatment
18:50
Defining goals at the start of treatment
M.S. Freedman (Ottawa, CA)
with patients to achieve treatment
goals
V. Devonshire (Vancouver, CA)
role of the specialist MS nurse in optimizing
treatment management
G. Tousignant (Montreal, CA)
Summary
D. Bates (Newcastle upon Tyne, UK)
our patients: the importance of
effective communication
D. Langdon (London, UK)
17:30 – 19:00
Room C
Sunday, 9 June 2013
Targeting the glutamate AMPA receptor – A novel
approach in clinical practice
Chairperson: H. Cock (London, UK)
112The
glutamate AMPA receptor as a target for
treating neurological diseases
113The
glutamate AMPA receptor: A new target in
epilepsy
R. Rocamora (Barcelona, ES)
114Perampanel:
Clinical evidence in epilepsy
M. Holtkamp (Berlin, DE)
07:30 – 09:00
Room F
Practical Session 1
Conventional needle electromyography
120
Conventional needle electromyography
Supported by 09:00 – 11:00
Plenary Hall
Symposium
Advances in stroke prevention and treatment
Chairpersons:G. Stoll (Würzburg, DE)
M. Brainin (Krems, AT)
09:00
121Thrombolysis
09:30
122Novel
10:00
123Handling
10:30
124Mechanisms
09:00 – 11:00
Room A
Symposium
Parkinson and Parkinsonism
Chairpersons:K. Bhatia (London, UK)
09:00
125
Diagnosing
09:30
126Parkinson
10:00
127
10:30
128Newly
and endovascular recanalisation in
acute stroke
G. Schroth (Berne, CH)
anticoagulants in stroke prevention in
patients with atrial fibrillation
H.-C. Diener (Essen, DE)
of symptomatic extracranial and
intracranial artery stenosis
M.M. Brown (London, UK)
and treatment of brain oedema
formation
G. Stoll (Würzburg, DE)
Parkinson’s disease – is it always
easy?
E. Tolosa (Barcelona, ES)
plus syndromes: advances in
diagnostics and management
G. Wenning (Innsbruck, AT)
The patient with advanced Parkinson’s disease
recognised atypical parkinsonian
conditions – beyond MSA, PSP, CBD
37
09:30 – 11:00
Room E
Workshop 6
How to deal with ICU acquired weakness
Chairperson: Z. Argov (Jerusalem, IL)
129
Clinical approach to the ICU weakness
Z. Argov (Jerusalem, IL)
130Electrophysiological
evaluation of the weak ICU
patient
M.R. Magistris (Geneva, CH)
ENS Subcommittee Peripheral Neuropathy
(Chair: C. Sommer (Würzburg, DE))
09:30 – 11:00
Room F
Workshop 7
Complex regional pain syndrome
Chairperson: F. Birklein (Mainz, DE)
131Complex
regional pain syndrome – facts instead
of mystification
F. Birklein (Mainz, DE)
132
Changing views on an intriguing syndrome
J.J. van Hilten (Leiden, NL)
ENS Subcommittee Pain
(Chair: P. Schestatsky (Porto Alegre, BR))
Time matters: early and enduring treatment
options in MS
Chairperson: X. Montalban (Barcelona, ES)
11:45 – 13:15
Plenary Hall
133MS
pathology: inflammation and
neurodegeneration
134Treatment
decisions debate: early vs. late
switching
B. Kieseier (Düsseldorf, DE); G. Giovannoni (London, UK)
Moderator: X. Montalban (Barcelona, ES)
134a
Panel discussion: when to switch treatment
T. Vollmer (Colorado, US); all faculty
Moderator: X. Montalban (Barcelona, ES)
Concluding remarks
12:15 – 13:15
Room F
Special Session ENS-EAYNT
Translational neurology – a challenge for
clinician-scientists
Chairpersons:J. Sellner (Salzburg, AT / Munich, DE)
G. Stoll (Würzburg, DE)
12:15
143Coma
12:35
144Vertigo
M. Dieterich (Munich, DE)
12:55
145Neuroimaging
13:30 – 17:00
Room D
Teaching Course 14
Practical movement disorders
Chairpersons:E. Ruzicka (Prague, CZ)
D. Grabli (Paris, FR)
13:30
146Phenomenology
14:15
147
Falls in the elderly
V. Weerdesteyn (Nijmegen, NL)
15:00
Coffee break
15:30
148Rehabilitation
16:15
149What
and differential diagnosis of gait
disorders
E. Ruzicka (Prague, CZ)
of gait disorders in Parkinson‘s
disease
C. Schlick (Munich, DE)
can we learn from animal models of gait
disorders?
D. Grabli (Paris, FR)
39
13:30 – 17:00
Room E
Teaching Course 15
Brain endothelium as therapeutic target in
neurological disorders
Chairpersons:P. Annunziata (Siena, IT)
N. Gutowski (Exeter, UK)
13:30
150Established
14:15
151Role
15:00
15:30
152
Haematopoietic
16:15
153
and emerging features of brain
vessel inflammation
P. Annunziata (Siena, IT)
of cerebral endothelium in demyelinating
nervous disorders
N. Gutowski (Exeter, UK)
Coffee break
and endothelial growth factors
in neurodegenerative disorders
A. Schneider (Heidelberg, DE)
Contrasting angiogenesis in brain tumours
R. Soffietti (Turin, IT)
ENS Subcommittee Basic/Preclinical Neuroscience
(Chair: P. Annunziata (Siena, IT))
17:15 – 18:45
Room F
Practical Session 2
Single fibre electromyography
154
Single fibre electromyography
S. Nandedkar (New York, US)
Supported by 40
17:30 – 19:00
Room A
Current challenges of MS therapy: accepted
17:30
17:35
159New
18:00
160Balance
18:25
161Improving
18:50
aspiration in MS outcomes:
challenge accepted
T. Ziemssen (Dresden, DE)
the efficacy and safety of the treatment:
challenge accepted
P. Vermersch (Lille, FR)
the adherence to therapy:
challenge accepted
B. Kieseier (Düsseldorf, DE)
Questions and Panel discussion
07:30 – 09:00
Room F
Practical Session 3
167
Supported by Symposium
Personalised treatment in Multiple Sclerosis
Chairperson: G. Comi (Milan, IT)
09:00 – 11:00
Plenary Hall
09:00
168Efficacy
G. Comi (Milan, IT)
09:30
169Safety
10:00
170
Towards
10:30
171
09:00 – 11:00
Room A
Symposium
Recent advances in Alzheimer and other dementias
Chairperson: J.D. Rohrer (London, UK)
09:00
172
Recent
09:30
173
The
10:00
174
Recent
10:30
175
42
personalized medicine in Multiple
Sclerosis
Shared decision-making and patient-centred care
A. Solari (Milan, IT)
advances in Alzheimer‘s disease and
other dementias
J.D. Rohrer (London, UK)
biomarker signature of preclinical
Alzheimer's disease
J.L. Molinuevo (Barcelona, ES)
advances in Alzheimer and other
dementias: treatment perspectives
Is aging without dementia just a dream?
L. Fratiglioni (Stockholm, SE)
09:30 – 11:00
Room E
Workshop 8
Muscle biopsy and molecular diagnosis
Chairperson: C. Angelini (Venice/Padua, IT)
176Advances
in morphological and molecular
diagnosis
M. Sinnreich (Basel, CH)
177
Diagnostic and genetic protein studies
C. Angelini (Venice/Padua, IT)
ENS Subcommittee Muscle and Neuromuscular
Junction Disorders (Chair: C. Angelini (Venice/Padua, IT))
09:30 – 11:00
Room F
Workshop 9
Diagnostic procedures in CNS infections
Chairperson: E. Schmutzhard (Innsbruck, AT)
178Molecular
diagnostic techniques: PCR & co in CNS
infections
E. Schmutzhard (Innsbruck, AT)
techniques in infections and
autoimmune CNS inflammation
P. Demaerel (Leuven, BE)
179Neuroimaging
ENS Subcommittee Infectious Disorders
(Chair: E. Schmutzhard (Innsbruck, AT))
25 Years of Partnership: working towards a better
furture for patients with MS
11:45 – 13:15
Room A
184
25 Years of Partnership: the early years
B. Arnason (Chicago, US)
185
25 Years of Partnerships: current focus
B. Singer (St. Louis, US)
186Towards
a better future for patients with MS:
European Initiatives
C. Thalheim (Brussels, BE)
18725
Years of Partnerships: Continuous efforts to
improve MS patient support
T. Ziemssen (Dresden, DE)
11:45 – 13:15
Room F
Practical Session 4
Reflexes and long latency responses
192
Reflexes and long latency responses
J. Valls-Solé, E. Papathanasiou (Barcelona, ES;
Nicosia, CY)
Supported by 13:30 – 17:00
Plenary Hall
Teaching Course 16
Dementia: tools for early diagnosis and
progression monitoring
Chairpersons:A. Verdelho (Lisbon, PT)
13:30
193
Vascular risk factors and dementia
A. Verdelho (Lisbon, PT)
14:15
194
Dementia: clinical assessment and treatment
G. Waldemar (Copenhagen, DK)
15:00
Coffee break
15:30
195
Imaging as a tool for early diagnosis in dementia
16:15
196
Genetics: why, who and when?
D. Galimberti (Milan, IT)
ENS Subcommittee Behavioural and Cognitive
Neurology & Dementia (Chair: D. Galimberti (Milan, IT))
44
13:30 – 17:00
Room A
Teaching Course 17
Measuring heterogeneity in Multiple Sclerosis:
the MRI perspective
J. Geurts (Amsterdam, NL)
13:30
197Lesions
14:15
198
Normal-appearing white matter
15:00
Coffee break
15:30
199
Gray matter
J. Geurts (Amsterdam, NL)
16:15
200Imaging
the spinal cord in Multiple Sclerosis and
clinical correlations
O. Ciccarelli (London, UK)
13:30 – 17:00
Room B
Teaching Course 18
Challenges in neurodegenerative diseases:
ALS and FTD
Chairpersons:V. Silani (Milan, IT)
J. Hardy (London, UK)
13:30
201
Genetic merging of ALS/FTD
J. Hardy (London, UK)
14:15
202
New targets for interventions in ALS/FTD
W. Robberecht (Leuven, BE)
15:00
Coffee break
15:30
203The
16:15
204The
MAGNIMS.
emerging profile of neuropsychological
dysfunction in ALS
M. Strong (London, CA)
neuroradiological extramotor involvement
in ALS
ENS Subcommittee Motor Neuron Disease
(Chair: V. Silani (Milan, IT))
45
13:30 – 17:00
Room C
Teaching Course 19
Epilepsy, diagnostic advances
Chairpersons:P. Boon (Ghent, BE)
M. Carreño (Barcelona, ES)
13:30
205New
14:15
206
Advances
15:00
Coffee break
15:30
207
Epilepsy and imaging
M.P. Richardson (London, UK)
16:15
208
Epilepsy and genetic screening
S. Weckhuysen (Heeze, NL)
classification of epileptic seizures and
syndromes
P. Boon (Ghent, BE)
in electrophysiological diagnosis of
epilepsy
ENS Subcommittee Epilepsy (Chair: P. Boon (Ghent, BE))
13:30 – 17:00
Room D
Teaching Course 20
Emerging infections of the nervous system
Chairpersons:E. Schmutzhard (Innsbruck, AT)
M. Grobusch (Amsterdam, NL)
13:30
209
Emerging
14:15
210Neurological
15:00
15:30
211Multidrug-resistant
16:15
212Immune
arthropod-borne CNS infections in
Europe
E. Schmutzhard (Innsbruck, AT)
complications of EHEC and other
emerging food-borne pathogens
J. Sellner (Salzburg, AT / Munich, DE)
Coffee break
mycobacterioses – also an
issue for neurologists?
M. Grobusch (Amsterdam, NL)
reconstitution inflammatory syndrome
(IRIS) – a new disease entity in the area of HAART
B. Pfausler (Innsbruck, AT)
ENS Subcommittee Infectious Disorders
(Chair: E. Schmutzhard (Innsbruck, AT))
46
13:30 – 17:00
Room E
Teaching Course 21
Hot spots in neuro-oncology
Chairpersons:F. Graus (Barcelona, ES)
13:30
213Pitfalls
14:15
214Is
15:00
15:30
215Damage
16:15
216Antibodies
in the diagnosis and follow-up of brain
tumours: usefulness of modern neuroimaging for
the clinician
personalized treatment already feasible for
patients with malignant gliomas?
A. Idbaih (Paris, FR)
Coffee break
to CNS and PNS from old and new
antineoplastic agents
J. Reijneveld (Amsterdam, NL)
against neuronal surface antigens in
paraneoplastic neurological syndromes
F. Graus (Barcelona, ES)
13:30 – 17:00
Room F
Teaching Course 22
Genetics of pain
Chairpersons:P. Schestatsky (Porto Alegre, BR)
13:30
217
14:15
218Mutations
15:00
15:30
219A
16:15
220
Pain
ENS Subcommittee Neuro-oncology
(Chair: R. Soffietti (Turin, IT))
Nociceptive and neuropathic pain phenotypes
P. Schestatsky (Porto Alegre, BR)
in sodium-channel gene and genetic
pain disorders
G. Lauria (Milan, IT)
Coffee break
clinical approach to pain
A. Carson (Edinburgh, UK)
in Fabry disease: a genetically determined
and under diagnosed pain syndrome
ENS Subcommittee Pain
(Chair: P. Schestatsky (Porto Alegre, BR))
47
Oral Sessions Overview
Sunday, 9 June 2013
13:45 – 15:15
Room C
Room D
Room E
Room F
Oral Sessions 1 – 4
• Session 1 – Neurogenetics
• Session 2 – Multiple Sclerosis I
• Session 3 – Neurophysiology
• Session 4 – Pain and headache
15:45 – 17:15
Room C
Plenary Hall
Room E
Room F
• Session 5 – Infection and inflammation
• Session 6 – Motor neuron disease
• Session 7 – Neuro-oncology and miscellaneous
• Session 8 – General neurology I
09:30 – 11:00
Room B
Room C
Room D
• Session 9 – Epilepsy I
• Session 10 – Neuroimaging
• Session 11 – Paediatric neurology
13:30 – 15:00
Plenary Hall
Room A
Room B
Room C
Room F
• Session 12 – Cerebrovascular disorders I
• Session 13 – Multiple Sclerosis II
• Session 14 – Dementia I
• Session 15 – Muscle disorders
• Session 16 – Sleep disorders
15:30 – 17:00
Plenary Hall
Room A
Room B
Room C
Room F
09:30 – 11:00
Room B
Room C
Room D
48
Session 17 – Cerebrovascular disorders II
• Session 18 – Multiple Sclerosis III
• Session 19 – Dementia II
• Session 20 – Peripheral neuropathies
• Session 21 – Neurorehabilitation
•
• Session 22 – Epilepsy II
• Session 23 – Extrapyramidal disorders
• Session 24 – Cerebrovascular disorders III
Oral Sessions
Sunday, 9 June 2013
Oral Session 1
Neurogenetics
Chairpersons:D. Pareyson (Milan, IT)
H. Houlden (London, UK)
13:45 – 15:15
Room C
O221
PLA2G6 gene mutations cause evolving
spinocerebellar ataxia influenced by the
genotype
M. Salih, E. Mundwiller, A. Khan, A. Al Drees,
S. Elmalik, H. Hassan, M. Al-Owain, H. Alkhalidi,
I. Katona, M. Kabiraj, R. Chrast, A. Kentab,
H. Alzaidan, R. Rodenburg, T. Bosley, J. Weis,
M. Koenig, G. Stevanin, H. Azzedine (Riyadh, SA;
Paris, FR; Aachen, DE; Lausanne, CH; Nijmegen, NL;
Strasbourg, FR)
14:00
O222
Clinical and genetic features of dysferlinopathies
in Saudi Arabia
M. Al Yahya, E. Cupler, D. Monies, Y. Al Sayed,
I. Alhomoud, H. Al Hindi, M. Dababo, O. Wazan,
M. AlMuhaizea, S. Wakil, B. Meyer, S. Bohlega
(Riyadh, SA)
14:15
O223
High risk of severe cardiac adverse events
in patients with mitochondrial m.3243A>G
mutation
E. Malfatti, K. Wahbi, P. Laforet, A. Bèhin, T. Stojkovic,
B. Eymard, A. Lombes, N. Berber, C. Jardel, D. Duboc
(Paris, FR)
14:30
O224
Metabolic brain abnormalities in subjects with
X-linked adrenoleukodystrophy as detected by
[18F]-FDG-PET
E. Salsano, G. Marotta, V. Manfredi, A. Giovagnoli,
L. Farina, D. Pareyson, R. Benti, G. Uziel (Milan, IT)
14:45
O225
Novel trientine dihydrochloride encapsulated
alginate/chitosan nanoparticles for brain copper
chelation therapy in a rat model of copper
toxicosis
A. Pal, R. Badyal, R. Vasishta, R. Prasad (Chandigarh, IN)
15:00
O226
Clinical criteria of Huntington´s disease
phenocopies in adults and their uncommon
causes in Czech Republic
J. Roth, P. Havranková, J. Židovská, O. Klempírová,
J. Klempír (Prague, CZ)
Oral Sessions
13:45
49
Oral Sessions
Sunday, 9 June 2013
Oral Session 2
Multiple Sclerosis I: therapeutics
Chairpersons:X. Montalban (Barcelona, ES)
L. Kappos (Basel, CH)
13:45 – 15:15
Room D
13:45
O227
Clinical efficacy and safety of peginterferon beta1a in relapsing multiple sclerosis: data from the
pivotal phase 3 ADVANCE study
B. Kieseier, D.L. Arnold, L. Balcer, A. Boyko, J. Pelletier,
A. Deykin, S. Hung, A. Seddighzadeh, S. Liu, Y. Zhu,
B. Sperling, P. Calabresi (Düsseldorf, DE; Montreal,
CA; Philadelphia, US; Moscow, RU; Marseille, FR;
Cambridge, Baltimore, US)
14:00
O228
Use of JC virus antibody index to stratify risk
of progressive multifocal leukoencephalopathy
in natalizumab-treated patients with multiple
sclerosis
T. Plavina, M. Subramanyam, G. Bloomgren, S. Richman,
A. Pace, S. Lee, B. Schlain, D. Campagnolo, B. Ticho
(Weston, US)
14:15
O229
An integrated analysis of the clinical and
neuroradiological effect of BG-12 (dimethyl
fumarate) in subgroups of patients with
relapsing-remitting multiple sclerosis from the
phase 3 DEFINE and CONFIRM studies
A. Bar-Or, R.J. Fox, R. Gold, D.H. Miller, D.L. Arnold,
J. O’Gorman, M. Yang, S.I. Sheikh, V. Viglietta,
K.T. Dawson, M. Hutchinson (Montreal, CA;
Cleveland, US; Bochum, DE; London, UK; Weston, US;
Dublin, IE)
14:30
O230
Alemtuzumab improves disability by month
6 independent of relapse history in relapsingremitting multiple sclerosis patients: CARE-MS II
O. Fernández, D.L. Arnold, J.A. Cohen, A.J. Coles,
C. Confavreux, E.J. Fox, H.-P. Hartung, E. Havrdova,
K. Selmaj, H. Weiner, C.L. Twyman, T. Miller, S.L. Lake,
D.H. Margolin, M.A. Panzara, D.A.S. Compston for
the CARE-MS II Investigators
14:45
O231
Catastrophic multiple sclerosis rebound after
natalizumab treatment discontinuation
C. Tur, M. Tintoré, Á. Vidal-Jordana, J. Rio, A.C. Wing,
B. Canneti, M. Torres, M.J. Arevalo, J. Castillo, I. Galan,
R. Horno, M.J. Vicente, M.I. Martin, M. Comabella,
À. Rovira, J. Sastre-Garriga, X. Montalban (Barcelona, ES)
50
Oral Sessions
Oral Session 2
Multiple Sclerosis I: therapeutics (cont.)
13:45 – 15:15
Room D
15:00
Sunday, 9 June 2013
O232
Prognostic factors for long-term outcomes in
relapsing-remitting multiple sclerosis: exploratory
analysis of 15-year data from the PRISMS study
L. Kappos, B. Uitdehaag, J. Kuhle, D. Issard, F. CassetSemanaz (Basel, CH; Amsterdam, NL; Geneva, CH)
Oral Session 3
Neurophysiology
Chairpersons:J. Valls-Solé (Barcelona, ES)
13:45 – 15:15
Room E
O233
The prognostic value of electroencephalographic
asymmetries for the development of pharmacoresistance in medication-naïve patients with
idiopathic generalized epilepsies
I. Karakis, J. Pathmanathan, R. Chang, E.F. Cook,
S.S. Cash, A.J. Cole (Atlanta, Boston, US)
14:00
O234
Evoked potentials predict disease-modifying
treatment response in multiple sclerosis
L. Leocani, M. Bianco, G. Di Maggio, S. Medaglini,
J. Gonzalez-Rosa, R. Chieffo, U. Del Carro, L. Moiola,
V. Martinelli, G. Comi (Milan, IT)
14:15
O235
Rapid eye-movements triggered during head
impulses differentiate peripheral and central
patients with spontaneous nystagmus
L. Luis, J. Costa, E. Muñoz, E. Schneider, N. Lehnen,
M. Carvalho, J. Valls-Solé (Lisbon, PT; Barcelona, ES;
Munich, DE)
14:30
O236
Downbeat nystagmus: evidence for a
disinhibition of utricular otolith pathways by
ocular vestibular evoked myogenic potentials
T Bremova, S. Glasauer, M. Strupp (Munich, DE)
14:45
O237
Gait disturbances in patients with unilateral
vestibulopathy
C. Pradhan, M. Wühr, K. Jahn, R. Schniepp (Munich, DE)
15:00
O238
Clinical and neurophysiological effect of
repetitive deep transcranial magnetic stimulation
(rDTMS) with H-Coil in Parkinson’s disease
F. Spagnolo, M. Fichera, E. Houdayer, R. Chieffo,
D. Dalla Libera, L. Straffi, E. Coppi, A. Nuara, L. Ferrari,
G. Di Maggio, M. Bianco, S. Velikova, A. Zangen,
G. Comi, M.A. Volonté, L. Leocani (Milan, IT; Negev, IL)
Oral Sessions
13:45
51
Oral Sessions
Sunday, 9 June 2013
Oral Session 4
Pain and headache
Chairpersons:C. Sommer (Würzburg, DE)
S. Kuhn Natriashvili (Vienna, AT)
13:45 – 15:15
Room F
13:45
O239
Small fibre pathology in patients with
fibromyalgia syndrome
N. Üçeyler, A.-K. Kahn, S. Kewenig, D. Zeller,
S. Kittel-Schneider, A. Schmid, J. Casanova-Molla,
K. Reiners, C. Sommer (Würzburg, DE)
14:00
O240
Habituation and temporal summation of pain
perception to tonic thermal stimuli in healthy
subjects and in patients with central neuropathic
pain following spinal cord injury
S. Albu, E. Bravo Esteban, J. Gómez-Soriano,
G. Avila-Martín, I. Galán Arriero, C. Simón-Martínez,
J. Taylor (Toledo, ES)
14:15
O241
Is grey matter atrophy a biomarker of migraine?
A study in paediatric patients with migraine
M.A. Rocca, R. Messina, B. Colombo, E. Scola,
A. Falini, G. Comi, M. Filippi (Milan, IT)
14:30
O242
Juvenile migraine and the role of the autonomic
nervous system: a clinical study
G. Giordano, C. Spitaleri, D. Buffa, F. Consolo,
M. D’amelio, V. Raieli, G. Santangelo, F. Vanadia
(Palermo, IT)
14:45
O243
Personality traits in cluster headache: study in
22 patients and comparison with a population of
migraineurs
I. Muñoz, M.I. Pedraza, E. Domínguez, S. Herrero,
A.J. Valle, G. Isidro, M. Hernández, E.M. Sotelo,
P. Mulero, A.L. Guerrero, M.L. Cuadrado, F. Uribe
(Valladolid, Madrid, ES)
15:00
O244
Mirror therapy as a phantom limb pain treatment
for upper-extremity amputees
B.N. Perry, L.K. Hussey-Andersen, K.E. Hughes,
S.R. Weeks, V.C. Merritt, P.F. Pasquina, J.W. Tsao
(Bethesda, Falls Church, US)
52
Oral Sessions
Sunday, 9 June 2013
15:45
O245
The clinical spectrum of neurosyphilis today
I.M. Daey Ouwens, A.T.L. Fiolet, A. Ott, P.J. Koehler,
W.M.A. Verhoeven (Venray, Utrecht, Groningen,
Heerlen, NL)
16:00
O246
Neuropsychiatric manifestations in
systemic lupus erythematous and primary
antiphospholipid syndrome
R. Fonseca Samões, C. Ferrão, R. Faria, E. Santos,
C. Vasconcelos, A. Martins Silva (Porto, PT)
16:15
O247
Characterization of a cohort of 28 patients with
neuro-Behçet’s disease in a single centre in the
north of Portugal
J. Domingos, C. Ferrão, J. Ramalho, A.M. Silva,
C. Vasconcelos, E. Santos, J. Correia (Porto, PT)
16:30
O248
Pathogenic mechanisms of glycine receptor
antibodies and their clinical spectrum
A. Carvajal, M. Leite, L. Clover, M. Woodhall,
P. Waters, A. Vincent (Oxford, UK)
16:45
O249
Encephalitis and GABAB receptor antibodies:
novel findings in a new case series of 20 patients
R. Höftberger, L. Sabater, M. Kruer, S. Boyero,
A. de Felipe, A. Saiz, F. Graus, J. Dalmau (Barcelona,
ES; Sioux Falls, US; Barakaldo, Madrid, ES)
17:00
O250
Susac syndrome: a case series
I. Moreira, R. Loureiro, R. Samões, J.E. Alves,
A. Martins Silva, E. Santos (Porto, PT)
Oral Session 6
Chairpersons:V. Silani (Milan, IT)
15:45 – 17:15
Plenary Hall
15:45
O251
Resting state functional connectivity alterations
of the sensorimotor and extra-motor networks in
primary lateral sclerosis
E. Canu, F. Agosta, A. Inuggi, N. Riva, A. Chiò,
S. Messina, S. Iannaccone, A. Calvo, V. Silani, A. Falini,
G. Comi, M. Filippi (Milan, Turin, IT)
53
Oral Sessions
Oral Session 5
Infection and inflammation
Chairpersons:K.V. Toyka (Würzburg, DE)
J. Sellner (Salzburg, AT / Munich, DE)
15:45 – 17:15
Room C
Oral Sessions
Sunday, 9 June 2013
Oral Session 6
Motor neuron disease (cont.)
15:45 – 17:15
Plenary Hall
16:00
O252
Treatment of amyotrophic lateral sclerosis (ALS)
with autologous differentiated mesenchymal
stem cells: preliminary results of a phase I/II
clinical trial in 12 patients
D. Karussis, P. Petrou, D. Offen, Y. Gothelf, Y. Levy,
Z. Argov, M. Gotkine, A. Vaknin-Dembinsky, I. Kassis,
T. Ben Hur, E. Melamed (Jerusalem, Tel Aviv, Petah
Tikva, IL)
16:15
O253
Molecular mechanism generating TDP-43
pathology in amyotrophic lateral sclerosis (ALS)
motor neurones
S. Kwak, T. Yamashita, T. Hideyama, S. Teramoto
(Tokyo, JP)
16:30
O254
Search for novel biomarkers for ALS
P. Mahadeva Iyer, E. Lalor, R. Reilly, O. Hardiman
(Dublin, IE)
16:45
O255
Perceptions of quality of life in motor neurone
disease: views of patients and patient family
support group. Qualitative results from the
Trajectories of Outcome in Neurological
Conditions study
H. Ando, R. Cousins, C. Young on behalf of the
Trajectories of Outcome in Neurological Conditions
Study Group
17:00
O256
Motor unit number estimation as an outcome
measure in amyotrophic lateral sclerosis (ALS)
S. Jagtap, A. Kuruvilla, P. Govind, M. Nair, C. Sarada
(Trivandrum, IN)
Oral Session 7
Neuro-oncology and miscellaneous
Chairpersons:F. Graus (Barcelona, ES)
15:45 – 17:15
Room E
15:45
O257
Brain metastases in patients diagnosed with
a solid primary cancer during childhood:
experience from a single referral cancer centre
D. Suki, R. Khoury-Abdallah, M. Ding, S. Khatua,
R. Sawaya (Houston, US)
16:00
O258
Elevated prevalence of cancer in patients with
myasthaenia gravis
A. Pellise, X. Ustrell, V. Pascual, J. Casanova, M. Barcala,
A. Mañé, O. Pardina, J. Viñas, R. Marés (Tarragona, ES)
54
Oral Sessions
Sunday, 9 June 2013
Oral Session 7
Neuro-oncology and miscellaneous (cont.)
15:45 – 17:15
Room E
16:15
O259
IDH1 mutation in chondrosarcoma and glioma of
a patient with Ollier disease
B. Theeler, A. Ragunathan, K.D. Aldape,
I. Tremont-Lukats (Houston, US)
16:30
O260
Tosedostat and posterior reversible
encephalopathy syndrome (PRES)
J. Mandel, I. Tremont-Lukats, S. Tummala (Houston, US)
16:45
O261
Telemedicine: are tele-EEG, tele-electrophysiology
and telecytology possible. A feasibility study
E. Craemer, U. Craemer, E. Idris, F. Ahmad,
N. Durani, D. Bassa, B. Jacobi, C. Menon, S. Mohs,
C. Papendieck, M. Kress (Frankfurt, DE)
17:00
O262
Professionals’ opinions on the physical factors
affecting quality of life in multiple sclerosis
and motor neurone disease: pilot work from
the Trajectories of Outcomes in Neurological
Conditions study
B. O’Sullivan, N. Rose, J. Griffiths, C.A. Young on
behalf of the Trajectories of Outcome in Neurological
Conditions (TONiC) Study Group
Oral Sessions
Oral Session 8
General neurology I: neuro-otology and
neuro-ophthalmology
Chairpersons:M. Dieterich (Munich, DE)
C. Oreja-Guevara (Madrid, ES)
15:45 – 17:15
Room F
15:45
O263
Insights into antibody-associated encephalitis:
Bickerstaff’s 1950’s papers revisited
A. Merwick, J. Dalmau, N. Delanty (Dublin, IE;
Barcelona, ES)
16:00
O264
Vestibular perception following acute unilateral
vestibular lesions
S. Cousins, D. Kaski, N. Cutfield, B. Seemungal,
J.F. Golding, M. Gresty, S. Glasauer, A.M. Bronstein
(London, UK; Dunedin, NZ; Munich, DE)
16:15
O265
The role of motion sickness susceptibility in
vestibular disorders and migraine
L. Murdin, F. Chamberlain, S. Cheema, Q. Arshad,
M. Gresty, J.F. Golding, A.M. Bronstein (London, UK)
55
Oral Sessions
Sunday, 9 June 2013
Oral Session 8
General neurology I: neuro-otology and
neuro-ophthalmology (cont.)
15:45 – 17:15
Room F
16:30
O266
A preliminary study identifying the psychological
variables associated with phobic postural vertigo
and physiological
F. Smith, S. Mossman, A. Burston, K. Cunningham
(Wellington, NZ)
16:45
O267
Resistance to eye opening in patients with
disorders of consciousness: reflex or voluntary?
H.J. van Ommen, O. Gosseries, M.-A. Bruno,
A. Vanhaudenhuyse, A. Thibaut, V. Charland-Verville,
L. Heine, S. Laureys (Liège, BE)
17:00
O268
White matter changes and migraine in elderly
subjects. Results of the LADIS study
A. Verdelho, S. Madureira, C. Moleiro, J.M. Ferro,
F. Fazekas, F. Barkhof, P. Scheltens, R. Schmidt,
A. Poggesi, D. Inzitari, L. Pantoni on behalf of the
LADIS study group
56
Oral Sessions
Oral Session 9
Epilepsy I
Chairpersons:H. Cock (London, UK)
O269
ENS
fellowship
awardee
Impact of interictal epileptiform discharges on
occipital lobe cortical function: an EEG-fMRI
study
J. Rémi, F. Sales, C. Duarte, G. Cunha, S. Noachtar,
M. Castelo-Branco (Munich, DE; Coimbra, PT)
09:45
O270
Online automated hippocampal segmentation in
patients with epilepsy
G.P. Winston, M.J. Cardoso, E.J. Williams, J.L. Burdett,
P.A. Bartlett, M. Espak, C. Behr, J.S. Duncan,
S. Ourselin (London, UK; Strasbourg, FR)
10:00
O271
Effect of sleep and sleep deprivation on EEG
changes in patients with epilepsy
M. Markov, P. Kolev (Sofia, BG)
10:15
O272
Slow and fast inactivation of hNav1.3 voltagegated sodium channels by eslicarbazepine,
oxcarbazepine and carbamazepine
S. Heibesen, P. Soares-da-Silva (Witterswil, CH; Trofa, PT)
10:30
O273
Slow spindle cortical generators overlap with the
epileptogenic zone in temporal epilepsy patients:
an electrical source imaging study
A. Del Felice, C. Arcaro, S.F. Storti, A. Fiaschi,
P. Manganotti (Verona, Venice, IT)
10:45
O274
Improved diagnosis of temporal lobe epilepsy by
EEG interval analysis
J. Pyrzowski, A. Ossowska, M. Sieminski, W.M. Nyka
(Gdansk, PL)
Oral Session 10
Neuroimaging
09:30 – 11:00
Room C
09:30
O275
Effective connectivity in cortical networks
underlying visual motion processing and ocularmotor control
P. zu Eulenburg, T. Bauermann, S.B. Eickhoff (Mainz,
Düsseldorf, DE)
57
Oral Sessions
09:30 – 11:00
Room B
09:30
Oral Sessions
Oral Session 10
Neuroimaging (cont.)
09:30 – 11:00
Room C
09:45
O276
High resolution magnetization transfer imaging
to study the specific contribution of white matter
and grey matter to disability in multiple sclerosis
A. Papadopoulou, M. Amann, M. Andelova, N. MüllerLenke, Y. Naegelin, C. Stippich, E.W. Radue, O. Bieri,
L. Kappos, T. Sprenger (Basel, CH)
10:00
O277
Abnormalities of the brain connectome in
patients with multiple sclerosis
M. Filippi, P. Valsasina, S. Sala, A. Meani, A. Falini,
G. Comi, M.A. Rocca (Milan, IT)
10:15
O278
Prevalence of small cerebral bleeds in patients
with progressive supranuclear palsy: a
neuropathological study with 7.0-Tesla magnetic
resonance imaging correlates
J. De Reuck, D. Caparros-Lefebvre, V. Deramecourt,
L. Defebvre, F. Auger, N. Durieux, R. Bordet,
F. Pasquier, C.-A. Maurage (Lille, Wattrelos, FR)
10:30
O279
Effects of ageing and gender on brain intrinsic
functional connectivity: a resting state study in a
large cohort of healthy subjects
M.A. Rocca, P. Valsasina, P. Misci, A. Falini, G. Comi,
10:45
O280
Structural correlates of abnormalities of cervical
cord functional MRI activity in patients with
multiple sclerosis
M.A. Rocca, P. Valsasina, M. Copetti, D. Caputo,
M. Absinta, M. Filippi (Milan, San Giovanni Rotondo, IT)
Oral Session 11
Paediatric neurology
Chairpersons:D. Pohl (Ottawa, CA)
B. Plecko (Zurich, CH)
09:30 – 11:00
Room D
09:30
58
O281
Functional connectivity among resting state
networks increases after constraint-induced
movement therapy in children with brain injury
M.A. Rocca, S. Strazzer, A.C. Turconi, P. Valsasina,
M. Absinta, E. Beretta, M. Cazzagon, A. Falini, M. Filippi
(Milan, Bosisio Parini, Pasian di Prato, IT)
Oral Sessions
09:45
O282
White matter microstructure abnormalities in
paediatric migraine patients: in vivo measures of
brain hyperexcitability?
M.A. Rocca, R. Messina, B. Colombo, E. Pagani,
A. Falini, G. Comi, M. Filippi (Milan, IT)
10:00
O283
A virtual reality study of episodic memory in
5- to 14-year-old children presenting temporosylvian cysts
M. Abram, M.-L. Cuny, H. Piana, E. Esnault, B. Navarro,
C. Trousson, S. Puget, M. Zerah, F. Di Rocco,
T. Blauwblomme, T. Roujeau, M. Bourgeois, C. SainteRose, P. Piolino (Boulogne Billancourt, Paris, FR)
10:15
O284
The effectiveness and tolerability of adjunctive
treatment of lidocaine in children with refractory
status epilepticus
S.H. Kwon, H.E. Seo, S.K. Hwang (Daegu, KR)
10:30
O285
TRADESMA index: a proposal for a specific index
for quantifying gait alteration in children with
hereditary spastic paraplegia
D. Gómez-Andrés, I. Pulido-Valdeolivas,
A. Cinza-González, I. Rodríguez, J.A. Martín-Gonzalo,
J. López-López, S.I. Pascual-Pascual, E. Rausell (Madrid,
S.S. de los Reyes, ES)
10:45
O286
Abnormal neuronal migration with ischaemic
brain injuries may cause cognitive dysfunction in
extremely preterm infants
K. Deguchi, K. Kubo, D. Armstrong, K. Nakajima,
K. Inoue (Nagasaki, Tokyo, JP; Houston, US)
Oral Session 12
Cerebrovascular disorders I
Chairpersons:F. Fazekas (Graz, AT)
A. Chamorro (Barcelona, ES)
13:30 – 15:00
Plenary Hall
13:30
O287
ENS
fellowship
awardee
Acute ischaemic stroke: targeting arterial
occlusion and revascularization for individualized
treatment decisions
P. Vanacker, M. Faouzi, D. Lambrou, M. Heldner,
A. Eskandari, A. Slezak, A. Broeg-Morvay, G. Ntaios,
P. Maeder, R. Meuli, R. Sztajzel, V. Mendes Pereira,
U. Fischer, M. Arnold, P. Michel (Lausanne, Geneva,
Berne, CH; Larissa, GR; Bruges, BE)
59
Oral Sessions
Oral Session 11
Paediatric neurology (cont.)
09:30 – 11:00
Room D
Oral Sessions
Oral Session 12
Cerebrovascular disorders I (cont.)
13:30 – 15:00
Plenary Hall
13:45
O288
Why is atrial fibrillation associated with greater
mortality and disability after acute ischaemic stroke?
E.R. McGrath, M.K. Kapral, J. Fang, J.W. Eikelboom,
A. O Conghaile, M. Canavan, M.J. O Donnell on behalf
of the Ontario Stroke Registry
14:00
O289
Atrial fibrillation in young stroke patients: do we
underestimate its prevalence?
D. Prefasi, P. Martínez-Sánchez, A. Rodríguez-Sanz,
B. Fuentes, D. Filgueiras-Rama, E. Díez-Tejedor (Madrid, ES)
14:15
O290
Predictors of outcome after endovascular stroke
treatment for anterior circulation large vessel
occlusion in patients aged 80 years and older
W. Kurre, M. Aguilar-Pérez, L. Niehaus, E. Schmid,
H. Bäzner, H. Henkes (Stuttgart, Winnenden, DE)
14:30
O291
New twist to an old turn: hyperintense vessels
(proximal and distal) on early FLAIR MRI brain
scans help predict final infarct volume at 24
hours and outcome at three months in acute
ischaemic stroke with proximal vessel occlusions
S. Adatia, V. Nambiar, S. Sangll, M. Almekhlafi,
B. Menon, A. Demchuk (Calgary, CA; Korea, KP)
14:45
O292
Clinical outcomes of neurointerventional
emergency treatment of extra-/intracranial
tandem occlusions in acute major stroke
A. Mpotsaris, M. Bussmeyer, H. Buchner, W. Weber
(Recklinghausen, DE)
Oral Session 13
Multiple Sclerosis II: pathology and pathogenesis
Chairpersons:G. Comi (Milan, IT)
O. Ciccarelli (London, UK)
13:30 – 15:00
Room A
13:30
O293
ENS
fellowship
awardee
13:45
60
O294
Characterization of individual IgM oligoclonal
band antibodies from the cerebrospinal fluid
(CSF) of multiple sclerosis patients to identify
their antigens
E. Beltrán, B. Obermeier, F. Coret, M. Simó-Castelló,
F.C. Pérez-Miralles, R. Hohlfeld, B. Casanova,
K. Dornmair (Munich, DE; Valencia, ES)
Aquaporin-1 autoantibodies in patients with
neuromyelitis optica spectrum disorders
J.S. Tzartos, C. Stergiou, K. Kilidireas, P. Zisimopoulou,
T. Thomaidis, S. Tzartos (Athens, GR)
Oral Sessions
Oral Session 13
Multiple Sclerosis II: pathology and pathogenesis
(cont.)
13:30 – 15:00
Room A
14:00
O295
Construction of an antibody phage display
library from B-cells infiltrating brain tissue of
people with progressive multiple sclerosis
C. Maggiore, G. Giovannoni, J. Martin, A. Nissim
(London, UK)
14:15
O296
Semaphorin 7A and its receptor expression in
multiple sclerosis lesions
E. Martínez-Sáez, C. Costa, A. Gutiérrez,
A. Ortega-Aznar, S. Ramón y Cajal, X. Montalban,
C. Espejo (Barcelona, ES)
14:30
O297
Cerebrospinal fluid (CSF) transferrin levels are
reduced in patients with early multiple sclerosis
M. Khalil, B. Riedlbauer, C. Langkammer, C. Enzinger,
S. Ropele, T. Stojakovic, H. Scharnagl, V. Culea,
A. Petzold, J.J. Archelos, S. Fuchs, F. Fazekas (Graz, AT;
Amsterdam, NL)
14:45
O298
Gene therapy for hypomyelinating leukodystrophy
A. Kagiava, I. Sargiannidou, S. Bashardes, J. Richter,
C. Christodoulou, A. Gritti, K.A. Kleopa (Nicosia, CY;
Milan, IT)
13:30
O299
ENS
fellowship
awardee
13:45
O300
Oral Sessions
Oral Session 14
Dementia I
Chairpersons:E. Scarpini (Milan, IT)
A. Verdelho (Lisbon, PT)
13:30 – 15:00
Room B
Association between APOE genotype
and cerebral amyloid angiopathy (CAA)related vasculopathic changes: collaborative
metaanalysis
K. Rannikmäe, R.N. Kalaria, S.M. Greenberg,
H.C. Chui, F.A. Schmitt, C.L.M. Sudlow (Edinburgh,
Newcastle, UK; Boston, Los Angeles, Lexington, US)
The relationship between microglial microvesicles
and MRI metrics in probable Alzheimer’s disease
patients
F. Agosta, D. Dalla Libera, E.G. Spinelli, E. Canu,
G. Magnani, A. Bergami, A. Falini, G. Comi, R. Furlan,
61
Oral Sessions
Oral Session 14
Dementia I (cont.)
13:30 – 15:00
Room B
14:00
O301
Dementia paralytica and HIV infection
I.M. Daey Ouwens, A. Ott, P.J. Koehler, F.D.H. Koedijk,
C.C. Van den Wijngaard, M.A.B. van der Sande,
W.M.A. Verhoeven (Venray, Groningen, Heerlen,
Bilthoven, NL)
14:15
O302
Spatial orientation deficits in mild cognitive
impairment correlate with hippocampal
dysfunction
A. Zwergal, F. Schöberl, G. Kugler, S. Kohlbecher,
C. Fuchs, J. Engler, G. Xiong, T. Brandt, M. Dieterich,
M. Dichgans, K. Bürger, E. Schneider, C. la Fougere,
K. Jahn (Munich, DE)
14:30
O303
Predictors of cognitive decline and dementia in
individuals with subjective cognitive impairment:
a longitudinal study
V. Kirkova, L. Traykov (Sofia, BG)
14:45
O304
Early onset Alzheimer’s disease
A. Altinkaya, N. Behrem, N. Karagöz Sakalli,
P.N. Sütlas, D. Kirbas, B. Topcular (Istanbul, TR)
Oral Session 15
Muscle disorders
I. Illa (Barcelona, ES)
13:30 – 15:00
Room C
13:30
O305
ENS
fellowship
awardee
13:45
62
O306
Clinical, morphological and molecular study
of a large cohort of patients with congenital
myopathies
I. Colombo, M Scoto, L. Maggi, A. Manzur, S. Robb,
T. Cullup, R. Phadke, C. Sewry, H. Jungbluth,
F. Muntoni (Milan, IT; London, UK)
Slow progression of muscle impairment and
spliceopathy despite worsening of muscle
histopathology in myotonic dystrophy type 2
(DM2)
G. Meola, E. Bugiardini, L.V. Renna, A. Botta, G. Rossi,
C. Pizzamiglio, R. Cardani (San Donato Milanese,
Rome, IT)
Oral Sessions
Oral Session 15
Muscle disorders (cont.)
13:30 – 15:00
Room C
14:00
O307
New ETFDH mutations in a group of Italian
patients of riboflavin-responsive multiple acyl-CoA
dehydrogenase deficiency (RR-MADD) patients
O. Musumeci, E. Barca, C. Rodolico, S. Romeo,
A. Ciranni, M. Aguennouz, G. Vita, A. Toscano
(Messina, IT)
14:15
O308
Falls, fractures and vitamin D in myotonic
dystrophies
E. Bugiardini, E. Passeri, V. Sansone, R. Valaperta,
E. Costa, B. Ambrosi, S. Corbetta, G. Meola
(San Donato Milanese, IT)
14:30
O309
Prognostic factors and health-related quality of
life in ocular myasthaenia gravis (OMG)
G. Galassi, A. Ariatti, M. Stefani, P. Miceli, M. Tondelli,
F. Benuzzi, P. Faglioni (Modena, IT)
14:45
O310
Extrathymic malignancies in defined cohorts of
patients with myasthaenia gravis
I. Basta, S. Peric, V. Rakocevic Stojanovic, Z. Stevic,
A. Nikolic, I. Marjanovic, Z. Turkmanovic, S. Lavrnic,
D. Lavrnic (Belgrade, RS)
13:30
O311
White matter integrity in obstructive sleep apnea
(OSA) patients before and after continuous
positive airway pressure (CPAP) treatment
L. Ferini-Strambi, V. Castronovo, S. Cappa,
A. Castellano, M. Aloia, S. Marelli, P. Scifo, A. Falini
(Milan, IT)
13:45
O312
Sleep-disordered patients with restless legs
syndrome have higher values of nocturnal blood
pressure
M. SIeminski, M. Partinen (Gdansk, PL; Helsinki, FI)
14:00
O313
Rapid eye movement sleep behaviour disorder in
the prodromal phase of Lewy body disorders: a
prospective study
A. Iranzo, E. Tolosa, E. Gelpi, J.L. Molinuevo,
F. Valldeoriola, M. Serradell, R. Sanchez-Valle,
I. Vilaseca, F. Lomeña, D. Vilas, A. Llado, J. Santamaria
(Barcelona, ES)
63
Oral Sessions
Oral Session 16
Sleep disorders
Chairpersons:P. Maquet (Liège, BE)
J. Santamaria (Barcelona, ES)
13:30 – 15:00
Room F
Oral Sessions
Oral Session 16
Sleep disorders (cont.)
13:30 – 15:00
Room F
14:15
O314
Sustained efficacy of continuous positive airway
pressure therapy for migraine in sleep apnea
syndrome
H. Hidalgo, V. Uhl, L. Nelles, A.R. Gantenbein,
N. Dahmen, P. Sándor, U. Kallweit (Asbach, DE;
Bad Zurzach, CH; Katzenelnbogen, DE; Zurich, CH)
14:30
O315
Sleep disorders in myotonic dystrophy type 2:
a controlled polysomnographic study and selfreported questionnaires
M. Albanese, A. Romigi, F. Placidi, F. Izzi, C. Liguori,
B. DiGioia, C. Terracciano, N.B. Mercuri, R. Massa,
M.G. Marciani (Rome, IT)
14:45
O316
Modafinil for the treatment of idiopathic
hypersomnia: results of a randomized, doubleblind, placebo controlled study
G. Mayer, H. Benes, P. Young, M. Bitterlich,
A. Rodenbeck (Schwalmstadt-Treysa, Schwerin,
Münster, Berlin, DE)
Oral Session 17
Cerebrovascular disorders II
Chairpersons:M. Brainin (Krems, AT)
J.M. Ferro (Lisbon, PT)
15:30 – 17:00
Plenary Hall
15:30
O317
ENS
fellowship
awardee
Impact of AMD3100 on microglia activation
and recovery of lost neurological function after
experimental stroke
H.L. Walter, A. Madinier, T. Wieloch, K. Ruscher (Lund, SE)
15:45
O318
Polymorphisms on chromosome 4q25 and the
risk of stroke due to paroxysmal atrial fibrillation
in a Polish population
M. Wnuk, J. Burkot, A. Slowik (Krakow, PL)
16:00
O319
No association between severe thrombophilia
and cerebral venous thrombosis severity
D. Aguiar de Sousa, J.M. Ferro, P. Canhão,
F. Barinagarrementeria, M.-G. Bousser, J. Stam on
behalf of the International Study on Cerebral Vein and
Dural Sinus Thrombosis investigators
16:15
O320
Qualititative or quantitative flair changes on
MRI brain in acute ischaemic strokes with major
proximal occlusions does not predict intracranial
haemorrhage
S. Adatia, V. Nambiar, M. Almekhlafi, J. Sangll,
B. Menon, A. Demchuk (Calgary, CA)
64
Oral Sessions
Oral Session 17
Cerebrovascular disorders II (cont.)
15:30 – 17:00
Plenary Hall
16:30
O321
Spontaneous intracerebral haemorrhage: is
neuroimage monitoring useful?
M.A. Mangas-Guijarro, O. Trabajos-Garcia,
P. Martinez-Sanchez, A. Tallon-Barranco,
E. Blanco-Vicente, A. Martin-Montes, B. Fuentes,
E. Diez-Tejedor (Madrid, ES)
16:45
O322
Poor glycaemic control increases risk for new
early diffusion-weighted imaging lesions outside
the initially affected vascular territory in acute
stroke patients
T. Usnich, F.N. Albach, T.B. Braemswig, P. Brunecker,
J.B. Fiebach, C.H. Nolte (Berlin, DE)
Oral Session 18
Multiple Sclerosis III: other
Chairpersons:I. Milonas (Athens, GR)
15:30 – 17:00
Room A
O323
Abnormalities of the brain functional
connectome in paediatric patients with multiple
sclerosis
M. Filippi, P. Valsasina, M. Absinta, S. Sala,
V. Martinelli, A. Ghezzi, P. Veggiotti, A. Falini, G. Comi,
M.A. Rocca (Milan, Gallarate, Pavia, IT)
15:45
O324
R2* as a potential MRI measure for
demyelination in MS lesions
C. Langkammer, M. Khalil, C. Enzinger, D. Pinter,
S. Fuchs, S. Ropele, F. Fazekas (Graz, AT)
16:00
O325
Correlation of brain volume loss with multiple
sclerosis duration, MRI activity and disability:
impact of fingolimod across 3 phase III trials
F. Barkhof, J. Cohen, E.W. Radue, L. Kappos,
P. Calabresi, D. Haering, N. Sfikas, P. Von Rosenstiel,
G. Francis (Amsterdam, NL; Cleveland, US; Basel, CH;
Baltimore, US; East Hanover, US)
16:15
O326
Efficacy and safety of daclizumab high-yield
process (DAC HYP) treatment in relapsingremitting multiple sclerosis: results from the
SELECTION extension study
G. Giovannoni, R. Gold, K. Selmaj, E. Havrdova,
X. Montalban, E.-W. Radue, D. Stefoski, M. McNeill,
J. Rana, J. Elkins, G. O’Neill (London, UK; Bochum,
DE; Lodz, PL; Prague, CZ; Barcelona, ES; Basel, CH;
Chicago, US; Maidenhead, UK; Cambridge, US)
Oral Sessions
15:30
65
Oral Sessions
Oral Session 18
Multiple Sclerosis III: other (cont.)
15:30 – 17:00
Room A
16:30
O327
Effect of BG-12 (dimethyl fumarate) in newly
diagnosed patients with relapsing-remitting multiple
sclerosis from the DEFINE and CONFIRM studies
R. Gold, G. Giovannoni, J.T. Phillips, R.J. Fox, A. Zhang,
L. Meltzer, N.C. Kurukulasuriya (Bochum, DE; London,
UK; Dallas, Cleveland, Weston, US)
16:45
O328
The "Sapere Migliora" information aid for
newly-diagnosed multiple sclerosis patients:
developing and testing phases following the
MRC framework
A. Giordano, A. Lugaresi, V. Martinelli, F. Granella,
P. Confalonieri, M. Trojano, M. Messmer Uccelli,
C. Borreani, A. Solari on behalf of the SIMS project
Oral Session 19
Dementia II
Chairpersons:F. Agosta (Milan, IT)
G. Waldemar (Copenhagen, DK)
15:30 – 17:00
Room B
15:30
O329
Frontotemporal Lobar Degeneration due to the
C9ORF72 hexanucleotide repeat expansion:
psychotic clinical presentation
D. Galimberti, C. Fenoglio, M. Serpente, C. Villa, R. Bonsi,
A. Arighi, G. Fumagalli, R. Del Bo, A.C. Bruni, M. Anfossi,
A. Clodomiro, C. Cupidi, B. Nacmis, S. Sorbi, I. Piaceri,
S. Bagnoli, V. Bessi, A. Marcone, C. Cerami, S.F. Cappa,
M. Filippi, F. Agosta, G. Magnani, G. Comi, M. Franceschi,
I. Rainero, M.T. Giordana, E. Rubino, P. Ferrero,
E. Rogaeva, Z. Xi, A. Confaloni, P. Piscopo, G. Bruno,
G. Talarico, A. Cagnin, F. Clerici, B. Dell’Osso, G.P. Comi,
A.C. Altamura, C. Mariani, E. Scarpini (Milan, Lamezia
Terme, Florence, Turin, IT; Toronto, CA; Rome, Padua, IT)
15:45
O330
Phenotypic variability of familial and sporadic
progranulin p.Gln257ProfsX27 mutation
C. Pires, M. Coelho, A. Valadas, C. Barroso,
G. Miltenberger-Miltenyi, J. Pimentel, C. Duyckaerts,
A. de Mendonça, A. Verdelho (Ponta Delgada, Lisbon,
Setúbal, Vila Franca de Xira, PT; Paris, FR)
16:00
O331
Neuroanatomical correlates of disease
progression in a case of nonfluent/agrammatic
variant of primary progressive aphasia due to
progranulin (GRN) Cys157LysfsX97 mutation
F. Caso, F. Agosta, S. Galantucci, G. Magnani,
D. Galimberti, E. Pagani, G. Comi, A. Falini, M. Filippi
(Milan, IT)
66
Oral Sessions
Oral Session 19
Dementia II (cont.)
15:30 – 17:00
Room B
16:15
O332
Network analysis of intrinsic functional
connectivity in the semantic variant of primary
progressive aphasia
M. Filippi, F. Agosta, S. Galantucci, S. Sala, P. Valsasina,
A. Meani, S.F. Cappa, G. Magnani, M. Franceschi,
A. Falini, G. Comi (Milan, Castellanza, IT)
16:30
O333
The relationship between theory of mind and
executive function in Parkinson’s disease
G. Cummins, L. Collins, S. Mason, R. Barker
(Cambridge, UK)
16:45
O334
Should neuronal antibody determination
be performed in patients with suspected
Creutzfeldt-Jakob disease?
O. Grau, R. Sánchez-Valle, A. Saiz, J.L. Molinuevo,
J. Dalmau, F. Graus (Barcelona, ES)
15:30
O335
Skin sympathetic fibre alpha-synuclein deposits:
a potential biomarker for pure autonomic failure
V. Donadio, A. Incensi, P. Cortelli, M.P. Giannoccaro,
M. Abdel Jaber, A. Baruzzi, R. Liguori (Bologna, IT)
15:45
O336
Impaired small fibre function in patients with
Fabry disease
G. Siedler, A.-K. Kahn, D. Zeller, C. Sommer, N. Üçeyler
(Würzburg, DE)
16:00
O337
Vestibular and auditory function in patients with
Charcot-Marie-Tooth disease due to mutations in
the SH3TC2 gene
R. Sivera, H. Perez-Garrigues, L. Bataller, N. Muelas,
J.F. Vazquez, J.J. Vilchez, C. Espinos, T. Sevilla (Valencia, ES)
16:15
O338
Autoantibody heterogeneity in chronic
inflammatory demyelinating polyneuropathy
G. Nogales-Gadea, L. Querol, X. Suárez-Calvet,
J. Araque, M. Navas, E. Ortiz, J. Díaz-Manera,
E. Gallardo, R. Rojas-García, I. Illa (Barcelona, ES)
16:30
O339
West Nile virus infection and myasthaenia gravis
A.A. Leis, G. Szatmary, M. Ross, D. Stokic (Jackson,
Hattiesburg, Scottsdale, US)
67
Oral Sessions
Oral Session 20
Peripheral neuropathies
Chairpersons:G. Stoll (Würzburg, DE)
A. Steck (Basel, CH)
15:30 – 17:00
Room C
Oral Sessions
Oral Session 20
Peripheral neuropathies (cont.)
15:30 – 17:00
Room C
16:45
O340
Recurrence plot analysis of heart rate variability:
a novel method for detection of diabetic
cardiovascular neuropathy
T. Nedelka, J. Schlenker, L. Riedlbauchová, R. Mazanec
(Prague, CZ)
Oral Session 21
Neurorehabilitation
Chairpersons:G. Ickenstein (Aue, DE)
15:30 – 17:00
Room F
15:30
O341
Perceptual relearning of binocular fusion and
stereoacuity after brain injury: a follow-up study.
A.-K. Schaadt, L. Schmidt, M. Adams,
R. Garbacenkaite, E. Leonhardt, C. Kuhn, S. Reinhart,
G. Kerkhoff (Saarbrücken, DE)
15:45
O342
Measuring the changes induced by botulinum
toxin on wrist movement in spastic patients with
a standardized stretch reflex test
M. Fernández-Lobera, M. Morales, J. Valls-Solé
(Barcelona, ES)
16:00
O343
Motor imagery brain-computer interface trained
with healthy controls and used for stroke
patients
A. Espinosa, R. Ortner, G. Edlinger, C. Guger (Graz, AT)
16:15
O344
Development of a modified prism adaptation
procedure for clinical use
A.S. Champod, K. Taylor, L. Bogatz, G.A. Eskes
(Halifax, CA)
16:30
O345
Now you feel both: galvanic vestibular
stimulation induces lasting improvements in the
rehabilitation of chronic tactile extinction
L. Schmidt, K.S. Utz, L. Depper, M. Adams,
A.-K. Schaadt, S. Reinhart, G. Kerkhoff (Saarbrücken,
Erlangen, DE)
16:45
O346
Modifications of functional connectivity of the
anterior cingulum correlate with medium-term
effects of cognitive rehabilitation in patients
with multiple sclerosis
L. Parisi, M.A. Rocca, M. Copetti, P. Valsasina,
F. Mattioli, R. Capra, G. Comi, M. Filippi (Milan,
San Giovanni Rotondo, Brescia, IT)
68
Oral Sessions
Oral Session 22
Epilepsy II
Chairpersons:P. Boon (Ghent, BE)
M. Richardson (London, UK)
O347
ENS
fellowship
awardee
Motor system hyperexcitability constitutes a
possible endophenotype in juvenile myoclonic
epilepsy
B. Wandschneider, M. Centeno, C. Vollmar,
M. Symms, P. Thompson, J.S. Duncan, M.J. Koepp
(London, UK)
09:45
O348
Dynamic expression pattern of two proinflammatory cytokines and two inflammationrelated microRNAs in mesial temporal lobe
epilepsy development in the developing brain
A. Omran, M.U. Ashhab, J. Peng, F. Yin (Changsha, CN)
10:00
O349
Clinical outcome after repetitive seizures and
status epilepticus: prospective analysis of
patients
K. Rejdak, M. Godek, A. Czajka-Belz, M. Chlebicka,
Z. Stelmasiak (Lublin, PL)
10:15
O350
Efficacy and tolerability of ketogenic diet in adults
and adolescents with uncontrolled epilepsy
J. Nathan, D. Khedekar (Mumbai, IN)
10:30
O351
Prediction of outcome of initial treatment
with lamotrigine in adult patients with newly
diagnosed localization-related epilepsies
S. Lukic, N. Jovic, Z. Milosevic, B. Bjelakovic, M. Spasic
(Nis, Belgrade, RS)
10:45
O352
A comparative study of psychiatric comorbidities
in patients with mesial temporal lobe epilepsy
and juvenile myoclonic epilepsy and effects on
quality of life
D.H. Ertem, A. Dirican, A. Aydin, S. Baybas,
V. Sozmen, M. Ozturk (Istanbul, TR)
69
Oral Sessions
09:30 – 11:00
Room B
09:30
Oral Sessions
Oral Session 23
Extrapyramidal disorders
Chairpersons:E. Tolosa (Barcelona, ES)
09:30 – 11:00
Room C
09:30
O353
Quantitative and qualitative long-term mortality
analysis in Parkinson’s disease treated with deep
brain stimulation
S. Rocha, J. Gomes, A. Monteiro, P. Linhares,
C. Chamadoira, M. Ayres Basto, C. Reis, C. Sousa,
J. Lima, M.J. Rosas, J. Massano, R. Vaz (Braga, Porto, PT)
09:45
O354
Functional connectivity in patients with focal
dystonia
F. Agosta, L. Sarro, A. Tomic, A. Inuggi, M. Svetel,
N. Kresojevic, V.S. Kostic, M. Filippi (Milan, IT;
Belgrade, RS)
10:00
O355
Reduced cardiovascular risk factors and
cardiovascular events in idiopathic Parkinson`s
disease patients compared with controls
J. Rabey, G. Abbruzzese, T. Prokhorov, U. Bonuccelli
(Tzrifin, IL; Genoa, IT; Pisa, IT)
10:15
O356
Acquired hepatocerebral degeneration:
characterization of a cohort of 17 patients
J. Domingos, F. Correia, S. Cavaco, A. Almeida,
J. Damásio, H.P. Miranda, M. Magalhães (Porto, PT)
10:30
O357
Dystonia type and duration as a prognostic
indicator in patients with progressive
supranuclear palsy
D. Apetauerova, S. Scala, M. Alias (Burlington, US)
10:45
O358
Ocular tremor in Parkinson’s disease is due to
head oscillation
D. Kaski, T.A. Saifee, A.M. Bronstein (London, UK)
70
Oral Sessions
09:30
O359
Validation of a comfort scale in a population of
patients with stroke
C. Rogeau, F. Beaucamp, E. Allart, W. Daveluy,
M. Rousseaux (Lille, FR)
09:45
O360
Hyperdense middle cerebral artery sign and
stroke etiology
L. Pereira, M. Rodrigues (Almada, PT)
10:00
O361
Inpatient management of stroke: barriers to
optimal outcome
R. Patel, R. Hughes (Basildon, UK)
10:15
O362
Are we aware of the importance of high doses of
statins? Compliance three months after ischaemic
stroke
E. Blanco-Vicente, P. Martínez-Sánchez, B. Fuentes,
M. Mangas-Guijarro, O. Trabajos García,
Á. Martín-Montes, E. Díez-Tejedor (Madrid, ES)
10:30
O363
Clinical features of progressing pontine infarction
T. Nakase, M. Sasaki, Y. Ikeda, A. Suzuki (Akita, JP)
10:45
O364
The characteristics of the ipsilateral silent
period to ipsilesional focal transcranial magnetic
stimulation in acute stroke
S. Rudilosso, M. Morales, A. Cervera, S. Amaro,
X. Urra, V. Obach, A. Chamorro, J. Valls-Solé
(Barcelona, ES)
71
Oral Sessions
Oral Session 24
Cerebrovascular disorders III
Chairpersons:A.C. Fonseca (Lisbon, PT)
M. Dichgans (Munich, DE)
09:30 – 11:00
Room D
Poster Sessions – Overview
Posters are displayed in the exhibition area at the following times:
10:00 – 16:00
11:30 – 12:30
10:00 – 13:00
11:30 – 12:30
Sunday, 9 June 2013
Poster Session 1
• Multiple Sclerosis: clinical aspects I
• Cerebrovascular disorders: risk factors
• Sleep disorders
•Neurorehabilitation
•Neuroimaging
• Neuro-ophthalmology and balance
• Inflammatory and myasthenia
• Preclinical neurobiology
Poster Session 2
• Multiple Sclerosis: clinical aspects II
•Cerebrovascular disorders: semiology and
case reports
• Extrapyramidal disorders: Parkinson's disease
• Epilepsy I
• Clinical neurophysiology I: peripheral nerve
• Migraine and pain
• Dementia I: treatment and biomarker
•Neuro-oncology
Poster Session 3
• Multiple Sclerosis: clinical aspects III
• Cerebrovascular disorders: treatment
• Extrapyramidal disorders: other
• Epilepsy II: investigations and therapeutics
• Clinical neurophysiology II
• Headaches: other
• Dementia and higher function disorders
•Neurogenetics
14:30 – 18:30
17:30 – 18:30
72
Poster Sessions – Overview
10:00 – 13:30
11:30 – 12:30
Poster Session 4
• Multiple Sclerosis: pathology and pathogenesis
•Infection
• Muscle disorders
• General neurology: miscellaneous
• Motor neuron disease
• Child neurology
•Neuro-epidemiology
Posters
Please refer to the section "Instructions for authors" on p. 154 when
you have to put your poster up and take it down.
73
Poster Session 1
Sunday, 9 June 2013
11:30 – 12:30
Multiple Sclerosis: clinical aspects I
Poster Walk commences at Poster No. P365 at 11:30
Moderator:K. Fink (Stockholm, SE)
P365
Natalizumab treatment for multiple sclerosis: Middle East
and North Africa regional recommendations for patient
selection and monitoring
R. Alroughani, H. Aref, S. Bohlega, I. Al Sherooqi, M. Dahdaleh,
I. Feki, M. Jumah, M. Al-Kawi, S. Koussa, M. Sahraian, B. Yamout
(Kuwait, KW; Cairo, EG; Riyadh, SA; Manama, BH; Amman, JO;
Sfax, TN; Beirut, LB; Tehran, IR)
P366
Natalizumab is effective in patients with active relapsingremitting multiple sclerosis: a Middle Eastern experience
R. Alroughani, J. Al Hashel, S. Ahmed, A. Thussu (Kuwait, KW)
P367
Natalizumab saturation: potential biomarker for individual
duration of treatment holiday after natalizumab withdrawal
P. Wipfler, A. Harrer, G. Pilz, K. Oppermann, S. Afazel,
E. Haschke-Becher, E. Trinka, J. Kraus (Salzburg, AT)
P368
Clinical and instrumental predictors of efficacy of
natalizumab therapy in the course of multiple sclerosis:
a retrospective study from a single centre
V. Lo Re, G. Salemi, P. Ragonese, M. Lo Re, M.A. Mazzola,
S. Realmuto, G. Savettieri (Palermo, IT)
P369
A prospective, open-label, single-arm clinical trial of the effects
of natalizumab on measures of ambulation in relapsingremitting multiple sclerosis patients: the TIMER study
N. Voloshyna, T. Nechrych, X. You, S. Belachew, D. Paes (Kharkiv,
Lviv, UA; Weston, US)
P370
Clinical management of high-risk patients with relapsingremitting multiple sclerosis (MS) treated with natalizumab
K.H. Vo, L. Stazzone, N. Drago, H. Nguyen, G. Buckle (Boston,
Brookline, US)
P371
Follow-up of multiple sclerosis (MS) patients after
natalizumab interruption. Clinical and MRI findings.
Switching to treatment with fingolimod
M.E. Evangelopoulos, E. Andreadou, C. Deligianni, G. Saltogiannis,
I. Chasalevris, V. Chaina, C. Kilidireas (Athens, GR)
P372
Associations between baseline factors and on-treatment
relapses in natalizumab-treated patients with relapsingremitting multiple sclerosis in the TYSABRI® (natalizumab)
observational programme
H. Wiendl, H. Butzkueven, L. Kappos, F. Pellegrini, M. Trojano,
A. Zhang, S. Belachew (Münster, DE; Victoria, AU; Basel, CH;
Chieti, Bari, IT; Weston, US)
74
Sunday, 9 June 2013
P373
Successful desensitization in a patient with hypersensitivity
reaction to natalizumab: a case report
M. Bouktsi, A. Manikas, M. Zande, I. Milonas (Thessaloniki, GR)
P374
Association of improvement in fatigue with improvement in
depression and sleepiness in natalizumab-treated multiple
sclerosis (MS) patients: results from the TYNERGY study
I.-K. Penner, E.G. Celius, S. Fuchs, K. Schreiber, S. Berkö,
J. Sun, E. Falk, A. Svenningsson (Basel, CH; Oslo, NO; Graz, AT;
Copenhagen, DK; Upplands Väsby, SE; Weston, US; Umeå, SE)
P375
TYSTART: monitoring and management of MS patients
starting natalizumab treatment in Germany
B. Kallmann, R. Hoffmann, U. Walter, C. Wettmarshausen,
C. Wernsdoerfer, V. Zingler, A. Chan (Bamberg, Berlin, Fulda,
Ismaning, Bochum, DE)
P376
Observational programme Tysabri 24 plus: evaluating efficacy
and safety of natalizumab therapy beyond two years
M. Maeurer, H. Wiendl, C. Heesen, A. Gass, C. Wernsdoerfer,
C. Wettmarshausen, V. Zingler, B. Kieseier (Bad Mergentheim,
Münster, Hamburg, Mannheim, Ismaning, Düsseldorf, DE)
P377
Seroconversion rates to JC virus (JCV) in multiple sclerosis
patients is higher than previously reported
G. Izquierdo, M. Rus, M.D. Paramo, J.L. Peña, L. Dinca, S. Perez,
G. Navarro, M. Lucas (Seville, ES)
P378
Abnormally severe immune reconstitution inflammatory
syndrome (IRIS) in a multiple sclerosis (MS) patient
with natalizumab-associated progressive multifocal
leukoencephalopathy (PML)
A. Calvi, M. De Riz, A.M. Pietroboni, L. Ghezzi, A. Arighi,
G.G. Fumagalli, V. Maltese, G. Comi, D. Galimberti, E. Scarpini
(Milan, IT)
P379
Natalizumab-associated progressive multifocal
leukoencephalopathy in multiple sclerosis patients: survival
and functional outcome when asymptomatic at diagnosis
T. Dong-Si, S. Richman, G. Bloomgren, M. Wenten, J. Philip,
S. Datta, J. McIninch, C. Bozic, B. Ticho, N. Richert (Weston, US)
P380
Relationship between early disease activity and long-term
clinical outcome: results from the phase 3 TRANSFORMS
study extension at 4.5 years in relapsing-remitting multiple
sclerosis
H.-P. Hartung, F. Barkhof, G. Comi, L. Kappos, B. Khatri,
X. Montalban, J. Pelletier, E. Kornyeyeva, D. Piani Meier, S. Ritter,
P. von Rosenstiel, D. Tomic, J. Cohen (Düsseldorf, DE; Amsterdam,
NL; Milan, IT; Basel, CH; Milwaukee, US; Barcelona, ES; Marseille,
FR; East Hanover, US; Cleveland, US)
75
Posters
Poster Session 1
Poster Session 1
Sunday, 9 June 2013
P381
Patient adherence to subcutaneous interferon beta-1a
delivered via the electronic self-injection device RebiSmart:
an observational, retrospective study in the United Kingdom
and Ireland
L. Parkes, K. Marhardt, H. Willis, A.M. Larkin (Feltham, UK;
Geneva, CH; Chelmsford, UK; Dublin, IE)
P382
Adherence to, and effectiveness of, treatment with
subcutaneous interferon beta-1a in relapsing multiple
sclerosis patients using RebiSmart™ for self-injection:
one-year interim results of an international, prospective,
observational study
A. Bayas, J.-C. Ouallet, B. Kallmann, U. Fulda, K. Marhardt
(Augsburg, DE; Bordeaux, FR; Bamberg, Darmstadt, DE; Geneva, CH)
P383
Patient and nurse assessment of the ExtaviJect® 30G device
for subcutaneous self-injection of interferon beta-1b for
multiple sclerosis: a prospective European study
G. Boeru, I. Milanov, K. Kmetska, F. De Robertis, S. Rojas-Farreras,
A. Kulla, M. Tomlinson (Bucharest, RO; Sofia, BG; Lecce, IT; Barcelona,
ES; Basel, CH)
P384
Comparable efficacy of immunomodulatory treatment
of relapsing-remitting multiple sclerosis (RRMS) in daily
practice: the ASSET (AVONEX assessment in multiple sclerosis
therapy) study, an observational study in 1343 patients
M. Marziniak, K. Taipale, K. Rehberg-Weber, C. Wernsdörfer on
behalf of the ASSET study group
P385
Health-related quality of life over time of patients with
multiple sclerosis treated with interferon beta-1a: the
COMPARE study
B.G. Vickrey, L. Lee, F. Moore, K. Fortin (Los Angeles, US; Toronto,
CA; Montréal, US; Montréal, CA)
P386
Persistence, adherence, quality of life, and treatment
satisfaction in patients treated with the AVONEX® PEN™:
an interim analysis of PERSIST
B. Sperling, S. Slawka, C. Ghaus, X. You on behalf of the PERSIST
Study Group
P387
Safety, tolerability and patient evaluation of peginterferon
beta-1a administered via a single-use autoinjector in relapsing
multiple sclerosis: data from the Phase 3b ATTAIN sub-study
S. Hung, A. Deykin, A. Seddighzadeh, S. Liu, B. Sperling,
P. Calabresi (Cambridge, Baltimore, US)
76
Poster Session 1
Sunday, 9 June 2013
An integrated analysis of the clinical efficacy of BG-12
(dimethyl fumarate) in patients with relapsing-remitting
multiple sclerosis from the phase 3 DEFINE and CONFIRM
studies
R.J. Fox, D.H. Miller, J.T. Phillips, D.L. Arnold, K. Selmaj, M. Yang,
R. Zhang, K.T. Dawson, V. Viglietta, S.I. Sheikh, R. Gold (Cleveland,
US; London, UK; Dallas, US; Montreal, CA; Lodz, PL; Weston, US;
Bochum, DE)
P389
An integrated analysis of safety and tolerability of BG-12
(dimethyl fumarate) in patients with relapsing-remitting
multiple sclerosis from phase 2 and 3 placebo-controlled
studies
J.T. Phillips, R.J. Fox, R. Gold, E. Havrdova, L. Kappos,
K. Raghupathi, H. Yuan, V. Viglietta, S.I. Sheikh, K.T. Dawson,
M. Novas, M.T. Sweetser, K. Selmaj (Dallas, Cleveland, US;
Bochum, DE; Prague, CZ; Basel, CH; Weston, US; Lodz, PL)
P390
Immunomodulatory effects of a new CB2-selective
cannabinoid agonist on T-cells from multiple sclerosis patients
P. Annunziata, C. Cioni, L. De Santi, C. Mugnaini, S. Pasquini,
F. Corelli (Siena, IT)
P391
Improvement in quality of life outcomes with prolongedrelease fampridine treatment: six month interim analysis of
the ENABLE study
R. Macdonell, G. Nagels, P.S. Sorensen, D. Laplaud, C. Pozzilli,
B. de Jong, A.M. Silva, R. Nicholas, M. Niedhammer, J. Gaebler,
S. Agarwal, J. Potts (Heidelberg, AU; Melsbroek, BE; Copenhagen,
DK; Nantes, FR; Rome, IT; Nijmegen, NL; Porto, PT; London, UK;
Oldenburg, DE; Weston, US)
P392
Natalizumab rechallenge in multiple sclerosis patients:
postponing the unavoidable?
L. Ferrè, F. Sangalli, L. Moiola, M. Radaelli, V. Barcella,
M. Rodegher, B. Colombo, V. Martinelli, G. Comi (Milan, IT)
11:30 – 12:30 Cerebrovascular disorders: risk factors
Moderator:T. Brandt (Munich, DE)
P393
Median stroke volumes depend on the definition of
transient ischaemic attacks (TIA) used in a stroke cohort
A. Felbecker, F. Wagner, M. Galovic, J. Weber, B. Tettenborn
(St. Gallen, CH)
P394
Rasch analysis of the Stroke Impact Scale-16
R.J. Mills, M. Koufali, A. Sharma, C.A. Young (Preston, Liverpool, UK)
Posters
P388
77
Poster Session 1
Sunday, 9 June 2013
P395
3D dynamic modelling of primary mechanisms associated
with brain injuries
G. Machtoub (Leipzig, DE)
P396
Design of the Asian Stroke Disability Scale
K. Ghandehari (Mashhad, IR)
P397
Frequency of stroke recurrence after pregnancy
A. Cruz-Herranz, I. Illán-Gala, P. Martínez-Sánchez, B. Fuentes,
E. Díez-Tejedor (Madrid, ES)
P398
Clinical implications of peripheral artery disease (PAD)
diagnosed with ankle-brachial blood pressure index (ABI) in
acute ischaemic stroke patients
E. Imamura, E. Nomura, T. Ohshita, S. Kushitani, S. Wakabayashi,
H. Kajikawa, M. Matsumoto (Hiroshima, JP)
P399
Risk factors for short-term stroke recurrence in patients with
minor ischaemic cerebrovascular events
K. Ghandehari, M.R. Khajedaluei, Z. Yazdankhah, A. Sharifi Razavi,
S. Masoudinezhad, A. Nouraddin, A. Mousavi Mirzaei, S. Yazdani,
A. Ghabeli Jouybari (Mashhad, IR)
P400
Is stress an important risk factor for stroke?
K. Ghandehari, M.R. Khajedaluei, F. Behdani, M. Davari (Mashhad, IR)
P401
Relationship between carotid intima-media thickness and
arterial stiffness in young adults with carotid artery diseases
E. Vassileva, P. Ilieva, N. Spasova, E. Kinova, D. Somleva, T. Kurteva,
A. Gudev, M. Daskalov (Sofia, BG)
P402
Is carotid stenosis more frequent in stroke patients with
metabolic syndrome?
E. Terecoasa, V. Stefanescu, O. Rusu, C. Tiu (Bucharest, RO)
P403
Risk factor-related reduction in cerebral vasomotor reactivity
in patients with carotid disease
I.M. Krdžic, S.R. Djokovic (Belgrade, RS)
P404
Lipid profile as a risk factor in persons with specific
occupations
M. Tiric-Campara, S. Sijaric-Voloder, E. Tupkovic, J. Djelilovic-Vranic,
A. Alejbegovic (Sarajevo, Tuzla, BA)
P405
Relationships between low total serum cholesterol levels
and intracerebral haemorrhage
A. Gogu, D. Scutelnicu, A. Ignea (Timisoara, RO)
P406
What is the best scoring system for predicting the risk of
stroke in nonvalvular atrial fibrillation?
N. Diaconu, C. Gratii, A. Grosu, V. Racila, G. Pavlic (Chisinau, MD)
78
Sunday, 9 June 2013
P407
Left atrial diastolic dysfunction measured by transthoracic
echocardiography is a risk factor of developing acute
cerebral infarction
N. Mitsuma, T. Hirunagi, T. Ando, K. Kitamura, H. Sakurai,
T. Nakano, Y. Goto, K. Mano (Nagoya, JP)
P408
Heart failure, hypertension and carotid stenosis as factors in
poor outcome in ischaemic stroke
S.M. Deme, C.N. Hreniuc, D.S. Ioncu, D.C. Jianu, S. KoryCalomfirescu (Arad, Timisoara, Cluj-Napoca, RO)
P410
Patients with acute cerebral infarction and diabetes mellitus
versus patients with acute cerebral infarction without
diabetes mellitus
A. Nacu, L. Thomassen, A. Fromm, U. Waje-Andreassen, H. Naess
(Bergen, NO)
P411
Metabolic syndrome does not influence stroke subtype
C. Tiu, E.O. Terecoasa, O.A. Bajenaru (Bucharest, RO)
P412
The association between metabolic syndrome and
intracranial haemorrhagic stroke among adults aged 45-70
years in Isfahan, Iran
F. Dehghani, M. Saadatnia (Isfahan, IR)
P413
Role of extreme outdoor temperature in the development of
acute ischaemic stroke
A. Folyovich, D. Biczó, A. Fülöp, Á. Németh, H. Breuer, K.A. BéresMolnár, V. Varga, K. Vadasdi, N. Kaszás, J. Bartholy (Budapest, HU)
P414
Frequency of malignancy associated with ischaemic stroke:
yield of tumour markers
O. Trabajos-García, M.A. Mangas-Guijarro, P. Martínez-Sánchez,
A. Tallón-Barranco, M.J. Aguilar-Amat, E. Blanco-Vicente,
Á. Martín-Montes, B. Fuentes, E. Díez-Tejedor (Madrid, ES)
P415
Juxtaluminal echogenicity versus heterogeneity as measures
of carotid plaque instability
T.J. Tegos, A. Petrakis, A. Valavanis, A. Safouris, A. Papadimitriou,
A. Orologas (Thessaloniki, GR)
P416
Thrombophilia in young patients with cryptogenic ischaemic
stroke
J. Morgado, J. Rodrigues, A. Paiva Nunes, A. Amaral-Silva,
J. Alcântara (Lisbon, PT)
P417
An unusual complication of cerebral angiography
I. Ahmed, R. Michelson, N. Duggal, S. Khosla (Kansas City, US)
79
Posters
Poster Session 1
Poster Session 1
Sunday, 9 June 2013
11:30 – 12:30
Sleep disorders
Moderator:J. Santamaria (Barcelona, ES)
P418
Sleep-wake disturbances after traumatic brain injury in rats
D. Noain, E.-R. Symeonidou, S.R. Schreglmann, M. Morawska,
M. Penner, A. Hodor, C.R. Baumann (Zurich, Berne, CH)
P419
State space analysis of sleep after traumatic brain injury in
rats
E.-R. Symeonidou, L.L. Imbach, D. Noain, M. Penner, A. Hodor,
C.R. Baumann (Zurich, Berne, CH)
P420
Prospective long-term evaluation of sleep-wake disturbances
after traumatic brain injury
L.L. Imbach, P.O. Valko, T. Li, E. Werth, C.R. Baumann (Zurich, CH)
P421
Dynamic properties of sleep states in children and adults
L.L. Imbach, E. Werth, S. Kurth, M. LeBourgeois, R. Huber,
C.R. Baumann (Zurich, CH; Boulder, US)
P422
Actigraphic measures of subjective and objective sleepiness
in idiopathic Parkinson’s disease
Y.V. Gavrilov, E. Werth, S. Hauser, C.R. Baumann, P.O. Valko
(Zurich, CH)
P423
Excessive sleep need following traumatic brain injury: a case
control study
M. Sommerauer, P.O. Valko, E. Werth, C.R. Baumann (Zurich, CH)
P424
Cerebral haemodynamic changes at the onset of sleep and
at the transition into REM sleep assessed by near infrared
spectroscopy (NIRS)
K. Kaveh Moghadam, F. Pizza, M. Wolf, C.L. Bassetti (Bologna, IT;
Zurich, Berne, CH)
P425
Evolution of the clinical and polysomnographic picture of
childhood narcolepsy with cataplexy following disease onset
K. Kaveh Moghadam, F. Pizza, C. Franceschini, H. Peltola,
S. Vandi, E. Finotti, F. Ingravallo, L. Nobili, O. Bruni, Y. Dauvilliers,
L. Lin, M.J. Edwards, M. Partinen, E. Mignot, K. Bhatia, G. Plazzi
(Bologna, IT; Helsinki, FI; Milano, Rome, IT; Montpellier, FR; Palo
Alto, US; London, UK)
P426
Comparison between post H1N1 vaccination and sporadic
childhood narcolepsy with cataplexy in Finland and Italy
K. Kaveh Moghadam, F. Pizza, H. Peltola, G. Plazzi, M. Partinen
(Bologna, IT; Helsinki, FI)
80
Sunday, 9 June 2013
P427
Childhood sleep deprivation impairs melatonin biosynthesis
and metabolic function by depressing the calcium-mediated
signalling pathway in pinealocytes
L.-Y. Chen, W.-C. Liao, U.-I. Wu, F.-D. Mai, C.-H. Tsai, H.-M. Chang
(Taichung, Taipei, TW)
P428
Actigraphic assessment of periodic leg movements in
patients with restless legs syndrome
M. Cippa, C.R. Baumann, M.M. Siccoli, C.L. Bassetti, R. Poryazova,
E. Werth (Zurich, Berne, CH)
P429
Muscle sympathetic nerve activity during periodic leg
movements in sleep in a narcolepsy with cataplexy patient:
a microneurography study
V. Donadio, G. Plazzi, F. Pizza, S. Vandi, M. Abdel Jaber, V. Lete,
R. Liguori (Bologna, IT)
P430
Instrumental findings in carriers of DNMT1 mutation
causing autosomal dominant cerebellar ataxia, deafness and
narcolepsy
K. Kaveh Moghadam, F. Pizza, C. Tonon, R. Lodi, M. Seri,
J. Winkelmann, L. Lin, E. Mignot, G. Plazzi (Bologna, IT; Munich,
DE; Palo Alto, US)
P431
Limbic irritability in narcolepsy-cataplexy
K. Sonka, P. Kovalská, P. Bob (Prague, CZ)
P432
Longitudinal assessment of olfactory function in idiopathic
rapid eye movement sleep behaviour disorder
A. Iranzo, M. Serradell, I. Vilaseca, F. Valldeoriola, M. Salamero,
C. Molina, J. Santamaria, E. Tolosa (Barcelona, ES)
P433
Cerebral and muscular haemodynamics characterized with
near-infrared spectroscopy (NIRS) during all-night sleep
Z. Zhang, R. Khatami (Barmelweid, CH)
P434
Post H1N1 vaccine narcolepsy-cataplexy: spontaneous
improvement of excessive daytime sleepiness and
cataplexies after 2 years
H. Hidalgo, N. Dahmen, U. Kallweit (Katzenelnbogen, DE; Zurich, CH)
P435
Vitamin D supplementation in vitamin D-deficient narcolepsy
with cataplexy: improvement of excessive daytime
sleepiness?
H. Hidalgo, N. Dahmen, C.L. Bassetti, U. Kallweit (Asbach,
Katzenelnbogen, DE; Berne, Zurich, CH)
P436
Early onset of impulse control disorder in restless legs
syndrome under low dose pramipexole therapy
H. Hidalgo, V. Uhl, U. Kallweit (Asbach, DE; Zurich, CH)
81
Posters
Poster Session 1
Poster Session 1
Sunday, 9 June 2013
P437
The natural history of restless legs syndrome: retrospective
data on a clinical sample
L. Ferini-Strambi, R. Ferri, S. Marelli, A. Oldani, A. Galbiati,
M. Zucconi (Milan, IT)
P438
Recovery of augmentation in restless legs syndrome with
extended-release dopamine-agonists
M. Caporro, M. Maestri, S. Fulda, L. Ferini-Strambi, M. Zucconi,
S. Marelli, C.L. Bassetti, M. Manconi (Lugano, CH; Milan, IT;
Berne, CH)
P439
Neurocognitive function in patients with idiopathic restless
legs syndrome before and after dopaminergic treatment
L. Ferini-Strambi, S. Marelli, A. Galbiati, L. Giarolli, M. Zucconi,
A. Oldani (Milan, IT)
P441
Longitudinal polysomnographic assessment from acute to
subacute phase in infra- versus supratentorial stroke
M. Caporro, M. Manconi, I. Zavalko, C. Cereda, I. Pisarenco, S. Ott,
S. Fulda, C.L. Bassetti (Lugano, CH; Moscow, RU; Berne, CH)
P442
REM sleep reduction identifies patients with a poor recovery
after stroke
S. Fulda, M. Caporro, M. Manconi, I. Zavalko, S. Ott, L. Nobili,
J. Mathis, C.L. Bassetti (Lugano, CH; Moscow, RU; Berne, CH; Milan, IT)
P444
Sleep-disordered breathing in Parkinson’s disease
P.O. Valko, M. Sommerauer, S. Hauser, E. Werth, C.R. Baumann
(Zurich, CH)
P445
The association between fatigue and sleep in people with
post-polio syndrome
E. James, I. Pomeroy, A. Tennant, C. Young (London, Liverpool,
Leeds, UK)
11:30 – 12:30
Neurorehabilitation
Moderator:W. Paulus (Göttingen, DE)
P446
Brain computer interface based on vibrotactile stimulation
A. Espinosa, Z. R. Lugo, J. Rodriguez, R. Ortner, Q. Noirhomme,
S. Laureys, C. Guger (Graz, AT; Liège, BE)
P447
Analysis of real-time brain activity while controlling an
animated 3D cube
H. Nisar, H.C. Balasubramaniam, W.T. Lee, Q.W. Yeoh, A.S. Malik,
K. Yeap (Kampar, Tronoh, MY)
82
Poster Session 1
Sunday, 9 June 2013
Independent steady state visually evoked potential (SSVEP)based brain-computer interface for communication with
locked-in patients
D. Lesenfants, D. Habbal, C. Chatelle, E. Amico, F. Gomez, Z. Lugo,
S. Laureys, Q. Noirhomme (Liège, BE)
P449
A network effect when processing familiar faces in the
vegetative state
H. Sharon, Y. Pasternak, E. Ben Simon, M. Gruberger, N. Giladi,
T. Hendler (Tel Aviv, IL)
P450
Impact of spasticity in patients with disorders of
consciousness
A. Thibaut, C. Chatelle, M. Thonnard, S. Laureys, O. Gosseries
(Liège, BE)
P451
Zolpidem and recovery of consciousness: a positron emission
tomography study
C. Chatelle, A. Thibaut, O. Gosseries, M. Thonnard, A. Demertzi,
C. Bernard, R. Hustinx, S. Laureys, M.-A. Bruno (Liège, BE)
P452
Abdominal muscle contractions in brain death triggering the
respirator: a case report
M. Mulazzani, C. Wöber, C. Müller (Vienna, AT)
P453
Setting up a neuroscience stroke and rehabilitation centre
in South East Asia. Telemedicine: a useful tool to overcome
12,000 km not only for stroke but also neurological intensive
care patients. To teach to treat, to treat to teach
U. Meyding-Lamadé, E. Craemer, S. Menon, I. Jafaar, C. Choon,
A. Masri, C. Jacobi, C. Schwark, V. Jost, C. Mohs, H. Ilsen, K. Enk,
Z. Hanafi, A. Aziz, M. Papendieck, B. Kress (Frankfurt, DE)
P454
Wii balance board custom-made exercises to regain balance
after acquired brain injury: clinical evidence
R. Lloréns, E. Noé, S. Albiol, J.-A. Gil-Gómez (Valencia, ES)
P455
Effectiveness of a virtual board game to improve selfawareness in acquired brain injury patients
E. Noé, R. Lloréns, J. Ferri, M. Alcañiz (Valencia, ES)
P456
Balance rehabilitation through virtual reality: a randomized
controlled trial with acquired brain injury patients
R. Lloréns, E. Noé, C. Colomer, M. Alcañiz (Valencia, ES)
P457
Learning a motor sequence following traumatic brain injury:
evidence for a memory consolidation phase
K. Cismariu, S. Shaklai, C. Gal, M. Korman, O. Keren, Y. Sacher,
A. Karni (Raanana, Haifa, Tel Aviv, IL)
Posters
P448
83
Poster Session 1
Sunday, 9 June 2013
P458
Health-related quality of life as a predictor for long term
living at home after stroke
W. Schupp, R. Schmidt, E. Gräßel (Herzogenaurach, Erlangen, DE)
P459
Does the access to early rehabilitation after stroke meet
needs?
J.A. Opara, T. Larsen, J. Szczygiel (Katowice, PL; Odense, DK;
Tarnowskie Gory, PL)
P460
Recursive partitioning improves outcome prediction and
stratification of patients with spinal cord Injury
L. Tanadini, T. Hothorn, J. Steeves, A. Curt (Zurich, CH; Vancouver, CA)
P461
Activity-based therapy for recovery of walking in individuals
with chronic spinal cord injury: results from a randomized
clinical trial
M. Jones, N. Evans, C. Tefertiller (Atlanta, Denver, US)
P462
Neurocognitive rehabilitation by improving motor planning
versus treadmill training for freezing of gait in Parkinson’s
disease: a clinical and transcranial magnetic stimulation
(TMS) study
M. Catalan, S. Mezzarobba, L. Pellegrini, P. Busan, M. Belfiore,
A. Gorian, M. Banica, A. Cucca, G. Sgubin, L. Antonutti,
G. Pizzolato (Trieste, IT)
P463
Sustainable effects of a 12-week patient education
programme in multiple sclerosis patients: a qualitative
analysis
S. Kersten, J. Drosselmeyer, C.T. Haas (Saarbrücken, Idstein, DE)
P464
Prevalence of hypothyroidism in chronic fatigue syndrome
patients (CFS/ME)
T. Gaber, W.W. Oo (Wigan, UK)
11:30 – 12:30
Neuroimaging
Moderator:M.A. Rocca (Milan, IT)
P465
Higher optic nerve sheath diameter in normal divers
M. Mehrpour, N.S. Shams-Hosseini, S. Rezaali (Teheran, IR)
P466
Temporal artery Doppler ultrasonography may be a more
useful tool than temporal artery biopsy in patients with
termporal arteritis
M. Tan, O. Demirturk, B. Goksel, O. Alkan, U. Tan (Adana, TR)
P467
Correlation of arterial stiffness changes and body mass
index in healthy subjects
S. Morovic, M. Kovacicek, V. Demarin (Zagreb, HR)
84
Poster Session 1
Sunday, 9 June 2013
High resolution sonography, clinical and electrophysiological
evaluation of chronic inflammatory demyelinating
polyneuropathy: a case study
L.B. Tay, J. Eng, K. Verma (Singapore, SG)
P469
Correlation between ultrasonography and electrodiagnostic
studies in patients with clinical carpal tunnel syndrome: a
case series
J. Eng, L.B. Tay, K. Verma (Singapore, SG)
P470
A case of peripartum-postpartum angiopathy
V. Bignamini, M. Acler, D.M. Bonifati, M.C. Malaguti, A. Pellegrin,
R. Tanel, D. Orrico (Trento, IT)
P471
Analysis of cerebral neural activity during dual-task
performance of cognitive motor tasks
K. Goto, Y. Ikeda, T. Matsuda, H. Kuruma, A. Senoo (Tokyo, Chiba, JP)
P472
Resting-state fMRI and diffusion tensor imaging study in
patients with mild traumatic brain injury
H. Tan, W.B. Zheng, H.Y. Zheng (Shantou, CN)
P473
The acute effects of ethanol on rat brain diffusion tensor
imaging (DTI) and magnetic resonance spectroscopy (MRS)
study
H.M Liu, G. Yan, Y. Ding, W.B Zheng (Shantou, CN)
P474
White matter tract damage in pure and complicated
hereditary spastic paraparesis
E.G. Spinelli, F. Agosta, M. Scarlato, E. Canu, M.T. Bassi,
M. Copetti, S. Benedetti, M. Ferrari, A. Falini, M. Sessa, G. Comi,
M. Filippi (Milan, Lecco, Foggia, IT)
P475
Functional and structural disruption of the precuneus
contributes to cognitive impairment in paediatric multiple
sclerosis
M. Filippi, M. Absinta, M.P. Amato, A. Ghezzi, L. Moiola,
A. Fiorino, P. Veggiotti, G. Comi, M.A. Rocca and the MS and
Neuroimaging Study Groups of the Italian Neurological Society
P476
Effect on brain activity of cognitive motor tasks in healthy
elderly subjects: an fMRI study
T. Matsuda, K. Shiota, O. Nitta, T. Shiratani, A. Senoo, Y. Ikeda,
K. Goto (Chiba, Saitama, Tokyo, JP)
P477
Disruption of structural connectivity along the dorsal and
ventral language pathways in patients with nonfluent and
semantic variant primary progressive aphasia
S. Galantucci, F. Agosta, E. Canu, S.F. Cappa, G. Magnani,
M. Franceschi, A. Falini, G. Comi, M. Filippi (Milan, Castellanza, IT)
Posters
P468
85
Poster Session 1
Sunday, 9 June 2013
P478
Longitudinal patterns of brain atrophy in frontotemporal
lobar degeneration clinical syndromes compared with
Alzheimer’s disease
F. Agosta, E. Canu, E.G. Spinelli, G. Magnani, S.F. Cappa, G. Comi,
A. Falini, M. Filippi (Milan, IT)
P479
Effects of acute alcohol consumption on the human brain: a
resting-state fMRI study
H.Y. Zheng, H. Tan, W.B. Zheng (Shantou, CN)
P480
Schizencephaly: clinical and neuroimaging features and
correlation
R.I. Teleanu, D. Vasile, D. Epure, M.-C. Musetescu (Bucharest, RO)
P481
Joubert syndrome: a case report
H. Akgün, Ö.M. Akgün, M. Yücel, S. Tasdemir, S. Alay, O. Öz,
F.Ç. Gündogan, S. Demirkaya (Ankara, Istanbul, TR)
P482
A case of LGI1 limbic encephalitis from India with PET
documentation
P. Correia, R. Ranjan, C.S. Agrawal (New Delhi, IN)
P484
Assessment of the metabolic profile in type 2 diabetes
mellitus complicated with hypertension and non-diabetic
hypertension patients through proton magnetic resonance
spectroscopy
B. Ye, Y. Xiao, R. Wu, P. Zhang (Shantou, CN)
P485
Retinal nerve fibre layer and brain atrophy in relapsingremitting multiple sclerosis: a longitudinal correlation study
A. Bisecco, A. Gallo, M. Lanza, R. Sacco, S. Borrelli, L. Lavorgna,
M. Cirillo, S. Bonavita, F. Esposito, G. Tedeschi (Naples, IT)
11:30 – 12:30
Neuro-ophthalmology and balance
Moderator:A.M. Bronstein (London, UK)
P486
A temporoparietal junction timing mechanism mediates
human path integration
D. Kaski, Y. Nigmatullina, P. Malhotra, A.M. Bronstein,
B.M. Seemungal (London, UK)
P487
Do lesions restricted to the insula cause deficits in
perception of verticality?
B. Baier, J. Conrad, C. Geber, C. Best, W. Müller-Forell,
P. zu Eulenburg, M. Dieterich (Mainz, Munich, Marburg, DE)
P488
Bilateral tonic pupils as the initial symptom of Guillain-Barre
syndrome: a case report
D. Kiourtidis, T. Tsironis, D. Tsiptsios, V. Paraskeuopoulou,
G. Deretzi, R. Jobst, I. Tsiptsios (Thessaloniki, GR)
86
Poster Session 1
Sunday, 9 June 2013
An early presentation of neurosyphilis as persistent
headache and opthalmoplegia
M. Krommyda, G. Xiromerisiou, J. Rudolf, D. Kiourtidis,
D. Tsiptsios, T. Tsironis, E. Ameridis, I. Tsiptsios (Thessaloniki, GR)
P490
Brain response to 3D games as compared to 2D games
A.S. Malik, R.N. Hamizah, N. Kamel, D.M.A. Osman, M.L. Smith,
J.M. Abdullah (Tronoh, MY; New York, US; Kota Bharu, MY)
P491
Vestibular neuritis in the superior and inferior part of the
nerve: risk factor for an unfavourable outcome?
C. Best, L. Kreitner, P. Rausch, P. zu Eulenburg, B. Baier, F. Thömke,
M. Dieterich (Marburg, Mainz, Munich, DE)
P492
Retinal single layer analysis in Parkinsonian syndromes: an
optical coherence tomography study
M. Schneider, H.-P. Müller, F. Lauda, A.C. Ludolph, H. Tumani,
J. Kassubek, E.H. Pinkhardt (Ulm, DE)
P493
Significance of hypofunction of extraocular muscles in
myasthaenia gravis
V. Borislavova, S. Cherninkova (Sofia, BG)
P494
Relapsing optic neuritis: a pitfall entity. A case report
M. Gardinetti, M.L. Fusco, G. Cavaletti, C. Ferrarese, M. Frigo
(Monza, IT)
P495
A preliminary longitudinal study of the retinal nerve fibre
layer in clinically isolated syndromes (CIS)
C. Oreja-Guevara, S. Noval, A. Royo, B. Chamorro, J. Alvarez-Linera
(Madrid, ES)
P496
Does pharmacological reduction of postural symptoms
in acute unilateral vestibulopathy counteract vestibular
compensation?
A. Zwergal, L. Günther, R. Beck, C. la Fougere (Munich, DE)
P497
Triple therapy with darbepoetin alfa, idebenone and
riboflavin in Friedreich’s ataxia: open-label trial
J. Arpa, I. Sanz-Gallego, F.-J. Rodríguez-de-Rivera,
F.-J. Domínguez-Melcón, D. Prefasi, J. Oliva-Navarro,
M. Moreno-Yangüela, S.-I. Pascual-Pascual (Madrid, ES)
P498
Triple therapy with deferiprone, idebenone and riboflavin in
Friedreich’s ataxia: open-label trial
J. Arpa, I. Sanz-Gallego, F.-J. Rodríguez-de-Rivera,
F.-J. Domínguez-Melcón, D. Prefasi, J. Oliva-Navarro,
M. Moreno-Yangüela (Madrid, ES)
Posters
P489
87
Poster Session 1
Sunday, 9 June 2013
P499
Different correlations of cerebellar signs in spinocerebellar
ataxia type 3 and type 7
D. Gómez-Andrés, I. Pulido-Valdeolivas, O. Trabajos-Garcia,
F.-J. Díaz-de-Terán, I. Illán-Gala, I. Sanz-Gallego, F.-J. Arpa-Gutiérrez
(Madrid, ES)
P500
Two different domains of cerebellar signs in spinocerebellar
ataxia type 7 at the start of follow-up
I. Pulido-Valdeolivas, D. Gómez-Andrés, O. Trabajos-Garcia, I. Illán-Gala,
F.-J. Díaz-de-Terán, I. Sanz-Gallego, F.-J. Arpa-Gutiérrez (Madrid, ES)
P501
Final results of the treatment of patients with hereditary
ataxia with IGF-1
I. Sanz Gallego, J. Arpa on behalf of the Reference Unit of
Hereditary Ataxia and Paraplegia
P502
Spinocerebellar ataxia 37 (SCA37): clinical and molecular
findings in two Spanish families
C. Serrano-Munuera, M. Corral-Juan, H. San Nicolás Fernández,
J. Corral Seijas, B. Campos Estela, E. López Toledano,
M. Martínez Corral, E. Peral Pellicer, I. Sánchez,
J. Kulisevsky Bojarski, C. Roig Arnall, V. Volpini Bertrán,
A. Matilla-Dueñas (Barcelona, Badalona, L’Hospitalet, ES)
11:30 – 12:30
Inflammatory and myasthenia
Moderator:R. Paterson (London, UK)
P503
Stress cardiomyopathy in potential heart donors: is
successful explantation possible?
M. Möller, C. Roth, J. Dunkel, A. Ferbert, W. Deinsberger,
R. Gradaus, J. Neuzner (Kassel, DE)
P504
Takotsubo cardiomyopathy in a patient with myasthaenia
gravis: a case report
J. Dunkel, C. Roth, M. Möller, A. Ferbert (Kassel, DE)
P505
Myasthaenia gravis, pregnancy, puerperium, transient
neonatal myasthaenia and arthrogryposis multiplex
congenita in Slovakia (1978-2012)
I. Urminska, P. Spalek, M. Oros, K. Pisonova, I. Martinka (Bratislava, SK)
P506
Therapeutic dilemma in generalized myasthenia gravis with
Good’s syndrome overlap
V. Salanga, R. Govindarajan (Weston, US)
P507
Decreased platelet serotonin concentration and
polymorphisms in SERT gene in patients with Sjogren’s
syndrome: correlation with depression and fatigue
H. Sarac, J. Markeljevic, N. Henigsberg, J. Sertic, I. Barsic, V. Erdeljic
(Zagreb, HR)
88
Sunday, 9 June 2013
P508
Clinical follow-up of neuro-Behcet syndrome patients
treated with infliximab
B. Zeydan, N.O. Demirci, U. Uygunoglu, E. Seyahi, S. Ugurlu,
S. Saip, A. Siva (Istanbul, TR)
P509
A case of neuro-Behçet’s disease involving subcortical structures
and limbic system presenting with psychiatric symptoms,
memory impairment and decreased level of consciousness
G. Franco, S. Lanfranconi, L. Borellini, G. Conti, S. Bonato,
A. Di Fonzo, N. Bresolin (Milan, IT)
P510
Myelitis in systemic lupus erythematosus: clinical,
radiological and serological heterogeneity
J.P. Hryb, J.L. Di Pace, E. Chiganer, E. Carnero, P. Cairola, C. Lessa,
M. Perassolo (Buenos Aires, AR)
P511
Clinical and neuroradiological evaluation in neurosarcoidosis
G. Gözbatik-Celik, U. Uygunoglu, D. Uluduz, S.N. Yeni, S. Saip,
P512
Transverse myelitis associated with mixed polyneuropathy in
primary antiphospholipid syndrome: case report
A. Dolgan, S. Budrewicz, M. Ejma, M. Koszewicz,
M. Waliszewska-Prosol, P. Szewczyk, R. Podemski (Wroclaw, PL)
P513
MTCH1 antibodies in neuromyelitis optica patients with or
without aquaporin-4 antibodies
A. Çoban, F. Çavus, C. Ulusoy, S. Turan, B. Vural, R. Türkoglu,
M. Kürtüncü, M. Eraksoy, G. Akman-Demir, E. Tüzün (Istanbul, TR)
P514
Autoimmune steroid-responsive encephalitis associated
with GAD-antibody-positive type 1 diabetes mellitus and
Hashimoto-thyroiditis
S. Bernsen, U. Liebetrau, V. Limmroth (Cologne, DE)
P515
Kikuchi-Fujimoto disease and neurolupus: an initial
manifestation of systemic lupus erythematosus (SLE)
S.F. Machado, M. Amaral, M.J. Frade, A.N. Pinto (Amadora, Lisbon, PT)
11:30 – 12:30
Preclinical neurobiology
P516
Repetitive stimulation synaptic depression mediated by
exogenous ciliary neurotrophic factor (CNTF)
N. Ortiz, N. Garcia, M. Santafè, M. Priego, T. Obis, M. Tomàs,
M.A. Lanuza, N. Besalduch, J. Tomàs (Reus, ES)
P517
Age-dependent changes in brain-derived neurotrophic factor
(BDNF) expression in a mouse model of ischaemic stroke
S. Ress, E. Göb, F. Langhauser, R. Blum, E. Pasch, G. Stoll,
M. Sendtner, C. Kleinschnitz (Würzburg, DE)
89
Posters
Poster Session 1
Poster Session 1
Sunday, 9 June 2013
P518
Pathophysiological role of endothelial NOX4 in acute
ischaemic stroke in mice
E. Göb, F. Langhauser, K.A. Radermacher, H.H.H.W. Schmidt,
G. Stoll, C. Kleinschnitz (Würzburg, DE; Maastricht, NL)
P520
Transplantation of fetal neural stem cells into
the rat cerebellum during quinolinic acid-induced
neurodegeneration
M. Edalatmanesh, H. Nikfarjam, F. Vafaei-Bagheri (Fars, Mashhad, IR)
P521
Intrathecal transplantation of neural stem/precursor cells
derived from induced pluripotent stem cells improves the
clinical and neuropathological outcome of a mouse model of
multiple sclerosis
C. Laterza, A. Merlini, D. De Feo, F. Ruffini, E. Brambilla,
A. Lombardo, M. Onorati, E. Cattaneo, G. Comi, G. Martino
(Milan, IT)
P522
Role of oligodendrocytes in axonal regeneration in the
vertebrate central nervous system (CNS)
R.S. Parris, Q. Bai, E.A. Burton (Pittsburgh, US)
P523
Preclinical studies for the treatment of Pelizaeus-Merzbacher
disease with clinically applicable compounds, curumin and
chloroquine
K. Inoue, T. Morimura, Y. Numata, L.-H. Yu, L. Gotoh,
R. Yamamoto, N. Inoue, B. Antalfy, K. Deguchi, H. Osaka,
Y.-I. Goto (Tokyo, JP; Houston, US; Yokohama, JP)
P524
N-acetylcysteine prevents spatial memory impairment
induced by chronic early postnatal glutaric acid and
lipopolysaccharide in rat pups
F.S. Rodrigues, M.A. Souza, R.S. Scalco, L.F.F. Royes, M.R. Fighera
(Santa Maria, Porto Alegre, BR)
P525
Blockade of the kallikrein-kinin system protects from
experimental traumatic brain injury
C. Albert-Weissenberger, K. Goebel, S. Meuth, A.-L. Sirén, G. Stoll,
C. Kleinschnitz (Würzburg, Münster, DE)
P526
Effect of the sphingosine-1-phosphate receptor modulator
FTY720 on the outcome in a mouse model of focal cortical
cryolesion
C. Albert-Weissenberger, N. Hennig, A.-L. Sirén, C. Kleinschnitz
(Würzburg, DE)
P527
Effect of Lycopersicon esculentum extract on apoptosis
in the rat cerebellum following prenatal and postnatal
exposure to electromagnetic field
S. Köktürk, M. Yardimoglu, S.D. Celikozlu, E. Gelenli Dolanbay,
A. Cimbiz (Ordu, Koceali, Altintas, Kocaeli, Zirve, TR)
90
EUROPEAN JOURNAL OF
NEUROLOGY
THE OFFICIAL
JOURNAL OF EFNS
European Federation
of Neurological
Societies
ARE YOU
A MEMBER OF EFNS THROUGH
YOUR NATIONAL SOCIETY?
Access to the online version of the
European Journal of Neurology
is freely available to members of
your National Society via the
EFNS website.
Contact EFNS today for more info! Email: [email protected]
EFNS EUROPEAN FEDERATION OF
NEUROLOGICAL SOCIETIES
Poster Session 2
11:30 – 12:30 Multiple Sclerosis: clinical aspects II
Moderator:H.-P. Hartung (Düsseldorf, DE)
P528
Lymphocyte counts and infection risk among relapsingremitting multiple sclerosis patients treated with
alemtuzumab (CARE-MS II)
E. Havrdova, D.L. Arnold, J.A. Cohen, A.J. Coles, C. Confavreux,
E.J. Fox, H.-P. Hartung, K.W Selmaj, H. Weiner, T. Miller,
C.L. Twyman, S.L. Lake, D.H Margolin, M.A. Panzara,
D.A.S. Compston for the CARE-MS II Investigators
P529
Long term follow-up of autologous stem cell transplantation
in multiple sclerosis patients
M. Radaelli, L. Moiola, R. Greco, V. Martinelli, F. Sangalli, P. Rossi,
L. Ferrè, M. Comola, P. Vezzulli, J. Peccatori, F. Ciceri, G. Comi
(Milan, IT)
P530
Autologous mesenchymal stem cell transplantation in
multiple sclerosis
Y. Motuzova, M. Zafranskaya, D. Nizheharodova, A. Borisov,
I. Svirid, D. Balvanovich, T. Kachan, M. Minzer, E. Selezneva,
A. Fedulov (Minsk, BY)
P531
Alemtuzumab improves quality of life compared to SC IFNB1a in CARE-MS II
R. Arroyo, D.L. Arnold, J.A. Cohen, A.J. Coles, C. Confavreux,
E.J. Fox, H.-P. Hartung, E. Havrdova, K. Selmaj, H. Weiner,
C.L. Twyman, T. Miller, A. Boscoe, S.L Lake, D.H. Margolin,
M. Panzara, D.A.S. Compston for the CARE-MS II Investigators
P532
Teriflunomide hepatic safety results: pooled data from three
placebo-controlled studies
C. Confavreux, T.P. Olsson, G. Comi, M.S. Freedman, A. Miller,
J.S. Wolinsky, L. Kappos, J.-L. Delhay, H. Li, P. Truffinet, P. O’Connor
(Lyon, FR; Stockholm, SE; Milan, IT; Ottawa, CA; New York,
Houston, US; Basel, CH; Chilly Mazarin, FR; Bridgewater, US;
Toronto, US)
P533
Exploring the impact of teriflunomide on immune cells in
patients with relapsing multiple sclerosis: design of the TeriDynamic study
F. Menguy-Vacheron, R. Varona, A. Posevitz-Fejfar, V. Posevitz,
L. Klotz, H. Wiendl (Chilly Mazarin, FR; Münster, DE)
P534
Treatment experience, burden and unmet needs (TRIBUNE)
in multiple sclerosis (MS): Turkish data
R. Karabudak, K. Karampampa, A. Gustavsson (Ankara, TR;
Stockholm, SE)
92
P535
Individualized dosing in the treatment of relapsing-remitting
multiple sclerosis (RRMS) using S1P receptor-modulating
therapies: a simulation study
F. Mercier (Wintzenheim, FR)
P536
Atrioventricular conduction abnormalities after the first dose
of fingolimod (Gilenya®) in patients with relapsing-remitting
mulitple sclerosis: design of a phase IIIb-study (START)
K. Schuh, M. Meergans, V. Limmroth (Nuremberg, Cologne, DE)
P537
Overall safety and relapse outcomes in fingolimod-treated
patients previously exposed to natalizumab in the 4-month,
open label FIRST study
G. Comi, R. Gold, F. Dahlke, A. Sinha, P. Von Rosenstiel, D. Tomic,
L. Kappos (Milan, IT; Bochum, DE; Basel, CH; Hyderabad, IN)
P538
Safety and cardiac outcomes of fingolimod 0.5 mg in the
Italian cohort from the 4-month, open-label, single-arm,
multi-centre FIRST study
G. Marrosu, G. Comi, S. Ruggieri, A. Francia, S. Cottone,
D. Maimone, R. Turrini, A. Sinha, P. Von Rosenstiel, D. Tomic
(Cagliari, Milan, Pozzilli, Rome, Palermo, Catania, Orrigio, IT;
Hyderabad, IN; Basel, CH)
P539
Long term efficacy of fingolimod in patients with relapsingremitting multiple sclerosis previously treated with
interferon beta-1a or disease modifying therapies: a posthoc analysis of the TRANSFORMS 4.5 year extension study
X. Montalban, F. Barkhof, G. Comi, H.-P. Hartung, L. Kappos,
B. Khatri, J. Pelletier, E. Kornyeyeva, S. Ritter, P. von Rosenstiel,
J. Cohen (Barcelona, ES; Amsterdam, NL; Milan, IT; Düsseldorf,
DE; Basel, CH; Milwaukee, US; Marseille, FR; East Hanover, US;
Cleveland, US)
P540
Oral fingolimod versus natalizumab on measures of diseasefreedom: indirect comparison of results from FREEDOMS and
AFFIRM studies
R. Nixon, N. Bergvall, N. Sfikas, P. Chin, D. Tomic, G. Cutter (Basel,
CH; East Hanover, US; Birmingham, US)
P541
Improvement in physical disability with fingolimod: post-hoc
analyses of FREEDOMS and TRANSFORMS
N. Bergvall, N. Sfikas, P. Chin, D. Tomic, G. Cutter (Basel, CH;
East Hanover, US; Birmingham, US)
P542
Effects of fingolimod on disability progression by expanded
disability status scale (EDSS) score at baseline: post-hoc
analyses of FREEDOMS and FREEDOMS II
N. Bergvall, N. Sfikas, P. Chin, D. Tomic, P. Von Rosenstiel,
G. Cutter, D. Jeffery (Basel, CH; East Hanover, US; Birmingham,
Advance, US)
93
Posters
Poster Session 2
Poster Session 2
P543
Treatment satisfaction and clinical improvement after switch
to fingolimod
E. Fox, K. Edwards, J.G. Burch, E. Kim, L. Pestreich, K. McCague,
L. Barbato (Round Rock, Latham, Roanoke, East Hanover, US)
P544
Improved quality of life after therapy change to fingolimod
H. Crayton, S.F. Hunter, C. Huffman, N. Agashivala, L. Schofield,
K. McCague, L.M. Barbato (Vienna, Franklin, Tampa, East Hanover, US)
P545
No effect on incidence of infection after therapy switch to
fingolimod
C. LaGanke, D.R. Wynn, K. McCague, L.M. Barbato, R. Hashmonay
(Cullman, Northbrook, East Hanover, US)
P546
Cardiac effects of fingolimod in patients with multiple
sclerosis
B.L. Hughes, M. Cascione, K. McCague, L. Pestreich, L. Schofield,
E. Kim, L.M. Barbato (Des Moines, Tampa, East Hanover, US)
P547
Optical coherence tomography (OCT) study in multiple
sclerosis patients treated with fingolimod
C. Oreja-Guevara, M. Capote Díez, B. Chamorro Hernández,
S. Noval Martin (Madrid, ES)
P548
MRI timings and their impact on new T2 lesions’ ability to
predict treatment failure in multiple sclerosis (MS)
C. Tur, À. Rovira, J. Rio, M. Tintore, J. Sastre-Garriga, C. Auger,
J. Castillo, Á. Vidal-Jordana, I. Galan, M.J. Arevalo, R. Mitjana,
E. Anglada, G. Arrambide, C. Nos, M. Comabella, X. Montalban
(Barcelona, ES)
P549
Impact of a single relapse in disability and progression in
multiple sclerosis: a random forest approach
L.A. Rodríguez de Antonio, I. Pulido-Valdeolivas, D. Gómez-Andrés,
M.J. Aguilar-Amat, A. Cruz-Herranz, I. González-Suárez, A. TallónBarranco, E. Díez-Tejedor (Madrid, ES)
P550
Impact of expanded disability status scale (EDSS) on oral
health in multiple sclerosis patients: a preliminary study
S. Canbaz Kabay, H. Hatipoglu, M. Gungor Hatipoglu, H. Ozden
(Kutahya, Eskisehir, TR)
P551
Prognostic factors for the early development of clinically
definite multiple sclerosis in patients with clinically isolated
syndromes
V. Martinelli, G. Dalla Costa, G. Di Maggio, B. Colombo, D. Dalla
Libera, L. Leocani, R. Furlan, M. Filippi, G. Comi (Milan, IT)
P552
Intrathecal combined methotrexate and dexametasone
therapy in progressive multiple sclerosis
M. Volpini, C. Monaldini, M. Stumpo, S. Guttmann (Cailungo, SM)
94
Poster Session 2
The relationship between dehydroepiandrosterone and
cortisol with fatigue and depression in multiple sclerosis
S. Rashidfard, M. Moghadasi, A. Moeini, A. Rahimi,
M. Edalatmanesh (Fars, Shiraz, IR)
P554
Safety and efficacy of intravenous injection of autologous
bone marrow-derived mesenchymal stem cell in patients
with multiple sclerosis: a double blind randomized semicrossover clinical trial: preliminary report 1 – safety issues
S.M. Nabavi, N. Aghdami, L. Arab, A. Hamzeloo (Teheran, IR)
P555
Motor sequence learning in relapsing-remitting multiple
sclerosis (MS) patients
N. Zahiri, I. Abdollahi, A.M. Arab, S.M. Nabavi (Tehran, IR)
P556
Early mobility impairment: bridging the communication gap
between people with multiple sclerosis and their healthcare
providers
B. Anderseck, P. Van Asch, J. Johnson, S. Agarwal, S. Hudgens,
L. Humphrey, R. Medcalf, T. Ziemssen (Valens, CH; Kontich, BE;
Weston, MA, Weston, Boston, US; Cheshire, UK; Dresden, DE)
P557
Influence of the mode of walk on walking speed in multiple
sclerosis: are you walking comfortably?
R. Phan-Ba, G. Delrue, S. Pierard, E. Lommers, P. Calay,
M. Vandroogenbroeck, V. Delvaux (Liège, BE)
P558
Long-term effects of cognitive rehabilitation in multiple
sclerosis: 12-month follow-up
A. Altinkaya, I. Guclu, E. Kurt, A. Bingöl, A. Soysal, D. Yandim
Kuscu, D. Kirbas, B. Topcular (Istanbul, TR)
P559
Cognitive impairment in relapsing-remitting multiple
sclerosis patients
A. Altinkaya, E. Ozcan, D. Kuscu, E. Kurt, A. Bingöl, D. Kirbas,
B. Topcular (Istanbul, TR)
11:30 – 12:30 Cerebrovascular disorders: semiology and case reports
Moderator:A. Verdelho (Lisbon, PT)
P560
Frontal eye field infarction: a topodiagnostic challenge
F. Hoffmann, C. Cyran, C. Vollmar, A. Danek (Munich, DE)
P561
Ability of naming in patients with stroke
S. Golubovic, G. Savic (Belgrade, Banja Luka, RS)
P562
Epilepsy as a consequence of stroke in adults
S.T. Ristic, D.T. Ristic, I. Marinkovic (Nis, RS)
Posters
P553
95
Poster Session 2
P563
Isolated downgaze paresis as the sole presentation of a
unilateral stroke associated with an atrial myxoma
S. Cruz, E. Parreira (Amadora, PT)
P564
Recurrent lobar haemorrhages: an unusual case of probable
cerebral amyloid angiopathy
S. Cruz, E. Parreira (Amadora, PT)
P565
Focal cortical subarachnoid haemorrhage (FCSAH) revealed
by recurrent paresthesiae: clinical and imaging features
M. Apoil, J. Cogez, L. Dubuc, M. Bataille, V. De la Sayette, F. Viader
(Caen, Saint-Lô, FR)
P566
Symptomatic intracerebral cavernoma bleeding after
intravenous stroke thrombolysis
T. Gattringer, A. Pichler, N. Homayoon, K. Niederkorn, C. Enzinger,
P567
An autopsied case of cerebral amyloid angiopathy which
revealed unilateral cerebrovascular diseases after a
ventriculoperitoneal (VP)-shunt operation
K. Inoue, H. Fujimura, S. Sakoda, M. Kousaka, S. Tomita, T. Oheda,
H. Sawada (Osaka, Kyoto, JP)
P568
Acute Multifocal Placoid Pigment Epitheliopathy (AMPPE)
A. García-Chiclano (Alcázar de San Juan, ES)
P569
Multifocal brain haemorrhage and cerebral infarction due to
varicella zoster virus vasculopathy
I. González-Suárez, B. Fuentes, A. Martín-Montes,
A. Tallón-Barranco, P. Martínez-Sánchez, G. Ruiz-Ares,
E. Díez-Tejedor (Madrid, ES)
P570
Multiple fusiform cerebral aneurysms detected 12 years
after atrial myxoma resection
J. Chojdak-Lukasiewicz, M. Zagrajek, K. Guranski,
A. Krupinska-Dulemba, M. Waliszewska-Prosol,
A. Loster-Niewinska, R. Podemski (Wroclaw, PL)
P571
Hypoglossal palsy as an isolated symptom of spontaneous
carotid dissection
J. Hennings, D. Höhn, E. Schumann-Späth, F. Weber (Munich, DE)
P572
Ischaemic stroke in a patient with pseudoxanthoma
elasticum
J.N. Ferreira Carvalho, M. Marques, M. Arenga, A. Morgadinho
(Coimbra, PT)
P574
Unilateral opercular infarction presenting with FoixChavany-Marie syndrome
F. Sá, H. Nzwalo, I. Cordeiro, S. Mestre, C. Basílio (Faro, PT)
96
P575
The significance of cerebrovascular complications in patients
with acute infective endocarditis: a 12- year single centre
experience with 144 patients
S.-J. Lee, D.-S. Shim, S.-S. Oh, D.-S. Lim (Bucheon, KR)
P576
A rare case of cerebroretinal vasculopathy caused by a novel
Trex 1 mutation
E. Schuh, P. Lohse, T. Kümpfel (Munich, Singen, DE)
P577
Cognitive impairment in the acute stage of posterior
circulation stroke and its dynamic across 90-days of follow-up
K. Antonenko, L. Sokolova (Kiev, UA)
P578
Fantastic perceptive distortion after a paramedian thalamic
syndrome
M.G. Delgado, J. Bogousslavsky (Asturias, ES; Valmont-Montreaux, CH)
11:30 – 12:30 Extrapyramidal disorders: Parkinson’s disease
Moderator:A. Macerollo (London, UK)
P579
Sex in Parkinson’s disease
E. Scelzo, R. Ferrucci, V. Raoli, G. Ardolino, F. Cogiamanian,
P. Barone, L. Bertolasi, A. Padovani, M. Panzeri, L. Ronconi,
M. Ciocca, A. Priori (Milan, Salerno, Verona, Brescia, Padua, IT)
P580
Impulsive-compulsive behaviour in patients with Parkinson´s
disease
M. Muldmaa, S. Põldsepp, L. Kadastik-Eerme, K. Rallmann, P. Taba
(Tartu, EE)
P581
Urogenital dysfunction in Parkinson’s disease
A. Vogrig, P. Tocco, S. Monaco, L. Bertolasi (Verona, IT)
P582
Smell is more impaired in sporadic Parkinson’s disease than
LRRK2 Parkinson’s disease
J. Crespi, K. Johansen1, B. Warø, J. Aasly (Trondheim, NO)
P583
Acoustic analyses of vocal expression of contrastive stress in
Parkinson’s disease
T. Tykalova, J. Rusz, R. Cmejla, H. Ruzickova, E. Ruzicka (Prague, CZ)
P584
Visual hallucinations in Parkinson’s disease: are they related
to a specific motor phenotype? Evidence from a case control
study
L. Kiferle, M. Giuntini, G. Palermo, E. Del Prete, U. Bonuccelli,
R. Ceravolo (Pisa, IT)
P585
The influence of non-motor symptoms on quality of life in
patients in early stages of Parkinson’s disease
E.N. Gubanova, N.V. Fedorova (Moscow, RU)
97
Posters
Poster Session 2
Poster Session 2
P586
Association between gait and cognitive functioning in
A. Mendes, A. Gonçalves, N. Vila-Chã, I. Moreira, S. Cavaco,
A. Bastos Lima (Porto, PT)
P587
Assessment of the quality of life of patients suffering from
Parkinson’s disease: correlation with type of disease
N.S. Subasic, E. Suljic, J. Djelilovic-Vranic, A. Alajbegovic,
S. Sabanagic-Hajric, A. Mehicevic, Z. Ajanovic, A. Hrelja (Sarajevo, BA)
P588
Evaluation of the reliability of a questionnaire for gait
disorders in Parkinson‘s disease patients
H. Brozova, M. Hoskovcova, P. Dusek, K. Zarubova, R. Jech, J. Roth,
J. Rusz, E. Ruzicka (Prague, CZ)
P589
Association between PICALM rs3851179 polymorphism and
cognition in Parkinson’s disease
E. Giza, K. Kalinderi, G. Kourtesi, L. Fidani, Z. Katsarou,
S. Bostantjopoulou (Thessaloniki, GR)
P590
Evaluation of dietary iron intake, serum iron levels, serum
ferritin levels, and serum transferrin levels in patients with
D.P. Santana, C.G. Almeida, L. Scherer, C.M.M.B.S. Chaves,
I. Gomes, R.S. Scalco, L.F.F. Royes, M.R. Fighera (Santa Maria,
Porto Alegre, BR)
P591
Functional connectivity in early Parkinson’s disease:
a resting-state fMRI study
M. Filippi, F. Agosta, F. Caso, A. Inuggi, I. Stankovic, I. Petrovic,
V.S. Kostic (Milan, IT; Belgrade, RS)
P592
Rest and postural tremor in Parkinson’s disease are
accompanied by rhythmical motor unit spike doublets and
triplets at a common frequency
O.M. Agapaki, C.N. Christakos, S. Erimaki, D. Anastasopoulos
(Heraklion, Athens, GR)
P593
Patterns of grey matter atrophy associated with frontal
executive functions and freezing of gait in Parkinson’s
disease
F. Brugger, S. Hägele-Link, B. Tettenborn, G. Kägi (St. Gallen, CH)
P594
Cerebrospinal fluid and serum from Parkinsonian patients
are cytotoxic for dopamine neurons and serum nitro-alphasynuclein could participate in Parkinsonian damage
E. Fernandez, C. Mendez-Lucena, F. Damas-Hermoso,
J.M. Garcia-Moreno, M.V. Lopez, A. Martin de Pablos (Seville, ES)
98
Poster Session 2
Serotonergic antidepressant drugs and L-dopa-induced
dyskinesias in Parkinson’s disease patients: evidence from a
retrospective study
S. Mazzucchi, D. Frosini, V. Nicoletti, M. Giuntini, G. Palermo,
U. Bonuccelli, R. Ceravolo (Pisa, IT)
P596
Fluctuating Cotard syndrome in a patient with advanced
P. Solla, A. Cannas, C.S. Mulas, S. Argiolas, F. Marrosu
(Monserrato, IT)
P597
Influence of dopaminergic drugs on fatigue syndrome in
patients with Parkinson`s disease
V. Datieva, O. Levin (Moscow, RU)
P598
Evidence of impaired synaptic homeostasis underlying
the appearance of levodopa-induced dyskinesia: an
electrophysiological and molecular study in a rat model for
Parkinson’s disease (PD)
S. Galati, M. Pace, F. Baracchi, S. Sarasso, C. Prosperetti,
C.L. Bassetti, C. Staedler, J.C. Moeller (Lugano, Berne, CH)
P599
Acoustic evaluation of vowel articulation in early Parkinson’s
disease: effect of pharmacotherapy
J. Rusz, R. Cmejla, T. Tykalova, H. Ruzickova, J. Klempir,
V. Majerova, J. Picmausova, J. Roth, E. Ruzicka (Prague, CZ)
P600
Low and combination frequency stimulation post deep brain
stimulation (DBS) in Parkinson’s disease (PD) patients with
gait and speech problems
D. Apetauerova, J. Zani, N. Ventura, S. Scala (Burlington, US)
P601
Patient expectation and outcome after deep brain
stimulation (DBS)
N. Esnaashari (Los Angeles, US)
11:30 – 12:30 Epilepsy I
Moderator:G. Winston (London, UK)
P602
Unilateral hemispheric encephalitis
M.L. Noone, S.T. John (Kerala, IN)
P603
Refractory epilepsy and amnesia after anti-GABA-1B limbic
encephalitis
R.C.O.S. Pasmans, K. Beerhorst (Heerlen, NL)
P605
About the role of inflammation in drug-resistant epilepsy
L. Lipatova, N. Serebryanaya, N. Sivakova (St. Petersburg, RU)
Posters
P595
99
Poster Session 2
P606
Status epilepticus caused by scleromyxoedema
S. Zouroudi, S. Giannopoulos, A. Zikou, K. Tsoukanelis, A. Kyritsis,
S. Markoula (Ioannina, GR)
P607
Successful treatment of refractory tonic status epilepticus
with rufinamide: a case study
A.G.B. Thompson, U.A. Khan, M.R.S. Brothwell, H. Cock
(London, UK)
P608
Status epilepticus in a neurocritical care unit: from
classification to outcome
P. Barros, H. Rocha, C. Dias, A. Mendes (Vila Nova de Gaia, Porto, PT)
P609
Expression pattern of brain specific miR-124 and miR-134 in
an immature rat model and children with mesial temporal
lobe epilepsy
A. Omran, M.U. Ashhab, J. Peng, F. Yin (Changsha, CN)
P611
Neurobehavioural performance in mice during first two
weeks of life which were exposed prenatally to different
doses of valproic acid
J. Podgorac, S. Sekulic, I. Capo, G. Kekovic, L. Martac, D. Lalosevic,
M. Mijajlovic (Belgrade, Novi Sad, RS)
P612
Visual hypersensitivity attacks: an Italian case
P. Benna, E. Montalenti, M.G. Caprioli (Turin, IT)
P613
Reproductive features of onset of epilepsy in women
G. Odintsova, N. Koroleva, V. Guzeva (Saint Petersburg, RU)
P614
"His tics have changed a lot": beyond Gilles de la Tourette
syndrome
M. Arenga, H. Ramos, I. Luzeiro, A. Morgadinho
(São Martinho do Bispo, PT)
P615
Geriatric epilepsy with vestibular symptoms: clinical and EEG
features
Y.-M. Shon, Y.H. Lee, S.H. Kim, S.C. Lim, W.J. Kim (Seoul, KR)
P616
Do medical trainees need more teaching about seizure
management? An anonymous survey of junior doctors and
final year medical students
J. Cosgrove, S. Williams, A. Lansbury (Leeds, Bradford, UK)
P617
A comparative study of quality of life (QOL) and psychosocial
factors in a rural and urban epilepsy population in India
J. Nathan, S. Panjwani (Mumbai, IN)
100
P618
Therapeutic effects of Mozart’s music on epileptic patients:
systematic review and metaanalysis of the literature
A. Shoeibi, S. Dastgheib, P. Layegh, R. Sadeghi, A. Gorji (Mashhad,
Tehran, IR; Münster, DE)
P619
Bone health advice in an adult epilepsy service: re-audit of
practice and influence of national guidance
D. Danquah-Boateng, H. Cock (London, UK)
P620
The application of traditional medicine in epilepsy:
Canakkale sample
G. Tanriverdi, M.H. Yalcin Gursoy, H.M. Sen, H.I. Ozisik Karaman
(Canakkale, TR)
11:30 – 12:30
Clinical neurophysiology I: peripheral nerve
Moderator:S. Peric (Belgrade, RS)
P621
Unmyelinated fibre distribution in the aortic depressor
nerve: comparison between short-term and long-term
experimental diabetes
F.S. Oliveira, R.A. Nessler, J.A. Castania, H.C. Salgado, V.P.S. Fazan
(Ribeirão Preto, BR; Iowa City, US)
P622
Study of AMAN (acute motor axonal neuropathy) with anti
GM1 ganglioside antibody following Campylobacter jejuni
enteritis: distribution of GM1 ganglioside epitopes in ventral
and dorsal spinal roots
T. Miyatake (Wako, JP)
P623
Advanced MRI techniques reveal distinct cerebral tissue
alterations in hereditary and diabetic neuropathic pain
(preliminary results)
A. Taskiran Sag, A. Ceylan Has, Z.N. Oztekin, C.M. Temucin, F. AK,
K. Karli Oguz (Ankara, TR)
P624
Anti-MAG neuropathy in CMT1A: double hit on peripheral
nerves
G. Piscosquito, E. Salsano, C. Ciano, L. Palamara, M. Morbin,
P625
Gait variability during different locomotion speeds in
patients with polyneuropathy
M. Wuehr, C. Pradhan, K. Jahn, R. Schniepp (Munich, DE)
P626
Neuralgic amyotrophy with involvement of cranial nerves IX,
X, XI and XII
L.V. Leon Cejas, P. Zuberbuhler, D. Binaghi, R. Reisin,
M. Fernandez Pardal (Buenos Aires, AR)
101
Posters
Poster Session 2
Poster Session 2
P627
Bortezomib-induced peripheral neuropathy and
neuronopathy in patients with multiple myeloma
N. Turgut, B. Turgut, M. Oran, T. Yetisyigit, R. Alp, A. Unal
(Tekirdag, TR)
P628
Brachial neuritis: a complication of hepatitis E infection
E. Theochari, L. Vincent-Smith, C. Ellis (Gillingham, UK)
P629
Hanging on by the fingertips
M. Brinkman, T. Schreuder (Heerlen, NL)
P630
The beneficial effects of high doze capsaicin patches in
patients with treatment resistive HIV-associated peripheral
neuropathy (PN-HIV)
R. Zmarandescu, O. Milea, M. Antoce, I. Buraga (Bucharest, RO)
P631
Efficacy of autologous peripheral blood stem cell
transplantation (Auto-PBSCT) on the neuropathic
manifestations of POEMS syndrome
C. Desnuelle, S. Gronier, L. Legros, P.-Y. Jeandel, E. Delmont (Nice, FR)
P633
Relationship between nitric oxide, asymmetric
dimethylarginine levels and diabetic neuropathy
Y. Tamam, E. Uzar, O. Evliyaoglu, A. Tay, F. Kilinc, M. Cevik
(Diyarbakir, TR)
P634
Evaluation of cardiovascular autonomic reflexes in
adolescents with type 1 diabetes mellitus
J. Gutiérrez, P. González, A. Olivares, M. Alvarez, M. Estévez
(Havana, CU)
P635
Serial electrophysiological tests in Bell’s palsy
J.H. Cho, S. Shin (Goyang, KR)
P636
Usefulness of recording the sympathetic sudomotor skin
response together with the evoked potentials in painful
polyneuropathies
G. Barraza-Sandoval, C. Medici, J. Casanova-Mollá, J. Valls-Solé
(Santiago de Chile, CL; Barcelona, ES)
P637
Dynamic thermal testing as an additional test for the
assessment of patients with small fibre neuropathies
C. Medici, G. Barraza-Sandoval, M. Morales, C. Castillo-Hernández,
J. Casanova-Mollá, P. Schestatsky, J. Valls-Solé (Barcelona, ES;
Santiago de Chile, CL; Porto Alegre, BR)
P638
Heat and cold perception in hand palm and dorsum in
patients with small fibre polyneuropathy
A.C. Westgeest, G. Barraza-Sandoval, C. Medici, M. Morales,
J. Casanova-Mollà, J. Valls-Solé (Leiden, NL; Barcelona, ES)
102
Poster Session 2
Somatosensory evoked potentials for early detection of
peripheral nerve dysfunction in patients with chronic alcohol
abuse
W.-K. Kim, J. Shin, J.-H. Lee, H.-K. Song (Seoul, KR)
P640
A rare clinical association: chronic inflammatory
demyelinating polyneuropathy (CIDP) and human
T-lymphocyte virus (HTLV-1)
V. Serban (Philadelphia, US)
P641
Electromyography (EMG) and magnetic resonance imaging
(MRI) in evaluation of root injury in symptomatic cervical
spine disorders (CSD). Specificity and sensitivity test
O. Kwast-Rabben, H. Heikkilä, M. Fagerlund (Umeå, Stockholm, SE)
P642
Electromyography and nerve conduction studies in
patients with lumbar spinal stenosis: is neurophysiological
examination an important tool?
R.S. Scalco, M.S. Ziegler, E.A. Zardo, J. Becker, I. Gomes (Porto
Alegre, BR)
P643
Is carpal tunnel syndrome a slow, chronic, progressive nerve
entrapment?
J. Becker, R.S. Scalco, F. Pietroski, L.F.S. Celli, I. Gomes (Canoas,
Porto Alegre, BR)
11:30 – 12:30 Migraine and pain
Moderator:J. Mawet (Paris, FR)
P646
Ways of coping with pain in the elderly
G. Tanriverdi, H.I. Ozisik Karaman, A. Okanli, H. Cetin,
N. Ozyazicioglu (Canakkale, Erzurum, Mersin, Bursa, TR)
P647
Effectiveness of osteopathic manipulative treatment in
migraine: three-armed randomized controlled trial
F. Cerritelli, L. Ginevri, G. Messi, C. Renzetti, V. Cozzolino,
G. Barlafante, N. Foschi (Pescara, Ancona, IT)
P648
Health-related quality of life among migraine patients
F.J. Carod-Artal, E. Toribio, M.L. Peñas, L. Ruiz, S. Herrero,
A.L. Guerrero (Cuenca, Coslada, Zamora, Toledo, Valladolid, ES)
P649
From wakefulness to sleep: migraine and hypnic headache
association in a series of 15 patients
M. Ruiz, P. Mulero, S. Herrero, C. de la Cruz, J. Barón, M.I. Pedraza,
I. Muñoz, L. López-Mesonero, A.L. Guerrero, J. Porta-Etessam,
J. Pareja (Valladolid, Madrid, ES)
Posters
P639
103
Poster Session 2
P650
Migraine misdiagnosis as sinusitis, a delay that can last for
many years
J.Y. Al Hashel, S.F.A. Mohammad (Safat, KW)
P651
Evaluating quality of life and sleep disorders of migraine
patients at ages 8 to 18
F. Eren, G. Gül (Erzurum, Istanbul, TR)
P652
High asymmetric dimethylarginine levels in migraine during
the interictal period
A. Reyhani, Y. Çelik, T. Asil, H. Karadag, O. Gunduz, N. Sut
(Edirne, TR)
P653
Incobotulinumtoxin A (Xeomin®) in chronic refractory
migraine
G. Castelnovo, A. Le Floch, C. Campello, S. Bouly (Nimes, FR)
P654
Impact of chronic pain on the quality of life of patients with
multiple sclerosis
C. Voiticovschi-Iosob, I. Moldovanu (Chisinau, MD)
P655
Brain structural and functional abnormalities in Fahr’s
disease: report of two cases
R. Messina, M.A. Rocca, B. Colombo, D. Dalla Libera, A. Falini,
G. Comi, M. Filippi (Milan, IT)
P656
Clinical and neuropsychological profile of patients affected
by refractory chronic migraine applying for non-invasive
neurostimulation treatment
D. Dalla Libera, B. Colombo, R. Messina, G. Pavan, L. Leocani,
G. Comi (Milan, IT)
P657
The role of sigma-1 receptor in zymosan-induced
inflammatory pain in rats: involvement of spinal microglia
Y.C. Jeong, Y.B. Kwon (Jeonju, KR)
P658
Fibromyalgia and dissociative experiences
J.M. Duarte, C. Crow, A. Antik, M.F. Otero, H.M. D´Onofrio,
A. Caride, A.C. Bertotti (Buenos Aires, AR)
11:30 – 12:30 Dementia I: treatment and biomarker
Moderator:D. Galimberti (Milan, IT)
P660
The possible effect of computer-assisted cognitive
rehabilitation in acute demarcated brain lesions: pilot study
P. Nilius, P. Ressner, D. Berankova, P. Krulova, L. Holuschova,
H. Srovnalova, M. Bar (Ostrava, CZ)
104
Poster Session 2
Computer-assisted cognitive rehabilitation in stroke and
Alzheimer’s disease: pilot study
P. Ressner, P. Nilius, D. Berankova, H. Srovnalova-Zakopcanova,
P. Bartova, P. Krulova, M. Bar (Ostrava, CZ)
P662
Robotherapy in dementia: pilot study
M. Valentí, C. Mendoza, G. Abella, L. Agüera, J. López, B. Frades,
M. Ávila, M. Fernández, B. León, J. Olazarán, F. Martín, J.M. Cañas,
P. Martínez (Madrid, ES)
P663
Fixed-dose dextromethorphan and quinidine is effective
in the treatment of pseudobulbar affect due to
neurodegenerative conditions: a case series
D. Kantor (Ponte Vedra, US)
P665
Cholinesterase inhibitors affect disease progression in
Alzheimer’s disease
S. Marini, V. Bessi, S. Padiglioni, B. Nacmias, S. Bagnoli, S. Sorbi,
L. Bracco (Florence, IT)
P666
Does low-dose acetyl-salicylic acid reduce cognitive decline
in patient with mild cognitive impairment?
S. Marini, G. Lucidi, V. Bessi, S. Padiglioni, L. Bracco, S. Sorbi
(Florence, IT)
P667
Usefulness of treatment with yokukansan, a traditional
Japanese medicine, in patients with dementia with Lewy
bodies: retrospective observational study for efficacy and
safety of long-term treatment
Y. Ishida, Y. Hayashi, T. Tsuchiya (Miyazaki, JP)
P669
Metaanalysis: donepezil in the treatment of cognitive
impairment and dementia in patients with Parkinson’s
diseases
E. Barcelon, L. Shiong Shiu, P.M. Pasco (Manila, PH)
P670
Cerebrospinal fluid and neuroimaging biomarkers in
posterior cortical atrophy
A. Arighi, C. Donelli, D. Galimberti, A.M. Pietroboni, M. De Riz,
L. Ghezzi, G. Fumagalli, F. Jacini, A. Calvi, S. Zago, E. Rotondo,
P. Corti, M. Mercurio, R. Vimercati, C. Fenoglio, E. Ridolfi,
P671
An investigation into the presence of pyroglutamyl
peptidases in the Alzheimer’s disease brain: relevance to
pathology?
J.E. Holley, J. Slonka, J. Littlechild, N.J. Gutowski (Exeter, UK)
Posters
P661
105
Poster Session 2
P672
Application of new diagnostic criteria using biomarkers in
Alzheimer’s disease continuum
M. Carmona-Iragui, A.M. Carra-Vélez, E. Granell, F. Núñez,
B. Gómez-Ansón, J. Fortea, M. Suarez-Calvet, R. Blesa,
M.B. Sánchez-Saudinós, I. Sala-Matavera, S.S. Antón-Aguirre,
D. Alcolea, A. Lleó (Barcelona, Malaga, ES)
P673
Treatment of mild vascular cognitive impairment
O. Kopchak (Kiev, UA)
P674
Association of leptin levels with cognitive impairment in
patients with metabolic syndrome
O. Kopchak (Kiev, UA)
P675
Post-lumbar puncture complications in the study of
Alzheimer disease biomarkers in cerebrospinal fluid (CSF):
a prospective analysis
E. Morenas-Rodríguez, M. Carmona-Iragui, J. Fortea,
M. Suárez-Calvet, D. Alcolea, A. Lleó (Barcelona, ES)
P676
Non-neuronal tau protein expression
A. Mohring, I. Hilbrich, H. Gruschka, U. Wagner, I. Lachmann,
T. Arendt, M. Holzer (Leipzig, DE)
11:30 – 12:30
Neuro-oncology
P677
Bilateral oculomotor nerve palsy due to
neurolymphomatosis as the initial manifestation of Burkitt’s
lymphoma
V. Zisimopoulou, R. Tsatovidou, S. Ververaki, V. Argiriadou,
A. Tavernarakis (Athens, GR)
P678
Intramedullary spinal cord metastasis presenting as the
initial manifestation of non-small-cell lung cancer: a case
report
S. Pollanz, A. Tinchon, B. Calabek, L. Alpaslan, E. Lindeck-Pozza,
B. Horvath-Mechtler, R. Pöhnl, W. Grisold (Vienna, AT)
P679
Combination treatment for malignant glioblastoma with
tumour necrosis factor-related apoptosis-inducing ligand and
oncolytic adenovirus delta-24
K. Tsamis, G.A. Alexiou, E. Vartholomatos, A.P. Kyritsis (Ioannina, GR)
P680
Radiation-induced myelopathy: a clinical and radiological
improvement after hyperbaric oxygen therapy
C. Andrade, P. Barros, Ó. Camacho, C. Garrett, J. Guimarães
(Porto, PT)
106
Poster Session 2
Optic neuritis as isolated manifestation of neoplastic
meningitis. Case report and review of the literature
L. Borellini, P. Basilico, I. Trezzi, G. Franco, V. Civelli, N. Bresolin,
P. Baron, S. Lanfranconi (Milan, IT)
P682
Multiorgan ischaemic infarcts in invasive fungal infection
S. Shivaprasad, S. Yust-Katz, S. Tummala, I. Tremont-Lukats
(Houston, US)
P683
Severe neurological disability in cancer patients acutely
infected with the West Nile virus (WNV)
J. Mandel, K. Woodman, S. Tummala, I. Tremont-Lukats (Houston,
Texas, Houston, TX, US)
P684
Paraneoplastic opsoclonus-myoclonus-ataxia syndrome in a
patient with an occult thymoma
S. Dias, C. Matos, M. Dias, R. Pedrosa (Lisbon, PT)
P685
Myelomatous meningitis: a rare neurological complication of
multiple myeloma
M. Brum, A.M. Carrilho, A. Santo António, R. Guerreiro (Setubal, PT)
Posters
P681
107
Poster Session 3
17:30 – 18:30
Multiple Sclerosis: clinical aspects III
Moderator:J. Sastre-Garriga (Barcelona, ES)
P686
Female sexual dysfunction and sex hormone level during
menstrual cycle in multiple sclerosis patients
S. Shahdaei, S. Rastyar, M. Moghadasi, F. Alipour, M. Norouzpour,
M.A. Edalatmanesh (Fars, Shiraz, IR)
P687
Rasch and traditional validation of the COSM-R, a
questionnaire on satisfaction with communication of
multiple sclerosis diagnosis
A. Solari, M. Grzeda, A. Giordano, A. Simone, L. Vignatelli,
K. Mattarozzi, R. D’Alessandro, L. Tesio on behalf of the Agorà,
GERONIMUS, SIMS-Trial and SIMS-Practice groups
P688
Unmet needs of people with severe multiple sclerosis and
their carers: qualitative data to construct a home palliative
care programme
C. Borreani, E. Bianchi, S. Cilia, M. Giuntoli, E. Pietrolongo,
I. Rossi, M.G. Grasso, F. Patti, L. Lopes, A. Lugaresi, P. Confalonieri,
P. Morino, L. Palmisano, G. Martino, M. Ponzio, R. Amadeo,
P. Zaratin, M.A. Battaglia, A. Giordano, A. Solari on behalf of the
PeNSAMI project
P689
Which test is most suitable to assess cognitive impairment
in multiple sclerosis? Comparison of neuropsychological
standard tests and the paradigm of visual search
K.S. Utz, T.M.A. Hankeln, A. Waschbisch, D.-H. Lee, R.A. Linker,
T. Schenk (Erlangen, DE)
P690
Lower functional connectivity in the default network of
memory-impaired patients with multiple sclerosis (MS)
V.M. Leavitt, J. Paxton, J.F. Sumowski (West Orange, US)
P691
Lifetime hazard of patients with multiple sclerosis according
to the database of the Department of Neurology at the
University of Szeged between 1993 and 2013
V. Zsiros, D. Sandi, J. Fuvesi, Z.T. Kincses, Z. Fricska-Nagy, M. Karacsony,
H. Huszka, G. Lencses, L. Vecsei, K. Bencsik (Szeged, HU)
P692
Use of optical coherence tomography in multiple sclerosis
patients
Z. Vladimirova, S. Cherninkova (Sofia, BG)
P693
Birth outcomes in fathers with multiple sclerosis
E. Lu, F. Zhu, Y. Zhao, M. van der Kop, A. Synnes, L. Dahlgren,
A.D. Sadovnick, A. Traboulsee, H. Tremlett (Vancouver, CA)
108
P694
Does exercise improve cognitive function in multiple
sclerosis? Report of a pilot study
B. Sangelaji, S.M. Nabavi (Tehran, IR)
P695
The relationship between fatigue and severity of disability
in multiple sclerosis
M. Heidari, M. Akbarfahimi, S.M. Nabavi (Tehran, IR)
P696
Long-term health-related quality of life in Hungarian
patients with multiple sclerosis
J. Füvesi, R. Januska, K. Bencsik, G. Lencsés, Z. Fricska-Nagy,
E. Losonczi, C. Rajda, É. Langane, M. Török, L. Vécsei (Szeged, HU)
P698
Cognitive decline emerges beneath a critical threshold
of total brain volume in patients with multiple sclerosis:
support for the brain reserve hypothesis
J.F. Sumowski, M.A. Rocca, V.M. Leavitt, G. Riccitelli, G. Comi,
J. DeLuca, M. Filippi (West Orange, US; Milan, IT)
P699
Multiple sclerosis and extra central nervous system
malignancies
I. Moreira, A. Martins Silva, E. Santos (Porto, PT)
P700
Movement disorders in two multiple sclerosis centres in
Venezuela
A. Soto, O Molina, M. Camacaro, I. Soto, M. Gallardo, R. León
(Caracas, Maracaibo, Valencia, VE)
P701
Impaired deficit recognition in multiple sclerosis
E. Reich, E. Arias, C. Torres, E. Halac, M. Kerszberg, M. Carlino
(Caba, AR)
P702
Rio score and modified Rio score validation in an Italian
cohort of relapsing-remitting multiple sclerosis patients
M. Romeo, V. Martinelli, M. Rodegher, S. Maida, E. Perego,
G. Comi (Milan, IT)
P703
Study of magnetisztion transfer MRI in clinically isolated
syndromes (CIS)
C. Oreja-Guevara, A. Royo, S. Noval, J. Alvarez-Linera (Madrid, ES)
P704
Risk-associated behaviour in multiple sclerosis: a case control
study
C.H. Hawkes, D. Boniface (London, UK)
P705
Frequency of HLA DRB1 gene alleles in patients with
multiple sclerosis and the importance of disease course in a
Lithuanian population
R. Balnyte, D Rastenyte, A. Vaitkus, I. Urbonaviciute,
A. Vitkauskiene, E. Skrodeniene (Kaunas, LT)
109
Posters
Poster Session 3
Poster Session 3
P706
Regional analysis of grey matter damage in AfricanAmericans with multiple sclerosis
M. Petracca, R. Teodorescu, J. Howard, L. Fleysher, N. Oesingmann,
I. Katz-Sand, J. Herbert, P. Carrieri, M. Inglese (Naples, IT;
New York, US)
P707
Cerebrospinal fluid (CSF) free light chains: diagnostic and
predictive relevance in multiple sclerosis and clinically
isolated syndrome
M. Senel, J. Brettschneider, H. Tumani (Ulm, DE)
P708
Japanese cases of neuromyelitis optica spectrum disorder
associated with myasthaenia gravis and a review of the
literature: a multicentre cooperative study
R. Ikeguchi, Y. Shimizu, S. Suzuki, K. Chiaki, M. Ubano,
S. Hashimoto, M. Masuda, Y. Nagane, K. Utsugisawa, Y. Suzuki,
Y. Takahashi, H. Utsumi, K. Fujihara, N. Suzuki, S. Uchiyama on
behalf of The East Japan MG Study Group
P709
Phenotype of neuromyelitis optica in the Czech Republic
P. Zbornikova, P. Nytrova, E. Havrdova, M. Tyblova, J. Lizrova
Preiningerova, I. Kovarova, V. Kral, E. Krasulova, M. Vaneckova,
D. Horakova (Prague, Usti, CZ)
P710
Development of a clinical practice guideline on the
managment of multiple sclerosis using the GRADE
methodological approach
S. Otero-Romero, M.D. Estrada, J. Sastre-Garriga, M. Tintoré,
A. Saiz, L.L. Ramió-Torrentà, D. Benítez, M. Espallargues,
X. Montalban (Barcelona, Girona, ES)
17:30 – 18:30 Cerebrovascular disorders: treatment
Moderator:J.M. Ferro (Lisbon, PT)
P711
Comparison of stroke awareness in Munich and Moscow
Y. Fris, R. Kalla, P. Kamchatnov (Moscow, RU; Munich, DE)
P712
Ensuring optimal nutrition in acute stroke units: development
of an evidence-based national practice guideline
M. Karaliute, A. Eltoft, M.T. Børvik, S.H. Johnsen, H. Nilssen,
I. Rasmussen, M.T. Kampman (Trondheim, Tromsø, NO)
P713
The prospective profile of endovascular coiling of cerebral
aneurysms:the impact of clinical presentation, procedural
results, aneurysm rupture and location
M.H. Harirchian, M. Mousavi, H. Ghanaati (Tehran, IR)
110
P714
Neuroprotective effect of cathodal transcranial direct current
stimulation
M. Pace, F. Baracchi, A. Uncini, C.L. Bassetti (Bellinzona, Berne, CH;
Chieti, IT)
P715
A pilot study to determine neuroprotective effects of
memantine in patients with mild-to-moderate ischaemic
stroke
M. Sistanzad, H. Kafi, J. Salamzadeh (Tehran, IR)
P716
Is the quality of life of stroke patients improved with the
new anticoagulants compared with anti-vitamin K? An
observational prospective study
P. Martinez-Sanchez, B. Fuentes, G. Ruiz-Ares,
J. Fernandez-Travieso, E. Diez-Tejedor (Madrid, ES)
P717
Intra-arterial eptifibatide: a treatment option for thrombotic
complications of aneurysm embolization
A.C. Mergeani, D. Popescu, B. Dorobat, A. Roceanu,
O.A. Bajenaru, F.A. Antochi (Bucharest, RO)
P718
Can we predict which patients will not respond to
intravenous recombinant tissue plasminogen activator (rt-PA)
for ischaemic stroke?
M. Apoil, G. Turc, A. Tataru, R. Allibert, J.-F. Meder, J.L. Mas,
J.-C. Baron, C. Oppenheim, E. Touze (Caen, Paris, FR)
P719
Transient bullous rash: a rare form of severe dermatologic
adverse reaction following the administration of tissue
plasminogen activator (TPA) in a case of acute stroke
S. Sabetay, Y. River, W. Zoabi (Hadera, IL)
P720
Association between prehospital stroke scale (TOPSPIN)
scores and outcome in tissue-plasminogen activator (t-PA)
intravenous therapy
N. Nakai, A. Ogura, K. Imai, S. Nishida, Y. Ito, T. Yasuda
(Toyota City, JP)
P721
Non-linguistic approach in informed consent for stroke
patient`s family
Y. Furuno, H. Sasajima, K. Aita, T. Kawabe, K. Owada,
K. Tatsuzawa, K. Mineura (Kyoto, JP)
P722
Stroke outcomes in the long-term
I. Pershyna (Kharkiv, UA)
P723
Haemorrhagic stroke: clinical and social impact
B. Pedro, H. Vieira Dias, A. Oliveira, S. Nascimento, F. Roque
(Santarem, PT)
111
Posters
Poster Session 3
Poster Session 3
17:30 – 18:30 Extrapyramidal disorders: other
Moderator:C. Falup-Pecurariu (Brasov, RO)
P724
Clinical and electrophysiological assessment of
dysautonomia in multisystem atrophy (MSA) and
progressive supranuclear palsy (PSP). A comparative study
B. Zakrzewska-Pniewska, M. Nojszewska, A. Potulska-Chromik,
Z. Jamrozik, P. Janik (Warsaw, PL)
P725
Role of D1-H3 heteromers in modulating neuronal death:
potential target for Huntington’s disease
D. Moreno-Delgado, E. Moreno, M. Rodriguez-Ruiz, J. Mallol,
V. Casado, A. Cortes, C. Lluis, P.J. McCormick (Barcelona, ES)
P726
Cognitive performance and dopamine receptor
pattern expression of prefrontal cortex in unilateral
6-hydroxydopamine rat model of Parkinsonism
F. Arenas, M.V. Sosti, G. Frigola, J. Kulisevsky (Barcelona, ES)
P727
Botox use for dystonia in patients with progressive
supranuclear palsy
D. Apetauerova, S. Scala (Burlington, US)
P728
Are patients with cervical dystonia being adequately
consented for treatment with botulinum toxin?
A documentation audit
S. Williams, J. Cosgrove, S. Jamieson (Leeds, UK)
P729
An epidemiological study of neurodegenerative
Parkinsonism prevalence in the population of ‘Upper Land’
in south-eastern Moravia, Czech Republic
K. Mensikova, P. Kanovsky, M. Kaiserova, L. Mikulicova, M. Vastik,
P. Jugas, J. Ovecka, L. Sachova, F. Dvorský, J. Krsa, V. Janout
(Olomouc, Veselí nad Moravou, Lipov, Velká nad Velickou, Blatnice
pod Svatým Antonínkem, CZ)
P730
Does education have a beneficial effect on behavioural
abnormalities in Huntington’s disease?
A.M. Lopatkiewicz (Krakow, PL)
P731
Brain structural changes in primary focal dystonia
L. Sarro, F. Agosta, A. Tomic, M. Svetel, F. Caso, N. Kresojevic,
V.S. Kostic, M. Filippi (Milan, IT; Belgrade, RS)
P732
SPECT imaging of dopamine transporters in patients with
Parkinsonism with scatter and attenuation correction.
T. Sasaki, J. Hashimoto, T. Amano, T. Furuya, N. Araki (Saitama,
Kanagawa, Tokyo, JP)
112
Poster Session 3
Evidence of delayed nigrostriatal dysfunction in corticobasal
syndrome: a SPECT follow-up
C. Rossi, R. Cilia, E. Unti, E. Dini, C. Del Gamba, U. Bonuccelli,
R. Ceravolo (Pisa, Milan, IT)
P734
Iodine-123 metaiodobenzylguanidine scintigraphy and skin
biopsy findings in Parkinson’s disease and parkinsonism: a
comparative study
M.P. Giannoccaro, V. Donadio, A. Incensi, P. Martinelli,
C. Scaglione, E. Cason, G. Treglia, G. Fagioli, R. Liguori (Bologna,
Roma, IT)
P735
Brain iron accumulation in calcium-independent
phospholipase A2 beta knockout mice
G. Beck, H. Sumi-Akamaru, K. Shinzawa, T. Yasuda, Y. Tsujimoto,
H. Mochizuki (Suita, JP)
P736
Brainstem and cerebellar encephalopathy with fluctuating
extra ocular palsies, asymmetric leg myoclonus and ataxia
in a 72 year old patient with antibodies against contactinassociated protein 2 (CASPR2)
K. Sedlakova, S.G. Paal, P. Oschmann, U. Hofstadt-van Oy
(Bayreuth, DE)
P737
Impact of kidney transplantation on restless legs syndrome
J. Martinkova, M. Chrastina, Z. Zilinska, P. Valkovic, M. Minar
(Bratislava, SK)
P738
High prevalence of restless legs syndrome in poliomyelitis
E. Portell, H. Kumru, R. Pelayo (Barcelona, ES)
P739
Prevalence of tremor in patients with adult coeliac disease
M. Moccia, R. Tortora, G. Santangelo, A. Rispo, I. Improta, R. Erro,
R. Allocca, P. Barone, C. Vitale (Naples, Salerno, IT)
P740
Parkinsonism after Hymenoptera sting
D. Apetauerova, M. Alias (Burlington, US)
P741
Multiple system atrophy as a possible new presentation of
DYT5 mutations
V. Nicoletti, L. Kiferle, C. Reale, G. Linsalata, B. Garavaglia,
U. Bonuccelli, R. Ceravolo (Pisa, Milan, IT)
P742
Clinical variability in a DYT6 family with a novel THAP1
mutation
D. Momcilovic-Kostadinovic, A. Potic, J. Vujovic, M. LeDoux
(Belgrade, RS; Memphis, US)
P743
Brain iron accumulation in juvenile Huntington’s disease
A. Macerollo, A. Batla, M. Stamelou, K. Bhatia (London, UK)
Posters
P733
113
Poster Session 3
P744
Variation of muscle activity in REM sleep in patients with
REM sleep behaviour disorder (RBD) and controls during
consecutive nights
G. Mayer, K. Kesper, W. Oertel (Schwalmstadt-Treysa, Marburg, DE)
17:30 – 18:30 Epilepsy II: investigations and therapeutics
Moderator:E. Varga (Szeged, HU)
P745
Safety study on prolonged video-EEG monitoring: the riskbenefit ratio
M. Ley, R. Vivanco, J. Jiménez, J. Roquer, R. Rocamora (Barcelona, ES)
P746
New approach of repetitive transcranial magnetic
stimulation used for the treatment of resistant epilepsy
V. Kistsen, V. Siamashka, V. Evstigneev, B. Dubovik (Minsk, BY)
P747
Early EEG predicts seizures after ischaemic stroke
M. Galovic, B. Erdelyi, F. Wagner, N. Döhler, P. Hakman, D. Flügel,
A. Felbecker, B. Tettenborn (St. Gallen, Zürich, CH)
P748
Fuzzification of epileptic data: an application for prediction
and identification of partial seizure
A.S. Malik, M. Shakir, N. Kamel, U. Qidwai (Tronoh, MY; Doha, QA)
P749
A new method for electroencephalography trace recording
in children younger than two years: an observational study
K. Nikkhah, A. Shoeibi (Mashhad, IR)
P751
What is the predictive value of postoperative EEG on
epilepsy surgical outcome in children?
K. Nickels, L. Wong-Kisiel, E. Wirrell (Rochester, US)
P752
Post-surgical outcome in children with focal cortical
dysplasia
M. Sigatullina, G. Garcia, J. Aparicio, J. Relova, J. Eiris, F. Sanmarti
(Santiago de Compostela, Barcelona, ES)
P753
Clinical spectrum, seizure outcomes, correlation of
neuroradiology and neuropathology in surgically-treated
epileptic patients
A.I. Uysal, Z. Gökçil (Kayseri, Ankara, TR)
P754
Hippocampal atrophy in patients with posttraumatic
epilepsy
S.C. Lim, S.-H. Kim, Y.-M. Shon (Suwon, Seoul, KR)
P756
SCN1A gene polymorphism and response to antiepileptic
treatment
C. Aggelopoulou, S. Veletza, I. Heliopoulos, G. Tripsianis,
C. Piperidou (Alexandroupolis, GR)
114
P757
Clarithromycin-induced acute carbamazepine intoxication in
three patients with refractory epilepsy
T. Uyar, N. Bebek, A. Aysen (Istanbul, TR)
P758
Slow and fast inactivation of hNav1.3 voltage-gated sodium
channels by eslicarbazepine, R-licarbazepine and lacosamide
P. Soares-da-Silva, S. Heibesen (Trofa, PT; Witterswil, CH)
P759
A pooled analysis of the tolerability of approved dosages
of eslicarbazepine acetate as adjunctive therapy for adult
patients with partial-onset seizures up to one year of followup
C. Elger, E. Ben-Menachem, A. Gil-Nagel, R. Sousa, T. Nunes,
P. Soares-da-Silva (Bonn, DE; Gothenburg, SE; Madrid, ES; Trofa, PT)
P760
A pooled analysis of the efficacy of approved dosages of
eslicarbazepine acetate as adjunctive therapy for adult patients
with partial-onset seizures up to one year of follow-up
A. Gil-Nagel, C. Elger, E. Ben-Menachem, R. Sousa, T. Nunes,
P. Soares-da-Silva (Madrid, ES; Bonn, DE; Gothenburg, SE; Trofa, PT)
P761
Pooled analysis of individual patient-level data from
European observational studies on zonisamide use in routine
clinical practice: efficacy and tolerability
S. Dupont, M. Brodie, A. Francia, K.O. Nakken, J. Pardo, H. Stefan,
S. Leproust, M. Bagul, I. Chouette, B. Allaf (Paris, FR; Glasgow, UK;
Rome, IT; Norway, NO; Santiago de Compostela, ES; Erlangen, DE;
Hatfield, UK)
P762
Seizure response and tolerability to antiepileptic drug
treatment across different age groups
M. Belluzzo, L. Stragapede, F. Monti, G. Pizzolato (Trieste, IT)
P763
Vagus nerve action potentials in vagus nerve stimulation for
epilepsy
M.P. Ward, D. Sabau, J.C. Kincaid, V. Salanova, R.M. Worth,
P.P. Irazoqui (West Lafayette, Indianapolis, US)
P764
Changes in body weight during long-term topiramate
therapy in epilepsy patients
A. Ilic (Belgrade, RS)
17:30 – 18:30
Clinical neurophysiology II
Moderator:R. Dengler (Hannover, DE)
P765
Event related potentials in patients with hyperthyroidism
H. Yasar, H. Akgün, A. Tasliinar, M. Yücel, S. Alay, O. Öz, Ü.H. Ulas,
S. Demirkaya (Ankara, TR)
115
Posters
Poster Session 3
Poster Session 3
P766
Rapid therapeutic response to anodal transcranial direct
current stimulation (tDCS) of right dorsolateral prefrontal
cortex in acute mania
P. Schestatsky, N. Janovik, M.I. Lobato, P. Belmonte-de-Abreu,
S. Schestatsky, P. Shiozawa, F. Fregni (Porto Alegre, São Paulo, Brz;
Boston, US)
P767
Improved naming after excitatory repetitive deep
transcranial magnetic stimulation over the right homologous
Broca’s region in chronic post-stroke aphasia
R. Chieffo, F. Ferrari, P. Battista, E. Houdayer, A. Nuara,
F. Alemanno, J. Abutalebi, A. Zangen, G. Comi, S. Cappa,
L. Leocani (Milan, IT)
P768
Repetitive transcranial magnetic stimulation (rTMS) in the
prophylactic treatment of chronic migraine:a double-blind,
randomized, placebo-controlled study
D. Dalla Libera, B. Colombo, A. Nuara, L. Straffi, F. Spagnolo,
M. Fichera, E. Coppi, L. Ferrari, G. Di Maggio, E. Houdayer,
R. Chieffo, A. Zangen, G. Comi, L. Leocani (Milan, IT; Rehovot, IL)
P770
Selective motor cortex activation in pianists’ brains during
music listening: a combined EEG and TMS study
A. Nuara, E. Houdayer, J. Gonzalez-Rosa, R. Chieffo, F. Spagnolo,
G. Comi, L. Leocani (Milan, IT)
P771
Disorder of inhibition of forearm reflexes in the nonparalyzed side of patients with acute stroke
M. Morales, M. Fernández-Lobera, J. Valls-Solé (Barcelona, ES)
P772
Right S2 cortex: an effective target for the treatment of
neuropathic pain with transcranial magnetic stimulation
P. Lindholm, S. Lamusuo, A. Lahti, U. Pesonen, T. Taiminen,
A. Virtanen, H. Forssell, J. Hietala, N. Hagelberg, R. Parkkola,
S.K. Jääskeläinen (Salo, Turku, FI)
P773
Sport addiction EEG indices: perspectives for treatment
S.G. Krivoschekov, O.N. Lushnikov (Novosibirsk, RU)
P774
Different types of vasovagal reaction observed during tiltinduced syncope in syncopal migraine patients
O. Grosu, G. Corcea, S. Odobescu, I. Moldovanu (Chisinau, MD)
P775
Computerized detection of movement artifacts in
polysomnogram data
J. Fairley, G. Georgoulas, A. Johnson-Long, C. Stylios, D. Bliwise,
D. Rye (Atlanta, US; Arta, GR)
116
P776
Sleep-wake patterns in vegetative state: 24 hour
polysomnographic findings in 27 subjects
R. Cremascoli, D. Arnaldi, F. De Carli, M. Terzaghi, G. Maggioni,
C. Pistarini, A. Moglia, R. Manni (Pavia, Genoa, Genova, IT)
P777
Multi-trial extended subspace-based approach for visually
evoked potentials (VEPs) extraction
N. Kamel, A.S. Malik (Tronoh, MY)
P778
Sensitivity of optical coherence tomography and visual
evoked potentials in multiple sclerosis
G. Di Maggio, B. Mariangela, R. Santangelo, L. Ferrari, S. Guerrieri,
S. Medaglini, M. Rodegher, B. Colombo, L. Moiola, U. Del Carro,
V. Martinelli, G. Comi, L. Leocani (Milan, IT)
P779
Investigation of central motor pathways in multiple sclerosis
with transcranial magnetic stimulation
K. Oikonomidi, V. Kimiskidis, S. Papagiannopoulos, M. Karagianni,
O. Argiropoulou, E. Koutsouraki, N. Vlaikidis (Thessaloniki, GR)
P780
Event-related P300 potentials, cognitive impairment and
brain atrophy in multiple sclerosis (MS)
N. Tevzadze (Tbilisi, GE)
P781
Traumatic lingual nerve injury assessed by sensory threshold
and masseter inhibitory reflex
C. Cabib, F. Biglioli, J. Valls-Solé, A. Lozza (Barcelona, ES; Milan, IT;
Pavia, IT)
P782
Shortening reaction time of eye opening with the StartReact
effect in blepharospasm
T. Serranová, T. Sieger, JM. Castellote, J. Roth, R. Jech, J. Valls-Solé
(Prague, CZ; Madrid, ES; Barcelona, ES)
P783
Pathophysiology of trigeminal blink reflex hyperexcitability
in patients with progressive supranuclear palsy
M. Bologna, C. Piattella, A. Formica, A. Conte, G. Fabbrini,
C. Colosimo, P. Pantano, A. Berardelli (Rome, IT)
P784
Tongue somatosensory evoked potentials: evaluation of the
afferent trigeminal pathway in patients with early multiple
sclerosis
M. Krbot Skoric, T. Gabelic, I. Adamec, M. Habek (Zagreb, HR)
P785
A comparative study of repetitive transcranial magnetic
stimulation for tinnitus treatment in an Asian population
Y.L. Lo, P.W.T. Cheong, M.C. Wong, S. Fook-Chong, H.W. Yuen,
Y.M. Chan (Singapore, SG)
117
Posters
Poster Session 3
Poster Session 3
P786
Ocular vestibular evoked myogenic potentials (VEMPs)
indicate repositioning of otoconia to the utricle
T. Bremova, M. Strupp, Y. Agrawal, O. Kremmyda, T. Brandt,
J. Teufel (Munich, DE; Baltimore, US)
P787
Vestibular ocular reflex dynamics during passive headimpulses: slow phase eye velocity and saccadic response
profiles in central and peripheral vestibular lesion patients
L. Luis, J. Costa, E. Muñoz, N. Lehnen, E. Schneider, J. Valls-Sole
(Lisbon, PT; Barcelona, ES; Munich, DE)
P788
Neurogenic vestibular evoked potentials: bilateral sound
stimulation does not produce waveforms that may be
vestibular in origin
E. Papathanasiou, M. Lazarou, S. Papacostas (Nicosia, CY)
P789
The role of cervical and ocular vestibular evoked myogenic
potentials in the follow-up of vestibular neuronitis
I. Adamec, M. Krbot Skoric, J. Handzic, A.K. Barusic, I. Bach,
T. Gabelic, M. Habek (Zagreb, HR)
P790
The evolution of visual evoked potentials (VEP) parameters
in the course of multiple sclerosis (MS)
B. Zakrzewska-Pniewska, M. Nojszewska, B. Jakubiak-Mazur,
Z. Lewandowski (Warsaw, PL)
17:30 – 18:30 Headache: other
Moderator:P. Schestatsky (Porto Alegre, BR)
P791
Headache and neurocysticercosis
A. Villalobos, C. Carpio (Lima, PE)
P792
Diagnostic difficulties in spontaneous intracranial
hypotension: case presentation
M. Sabau, M. Egri, L. Vaida, I. Popa (Oradea, Cluj-Napoca, RO)
P793
Spontaneous intracranial hypotension as the manifestation
of a spinal angiolipoma
S. Dias, A.P. Sousa, R. Relvas, L. Cerqueira, R. Pedrosa (Lisbon, PT)
P794
Bilateral episodic paroxysmal hemicrania: a case
presentation
Y. Kaplan, O. Kamisli, S. Kamisli, S. Altinayar, C. Ozcan (Malatya, TR)
P795
Postural headache: a challenging diagnosis
S. Varanda, J. Pinho, E. Lourenço, G. Carneiro (Braga, PT)
118
P796
Cerebral venous thrombosis in two patients with
spontaneous intracranial hypotension
M.C. Garcia Carreira, D. Canovas, J. Estela, E. Tió, M. Zauner,
J. Branera, G. Ribera (Sabadell, ES)
P797
Plasma adrenomedullin and calcitonin gene-related peptide
levels in tension-type headache and fibromyalgia
A.M. Neyal, S. Saglam, A. Aydeniz, R. Anarat, F. Yimenicioglu,
A. Neyal, S. Gursoy, A. Balat, M. Yilmaz, A. Akcali, R. Yigiter
(Gaziantep, Adiyaman, Adana, Eskisehir, TR)
P798
Psychological profile of a series of patients with epicrania
fugax
J.L. González-Gutiérrez, M.L. Cuadrado, I. Muñoz,
S. Hernández-Díaz, C.M. Ordás, A.L. Guerrero, A. López-López
(Madrid, Valladolid, ES)
P799
Chronic tension-type headache management with the
emotional freedom technique
A. Bougea, N. Spandideas, T. Thomaides, E. Stamboulis,
E. Kararizou, E. Kapaki, G. Chrousos, C. Darviri (Athens, GR)
P800
No olfactory deficit in episodic cluster headache
S. Naegel, N. Buckanie, D. Holle, F. Rosenow, S. Knake, H.-C. Diener,
Z. Katsarava, M. Obermann (Essen, Marburg, Unna, DE)
P801
Clinical features of mild or moderate headaches caused by
symptomatic cysts of the septum pellucidum
K. Takagi, K. Yamazaki, R. Hishida, M. Arai, S. Nojima,
H. Kobayashi (Inashikigun, JP)
P802
Primary stabbing headache: a new dural sinus stenosisassociated primary headache?
S. Montella, A. Ranieri, M. Marchese, R. De Simone (Naples, IT)
P803
A case of idiopathic intracranial hypertension without
papilloedema and Meniere disease in comorbidity
responsive to repeated lumbar punctures. A possible link
between two enigmatic conditions
A. Ranieri, S. Montella, M. Marchese, M. Cavaliere, S. Sicignano,
R. De Simone (Naples, IT)
P804
Headache and neurological deficits with lymphocytosis: no
correlation between focal deficit topography and EEG or
SPECT abnormalities in a series of five new cases
J. Barón, P. Mulero, M.I. Pedraza, C. Gamazo, C. De la Cruz,
M. Ruiz, M. Abete, M.C. Cebrian, M. Ayuso, P. García-Talavera,
M. Toledano, D. Ezpeleta, A.L. Guerrero (Valladolid, Madrid, ES)
119
Posters
Poster Session 3
Poster Session 3
P805
Headache in the elderly: clinical characteristics in a series of
305 patients
M. Ruiz, M.I. Pedraza, A.L. Guerrero, S. Herrero, C. de la Cruz,
J. Barón, I. Muñoz, B. Ayllon, M. Celorrio, C. Rodríguez, J. Carrión
(Valladolid, ES)
P806
Nummular headache: a series of 100 patients
M.I. Pedraza, E. Cortijo, S. Herrero, M. Ruiz, I. Muñoz, J. Barón,
C. Rodríguez, M. Celorrio, A.L. Guerrero (Valladolid, ES)
P807
Characteristics of headaches in an outpatient headache clinic
registry: results of the first 2000 patients
M.I. Pedraza, L. Bautista, A.L. Guerrero, S. Herrero, M. Ruiz,
C. de la Cruz, J. Barón, J. Carrión, B. Ayllón, M. Celorrio,
L. López-Mesonero, P. Mulero, C. Rodríguez, E. Rojo (Valladolid, ES)
P808
Reversible parieto-occipital ischaemia in a patient with aura
without headache treated with lamotrigine: a case report
H. Akgün, M. Yücel, S. Tasdemir, S. Alay, O. Öz, Ü.H. Ulas,
S. Demirkaya (Ankara, Istanbul, TR)
17:30 – 18:30
Dementia and higher function disorders
Moderator:E. Scarpini (Milan, IT)
P809
Anton´s syndrome and posterior cortical atrophy
C. Abdelnour Ruiz, V. Galán Sánches-Seco, P. Nieto González,
M. León Ruiz, M. Molina Sánchez, A. Parra Santiago, F. Cabrera
Valdivia, E. García-Albea Ristol, M.A. García-Soldevilla (Madrid, ES)
P810
Brain metabolic dysfunction in Capgras syndrome during
Alzheimer’s disease: a positron emission tomography study
H. Jedidi, N. Daury, R. Capa, M.A. Bahri, F. Collette, D. Feyers,
C. Bastin, P. Maquet, E. Salmon (Liège, BE)
P811
Subtle language in patients with stroke
M. Rousseaux, P. Dei Cas, S. Gossery, C. Jaman, O. Kozlowski (Lille, FR)
P812
Comparative characteristics of cognitive disorders in stroke
in men and women
Y. Abramenko, N. Iakovlev, T. Slyusar (Tver, RU)
P813
Age modulates the decline of verbal fluency after deep brain
stimulation (DBS) in patients with Parkinson’s disease (PD)
U. Gschwandtner, N. Benz, R. Zimmermann, F. Hatz,
M. Ehrensperger, E. Taub, C. Schindler, P. Fuhr (Basel, CH)
P814
Quantitative EEG (QEEG) for identification of attention
deficits in Parkinson’s disease (PD)
R. Zimmermann, U. Gschwandtner, N. Benz, F. Hatz, C. Schindler,
V. Roth, P. Fuhr (Basel, CH)
120
P815
Mild cognitive impairment (MCI) in Parkinson’s disease
(PD-MCI) and in probable Alzheimer’s disease (AD-MCI)
with similar mini-mental state exams (MMSE) differ in
quantitative EEG (QEEG) patterns
N. Benz, F. Hatz, M. Hardmeier, U. Gschwandtner, M. Ehrensperger,
S. Rueegg, R. Zimmermann, A.U. Monsch, P. Fuhr (Basel, CH)
P816
Cognitive impairment in general paresis: Alzheimer’s disease
(AD)-like pattern?
A. Altinkaya, M. Ozerden, N. Behrem, M. Colak, N. Karagöz
Sakalli, P.N. Sütlas, D. Kirbas, B. Topcular (Istanbul, TR)
P817
Clinical and neuropsychiatric profiles of early versus lateonset Alzheimer’s disease
V. Constantinides, S. Matsi, T. Kontaxis, V. Pappas, A. Kyrozis,
A. Bonakis, N. Kalfakis, S.G. Papageorgiou (Athens, GR)
P818
Rapidly progressive frontotemporal dementia due to the
progranulin gene Arg110X mutation
L. Ghezzi, A. Pietroboni, A. Arighi, F. Jacini, G. Fumagalli,
C. Donelli, A. Calvi, C. Fenoglio, M. Serpente, E. Ridolfi,
D. Galimberti, E. Scarpini (Milan, IT)
P819
Activation of the semantic associative relations in ageing:
resilient features
D. Di Giacomo, S. De Federicis, M. Palmiero, D. Passafiume
(L’Aquila, IT)
P820
Precuneus volumes and cognitive tests in older adults
A. Luedke, E. Dowds, A. Tam, A. Goel, J. Fernandez-Ruiz, A. Garcia
(Kingston, CA; Mexico City, MX)
P821
Do different profiles exist for white matter hyperintense
lesions in patients with cognitive impairment?
Á. Martín-Montes, B. Fuentes Gimeno, A. Frank García,
A. Simón Gozalbo, C. Acedo, E. Díez Tejedor (Madrid, ES)
P822
Neuropsychological parameters associated with driver
distraction in a driving simulator experiment: presentation
of methodology and preliminary findings
A. Economou, I. Beratis, M. Kosmidis, A. Loisidou, N. Andronas,
J. Papatriantafyllou, G. Yannis, S. Papageorgiou (Athens,
Thessaloniki, GR)
P823
Cerebral blood flow velocity changes during exposure to
noise and mental task performance
M. Nowakowska-Kotas, A. Pokryszko-Dragan, M. Brodowski,
M. Szydlo, R. Podemski (Wroclaw, Nowa Sol, PL)
121
Posters
Poster Session 3
Poster Session 3
P824
Burden of Alzheimer’s disease in the population of the
Basque Country and impact of potential early interventions
J. Mar, M. Soto, A. Arrospide, P. Martinez-Lage, F. Moreno-Izco
(Mondragon, Donostia-San Sebastian, ES)
P825
A Bulgarian family with Gerstmann-Straussler-Scheinker
disease and PrP-P102L mutation in PRNP gene
S. Zhelyazkova, T. Chamova, V. Guergueltcheva, N. Nikoevski,
M. Van den Broeck, A. Jordanova, C. Van Broeckhoven, I. Tournev
(Sofia, BG; Antwerp, BE)
P826
The many faces of sporadic Creutzfeldt- Jacob’s disease: a
one year case series at a tertiary hospital in Athens
C. Giavasi, C. Liantinioti, I. Myta, A.M. Simitsi, C. Zompola,
C. Arvaniti, L. Stefanis, S.G. Papageorgiou (Haidari, GR)
P827
Mortality and morbidity in patients with neurodegenerative
diseases (amyotrophic lateral sclerosis + Parkinson’s disease
+ dementia + essential tremor), A comparative study in
Turkish society
H.A. Idrisoglu, N. Polat (Istanbul, TR)
P828
Multidisciplinary approach to mild cognitive impairment
(MCI) helps to evaluate risk of conversion in Alzheimer’s
disease
G. Lucidi, S. Marini, B. Nacmias, V. Berti, S. Sorbi, A. Pupi (Florence, IT)
P829
A case of atypical Alzheimer’s disease carrying the missense
mutation Thr354Ile in the exon 10 of PSEN1 gene
G. Lucidi, S. Marini, B. Nacmias, A. Tedde, S. Bagnoli, I. Piaceri,
S. Sorbi (Florence, IT)
17:30 – Neurogenetics
18:30
P830
Genotype-phenotype correlations of cognitive impairment
and neuroimaging features of patients with myotonic
dystrophy type 1
T. Chamova, V. Guergueltcheva, M. Raycheva, D. Zlatareva,
A. Shopova, T. Todorov, A. Todorova, I. Tournev (Sofia, BG)
P832
Molecular characterization of Parkinson’s disease in Saudi
Arabia
D. Khalil, S. Boholega, T. Alkhairallah, B. Tawil, L. Al-Jomaa,
H. AbouAl-Shar, A. Magrashi, N. Al Tassan (Riyadh, SA)
P834
Novel mutation in CSF1R gene causing hereditary diffuse
leukoencephalopathy with spheroids
Y. Harigaya, H. Yokoo, S. Nagamine, A. Sekine, K. Mizushima,
T. Ikeuchi (Maebashi, Niigata, JP)
122
Poster Session 3
A study of the genetic markers of thromophilia in ischaemic
stroke patients from north India
P. Correia, V. Arya, R. Ranjan, C.S. Agrawal, M. Bhargava
(New Delhi, IN)
P836
Encephalopathy and mtDNA depletion due to a novel
mutation in ADP-forming succinyl-CoA synthetase
E. Jaberi, B. Farham, F. Chitsazian, G.A. Shahidi, M. Rohani, F. Sina,
E. Elahi (Tehran, IR)
Posters
P835
123
Poster Session 4
11:30 – 12:30
Multiple Sclerosis: pathology and pathogenesis
Moderator:O. Fernández (Malaga, ES)
P838
Oligoadenylate synthetase 1 gene polymorphism and
disease activity of multiple sclerosis
W. Fadel, E. El-seidy, K. Rashed, H. Mourad (Tanta, EG)
P839
Prognostic value of cerebrospinal fluid (CSF) cytology in
clinically isolated syndrome for subsequent progression to
multiple sclerosis
Y. Motuzova, F. Granieri, P. Valentino, A. Sala, G. Amadore,
A. Bertolotto (Minsk, BY; Orbassano, IT)
P840
Genetic associations and clinical course of familial multiple
sclerosis in Novosibirsk region of Russia
D. Korobko, N. Malkova, E. Sokolova, M. Filipenko (Novosibirsk, RU)
P841
Dynamic patterns of grey and white matter atrophy in
patients with clinically isolated syndrome suggestive of
multiple sclerosis one year from first clinical episode
P. Preziosa, M.A. Rocca, S. Mesaros, E. Pagani, D. Damjanovic,
T. Stosic-Opincal, J. Drulovic, M. Filippi (Milan, IT; Belgrade, RS)
P842
Influence of depression and fatigue on the regional
distribution of brain damage in patients with multiple
sclerosis
G. Riccitelli, M.A. Rocca, C. Gobbi, E. Pagani, P. Preziosa,
V. Martinelli, M. Radaelli, G. Comi, M. Filippi (Milan, IT)
P843
The importance of neutralizing antibodies in relapsingremitting multiple sclerosis
C. Baetu, R.E. Martin, I. Buraga (Bucharest, RO)
P844
Plasma adipocytokines and oral contraceptive use in patients
with relapsing-remitting multiple sclerosis
C. Capela, A. Sena, C. Nóbrega, A. Sousa, R. Roque, M. Cascais,
V. Ferret-Sena, R. Pedrosa (Lisbon, PT)
P845
Natalizumab treatment influences peroxisome proliferatoractivated receptors (PPARs) and CD36 receptor mRNA
expression in patients with multiple sclerosis
A. Sousa, V. Ferret-Sena, I. Cavaleiro, A. Maia e Silva,
G. Chinetti-Gbaguidi, B. Derudas, B. Staels, J. Vale, M. Veloso,
R. Pedrosa, A. Sena (Lisbon, PT; Lille, FR)
P846
Primary target of fingolimod in the CNS and its role in proinflammatory cascade: sphingosine 1-phosphate receptor
subtype-1 (S1P1)
V. Brinkmann, K. Kaupmann, A. Billich, T. Faller, B. Bollbuck,
M. Bigaud, J. Quancard, D. Guerini, M. Streiff (Basel, CH)
124
Poster Session 4
Serum levels of apoptosis-related proteins in multiple
sclerosis (MS) patients
M. Moreno, M. Sáenz-Cuesta, J. Castilló, E. Cantó, R. Nurtdinov,
C. Tur, X. Montalban, M. Comabella (Barcelona, ES)
P848
No evidence for single nucleotide polymorphisms in the
MMP9 gene conferring multiple sclerosis (MS) susceptibility
C. Wolf, S. Nischwitz, D. Buck, UK. Zettl, P. Rieckmann, B. Hemmer,
M. Ising, S. Lucae, T. Bettecken, B. Mueller-Myhsok, F. Weber
(Munich, Rostock, Bamberg, DE)
P849
Neuromyelitis optica and varicella zoster infection
J. Domingos, E. Santos, M.I. Leite, M. Magalhães (Porto, PT;
Oxford, UK)
P850
FTY720 is neuroprotective after toxin-induced central
nervous system demyelination
A. Slowik, T. Schmidt, S. Amor, C. Beyer, M. Kipp (Aachen, DE)
P851
Surface expansion of the hippocampal dentate gyrus in
multiple sclerosis: in vivo evidence of neurogenesis?
G. Longoni, M.A. Rocca, E. Pagani, G. Riccitelli, B. Colombo,
M. Rodegher, A. Falini, G. Comi, M. Filippi (Milan, IT)
P852
Microstructural damage to normal appearing white matter
(NAWM) and grey matter (GM) but not to cortical lesions
contributes to cognitive impairment in multiple sclerosis: a
diffusion tensor MRI study
M. Filippi, E. Pagani, M.E. Morelli, P. Preziosa, M. Copetti,
D. Dalla Libera, V. Martinelli, A. Falini, G. Comi, M.A. Rocca (Milan,
San Giovanni Rotondo, IT)
P853
Analysis of the integrity of the pyramidal tract (PT) in
response to lesions in patients with clinically isolated
syndrome (CIS)
M. Pawlitzki, J. Heidel, J. Kaufmann, E. Stadler, M. Sailer
(Magdeburg, DE)
P854
Loss of brain tissue accompanied by decrease of processing
speed: the main determinant of cognitive performance in
patients with multiple sclerosis?
E. Stadler, P. Bublak, R. Deppe, J. Feiss, M. Fischer, F. Hoffmann,
A. Kunkel, M. Schwab, K. Voigt, U. Zettl, W. Köhler, M. Sailer
(Magdeburg, Jena, Halle, Teupitz, Wermsdorf, Rostock, DE)
P855
Comparing objective measures of neurodegeneration in
multiple sclerosis (MS)
V. Fernandez, M.J. Postigo, P. Urbaneja, A. Leon, A. Alonso,
M. Guerrero, O. Fernandez (Malaga, ES)
Posters
P847
125
Poster Session 4
P856
PET study of pathogenesis of cognitive impairment in
varying degrees of disability in patients with different types
of multiple sclerosis
G. Shkilnyuk, A. Ilves, G. Katayeva, L. Prakhova, I. Stolyarov
(Saint Petersburg, RU)
P857
The effect of immunomodulating therapies on cGMP
concentration in brain cortex of experimental autoimmune
encephalomyelitis (EAE)
N. Lubina-Dabrowska, G. Sulkowski, B. Dabrowska-Bouta,
J. Langfort, A. Stepien, M. Chalimoniuk (Warsaw, PL)
P858
Protective effect of prolactin in a model of toxic cuprizoninduced demyelination in mice
E. Predtechenskaya, A. Khodakov (Novosibirsk, RU)
11:30 – 12:30
Infection
Moderator:J. Sellner (Salzburg, AT / Munich, DE)
P859
Lumbar epidural abscess in a patient with Crohn’s disease
M.G. Delgado, S. Calleja, E. Suárez, J. Vega, A. Sáiz, E. Santamarta,
L. Caminal (Asturias, ES)
P861
A case of tubercular meningoencephalitis and tubercular
myelitis showing paradoxical response
S.H. Kim, H.W. Jeon, J.H. Lim (Busan, Ulsan, KR)
P862
Case report: tetraparesis caused by cervical tuberculosis in
a young male as a first symptom of asymptomatic active
pulmonary tuberculosis
D. Athanasopoulos, T. Zaharis, G. Panagopoulos, S. Tsiara (Athens, GR)
P863
Rare case of pulmo-cerebral infectous disease in a nonimmunodeficient adult
J. Nickel (Duisburg, DE)
P864
Encephalitis with Listeria monocytogenes in an
immunosuppressed patient
H. Nicolae, R. Saftoiu, G. Cioara, C. Panea (Bucharest, RO)
P865
Acute HIV encephalopathy presenting with collapse and
neuropsychiatric disturbance
M.D. Phillips, A. Vas, S. Michael, D. Damodaran, C. Babu,
D. McKee (Manchester, Salford, UK)
P866
Psoriasis and chronic inflammatory polyradiculoneuropathy
as presenting features of advanced HIV infection
S. Michael, A. Vas, D. Damodaran, M. Phillips, D. McKee, C. Babu
(Salford, Manchester, UK)
126
P867
Progressive multifocal leukoencephalopathy (PML) in a
patient with co-infection of HIV and syphilis. A rare case of a
CNS triple infection with rapid cognitive impairment
A. Tinchon, K. Lindner, S. Pollanz, B. Horvath-Mechtler, C. Mildner,
W. Grisold (Vienna, AT)
P868
Remission of white matter lesions in MRI and clinical
recovery after initiating antiretroviral therapy in a case of
HIV infection
A. Jamroz-Wisniewska, J. Jaworski, D. Suszek, Z. Stelmasiak,
H. Bartosik-Psujek (Lublin, PL)
P869
Non-AIDS-defining malignancies are also more common in
HIV-infected patients: report of a case with neurological
involvement
A. Vas, M.D. Phillips, D. Damodaran, S. Michael, C. Babu,
D. McKee (Manchester, Salford, UK)
P870
Environmental impact and seroepidemiology for HTLV 1/2 in
two communities in the eastern Brazilian Amazon
L.S.F. Sousa, L.F.M. Falcao, H. Fuzii, R. Libonati, J. Quaresma
(Belem, BR)
P871
Four cases of Japanese encephalitis
H.W. Jeon, S.H. Kim, B.A. Yoon (Ulsan, Busan, KR)
P872
Anti-NMDA-receptor encephalitis: therapeutic and diagnostic
challenges
A.M. Carrilho, P. Santos, M. Brum, C. Semedo, A. Valadas,
R. Matos, J. Pinto Marques (Setúbal, PT)
P873
Relapse of anti-NMDAR encephalitis presenting with
complete recovery after treatment with plasmapheresis.
A case report
S. Buechner, I. Florio, G.J. Sixt, D.B. Daniel, R. Schoenhuber
(Bolzano, IT)
P874
Herpes encephalitis mimicked by the inflammatory variant
of cerebral amyloid angiopathy
W. Heide, O. Pape, D. Petersen (Celle, Lübeck, DE)
P875
Non-paraneoplastic limbic encephalitis caused by herpes
simplex-1 virus (HSV-1) infection complicating small cell lung
cancer
T. Stroubini, A.M. Mouzak, C. Bountziouka, D. Kanellopoulos,
K. Gkagkanaki, A. Visvardi, E. Alexiou (Athens, GR)
P876
Trigeminal neuropathy as the isolated symptom of a herpes
simplex type 1 infection
P. Tsitsi, M. Emin, J. Rudolf, A. Tychalas, G. Deretzi, A. Mouratidis,
I. Tsiptsios (Thessaloniki, GR)
127
Posters
Poster Session 4
Poster Session 4
P877
Uncommon presentation of subacute sclerosing
panencephalitis
A. Roceanu, F. Antochi, O. Bajenaru (Bucharest, RO)
P878
A case of Parkinsonism associated with West Nile virus
encephalitis
C. Koros, M. Rentzos, V. Zouvelou, S. Katsavos, A. Kyrozis,
E. Stamboulis (Athens, GR)
P879
Bilateral peripheral facial palsy and lumbar
polyradiculopathy following thoracal segmental herpes
zoster infection: a case report
E. Timer, S. Mumcu, N. Kuloglu Pazarci, Z. Tanriverdi, D. Necioglu
Orken (Istanbul, TR)
P880
Parainfectious opsoclonus-myoclonus syndrome secondary
to human metapneumovirus infection
G. Melikyan, B. Mesraoua, D. Deleu, A. D’Suoza, A.-S. Ibrahim,
M. Muslumani, H. Alsoub (Doha, QA)
P882
The effective use of laboratory data for healing and prevention
of pressure ulcers in patients with neuromuscular disorders
T. Mitsui, Y. Oyama, S. Yokoyama (Aomori-Ken, JP)
P883
Subacute corticobasal syndrome as presentation of sporadic
Creutzfeldt-Jakob disease
A. Vergallo, D. Frosini, C. Del Gamba, E. Unti, U. Bonuccelli,
R. Ceravolo (Pisa, IT)
P884
Cardioembolic stroke/thrombotic endocarditis as the initial
manifestation of Whipple’s disease?
T. Geraldes (Almada, PT)
11:30 – 12:30
Muscle disorders
Moderator:S. Iyadurai (St. Louis, US)
P885
New gene mutational form alpha-sarcoglycanopathies in
patients with muscular dystrophy girdle-2d: a case report
L.S.F. Sousa, L.F.M. Falcao, V. Souza, R.A. de Melo (Belem, BR)
P886
Salbutamol treatment in congenital myasthenic syndrome
with Dok-7 mutation: an open prospective study
P.J. Lorenzoni, R.H. Scola, C.S.K. Kay, L. Filla, A.P. Paranhos,
J.M.R. Pinheiro, H. Lochmuller, L.C. Werneck (Curitiba, BR;
Newcastle upon Tyne, UK)
P887
Scleroderma/myositis overlap syndrome: a case of atypical
presentation
H. Felgueiras, P. Barros, A. Carvalho, T. Santos, P. Ferreira, H. Morais
(Vila Nova de Gaia, PT)
128
Poster Session 4
Dropped head syndrome due to isolated neck extensor
myopathy: response to treatment with intravenous
immunoglobulin
M. Suzuki, M. Takeuchi, Y. Shimizu, M. Iwata, S. Uchiyama (Tokyo, JP)
P889
An assessment of results of thoracoscopic thymectomy in
myasthaenia gravis patients
M.H. Harirchian, K. Toolabi, A. Aminian, M. Jafari Javid (Tehran, IR)
P890
Thyrotoxic periodic paralysis and encephalopathy as
presenting symptoms of Graves’ disease: a case report
T. Tsironis, G. Deretzi, A. Tychalas, J. Rudolf, D. Kiourtidis, P. Tsitsi,
A. Mouratidis, I. Tsiptsios (Thessaloniki, GR)
P891
Artificial ventilatory management in myotonic dystrophy
type 1
S. Kon, H. Takada, Y. Oyama (Aomori, JP)
P892
Resting energy expenditure and regional body composition
in patients with myotonic dystrophy
K. Yoshida, Y. Aburakawa, Y. Suzuki, K. Kuroda, T. Kimura,
O. Yahara (Asahikawa, JP)
P893
Personality profile in patients with myotonic dystrophy type 1
M. Vujnic, S. Peric, V. Rakocevic Stojanovic (Banja Luka, BA;
Belgrade, RS)
P894
Transcranial sonography in patients with myotonic
dystrophy type 1
S. Peric, A. Pavlovic, D. Lavrnic, I. Basta, I. Marjanovic, A. Nikolic,
Z. Stevic, V. Rakocevic Stojanovic (Belgrade, RS)
P896
Neuroanatomical patterns of central nervous system
involvement in myotonic dystrophy type 1 and clinical
correlates
F. Caso, F. Agosta, S. Peric, V. Rakocevic-Stojanovic, L. Sarro,
V.S. Kostic, M. Filippi (Milan, IT; Belgrade, RS)
P897
Portuguese family with autosomal recessive myotonia
congenita responsive to acetazolamide
S. Moreira, J. Roriz (Santa Maria da Feira, PT)
P898
A case of telbivudine-induced myopathy
J.H. Cho, S.H. Kim (Goyang, Seoul, KR)
P899
Sulphonylurea drug-induced phenotype-dependent skeletal
muscle atrophy
S. Calzolaro, G. Cannone, A. Mele, D. Conte, D. Tricarico (Bari, IT)
Posters
P888
129
Poster Session 4
P900
Isolated gastrocnemius hypertrophy: can it be caused by
mild S1 radiculopathy?
B.O. Popescu, I. Mîndruta, A. Ene, C. Cîrstoiu, O. Bajenaru,
M. Gherghiceanu, E. Manole, L. Ceafalan (Bucharest, RO)
P901
Cerebral vascular anomalies in a large Italian family with
late-onset glycogenosis II
F. Cipullo, S. Sampaolo, O. Farina, M. Cirillo, G. Di Iorio (Napoli, IT)
P902
Becker myotonia in a Spanish family with a homozygous
nonsense mutation in the CLCN1 gene (K248X)
D. Alonso Modino, F. Martínez Bugallo, I. Tejera Martín,
A. Pérez Hernández, J.C. de León Hernández,
F.I. Monton Alvarez (Santa Cruz de Tenerife, ES)
P903
Anti-MUSK myasthaenia gravis responsive to rituximab
V. Serban (Philadelphia, US)
P904
Clinical and genetic features in a cohort of late onset
glycogen storage disease type II (GSD II) patients: typical and
atypical presentations
O. Musumeci, E. Barca, C. Rodolico, A. Ciranni, M. Aguennouz,
G. Vita, A. Toscano (Messina, IT)
P905
Dysferlin deficiency in patients with asymptomatic or
paucisymptomatic hyperCKaemia
P. Marti, N. Muelas, F. Mayordomo, P. Gallano, T. Sevilla, J. Vílchez
(Valencia, Barcelona, ES)
P906
Mutations in DNA2 cause progressive myopathy with
mtDNA instability
M. Ranieri, D. Ronchi, A. Di Fonzo, W. Lin, A. Bordoni, C. Liu,
E. Fassone, S. Pagliarani, M. Rizzuti, L. Zheng, M. Filosto,
M.T. Ferro, F. Magri, L. Peverelli, H. Li, Y.-C. Yuan, S. Corti,
M. Sciacco, M. Moggio, N. Bresolin, B. Shen, G.P. Comi (Milan, IT;
Duarte, US; London, UK; Brescia, Crema, IT)
P907
The Italian limb girdle muscular dystrophies (LGMD) registry:
molecular and clinical data
A. Govoni, C. Angelini, T. Mongini, A. Toscano, G. Siciliano,
G. Tomelleri, M. Mora, V. Nigro, P. Elena, O. Mesumeci, G. Ricci,
I. Moroni, R. Del Bo, S. Brajkovic, F. Fortunato, D. Ronchi,
G. Riboldi, M. Ranieri, S. Corti, M. Moggio, N. Bresolin, F. Magri,
G. Comi (Milan, Venice/Padua, Turin, Messina, Pisa, Verona,
Naples, IT)
P908
Insights into the pathogenesis of limb-girdle muscular
dystrophy type 1F
E. Peterle, M. Fanin, G. Cenacchi, J.J. Vilchaez Padilla, V. Nigro,
C. Angelini (Padua, Bologna, Valencia, Naples, Venice/Padua, IT)
130
11:30 – 12:30
General neurology: miscellaneous
Moderator:H. Cock (London, UK)
P910
A prospective survey of availability of neurological
equipment in clinical areas in a district general hospital
C. Porteous, R. Ellis, B.M. Davies (Crewe, Stoke-on-Trent, UK)
P911
Amantadine in the treatment of pathological gambling:
a case series
G. Martinotti, M. Pettorruso, L. Bonanni, A. Thomas, M. Onofrj,
M. Di Giannantonio (Chieti, Rome, IT)
P912
Nicolau syndrome with neurological involvement: a rare
condition related to intramuscular injection
C. Coclitu, A.-M. Cobzaru, I. Mindruta, L. Craciun, O. Bajenaru
(Bucharest, RO)
P913
Adult diagnosis of megalencephalic leukoencephalopathy
with subcortical cysts
A. Nitkunan, A. MacKinnon, H. Cock (London, UK)
P914
Death from hyperammonaemic encephalopathy following a
Whipple’s procedure: report of an unusual case
D. Damodaran, S. Michael, A. Vas, M. Phillips, D. Du Plessis,
C. Babu, D. McKee (Manchester, UK)
P915
Effects of gamma-hydroxybutyrate (GHB) and baclofen on
sleep and motor function in healthy rats and rats with focal
cerebral ischaemia
A. Hodor, S. Palchykova, F. Baracchi, B. Gao, C.L. Bassetti (Berne, CH)
P916
The King-Devick test is vastly superior to the Symbol Digit
Modalities Test as a sideline determinant of concussion in
mixed martial arts fighters
D. Kantor (Ponte Vedra, US)
P917
Changes in total serum glycosaminoglycan levels in patients
with syringomyelia
T.R. Mirsaev, L.R. Bogovazova, N.A. Borisova, R.V. Magzhanov (Ufa, RU)
P918
Harlequin syndrome: review of two cases
A.F. Santos, S. Rocha, Á. Machado, C. Ferreira (Braga, PT)
P919
Neuropsychiatric phenomena in the 13th century text
"Cantigas de Santa Maria" (Canticles of Saint Mary, CSM)
S.H. Griesbach, F.A.A. Gondim, O.C. Vale, F.P. Thomas (St. Louis,
US; Fortaleza, BR)
P921
Stress, serotonin genetics and post-stroke dementia
A. Korczyn (Tel Aviv, IL)
131
Posters
Poster Session 4
Poster Session 4
P922
How does intelligence testing affect brain signals?
A.S. Malik, H. Amin, N. Badruddin, N. Kamel, W.-T. Chooi (Tronoh,
Penang, MY)
P923
Recurrent confusional episodes associated with
hypomagnesaemia due to esomeprazol
M.G. Delgado, S. Calleja, L. Suárez, A. Sáiz, M. Suárez,
L. Benavente, D. Larrosa, J. Pascual (Asturias, ES)
11:30 – 12:30
Moderator:J. Gamez (Barcelona, ES)
P924
Classification of sporadic lower motor neuron disease in Jeju
Island
S.-Y. Kang, S.K. Song, J.S. Lee, J.C. Choi, J.-H. Kang, H. Kwen (Jeju, KR)
P926
Subclinical dysphagia in patients with amyotrophic lateral
sclerosis
K. Szacka, A. Potulska-Chromik, K. Fronczewska-Wieniawska,
M. Kuzma-Kozakiewicz (Warsaw, PL)
P927
C9ORF72 repeat expansions in patients with amyotrophic
lateral sclerosis-plus syndromes
N. Ticozzi, C. Tiloca, C. Morelli, D. Calini, A. Altieri, S. Messina,
A. Ratti, V. Silani (Milan, IT)
P928
Prominent formation of TDP-43-positive inclusions in
pyramidal cells of the primary motor area in ALS1 with
C111Y gene mutation in superoxide dismutase 1
H. Sumi-Akamaru, G. Beck, S. Kato, K. Toyooka, H. Fujimura,
S. Sakoda, H. Mochizuki (Suita, Yonago, Toyonaka, JP)
P929
Extramotor pathology is associated with cognitive deficits in
primary lateral sclerosis patients
E. Canu, F. Agosta, S. Galantucci, N. Riva, A. Chiò, S. Messina,
S. Iannaccone, A. Calvo, V. Silani, M. Copetti, A. Falini, G. Comi,
M. Filippi (Milan, Turin, San Giovanni Rotondo, IT)
P930
Amyotrophic lateral sclerosis in a patient with unrecognized
fragile X syndrome and review of literature
C. Morelli, M.T. Bonati, A. Lerario, F. Girotti, A. Altieri,
A. Ciammola, V. Silani (Milan, IT)
P931
Myocardal infarction and Takotsubo cardiomyopathy in
female patients with bulbar amyotrophic lateral sclerosis:
a possible relationship?
C. Morelli, A. Doretti, F. Verde, A. Altieri, N. Ticozzi, C. Tiloca,
L. Maderna, S. Messina, V. Silani (Milan, IT)
132
P932
Dysautonomia as onset symptom in amyotrophic lateral
sclerosis: a case report
A. Doretti, C. Morelli, N. Ticozzi, F. Verde, A. Altieri, S. Messina,
P933
Electronic (e)-multidisciplinary monitoring to improve
amyotrophic lateral sclerosis (ALS) care: the Umbria region
(Italy) ALS integrated delivery e-system
P. Brunori, K. Nardi, S. Perticoni, A. Chiarini, T.A.. Cantisani
(Perugia, Bologna, IT)
P934
Implication of integrated multimodal nano-based imaging
for early diagnosis of arteriosclerotic motor neuron disorders
L. Machtoub, P. Oertle, M. Loparic (Innsbruck, AT; Basel, CH)
P935
A promising therapeutic approach for amyotrophic lateral
sclerosis: induced pluripotent stem cell-derived neural stem
cell transplantation
S. Brajkovic, G. Riboldi, A. Govoni, M. Ranieri, M. Nizzardo,
C. Simone, S. Salani, F. Rizzo, M. Ruggieri, I. Faravelli, C. Zanetta,
N. Bresolin, G.P. Comi, S. Corti (Milan, IT)
P936
Unmodified and octa-guanidine-conjugated morpholino
oligomers rescue phenotype in mouse models of spinal
muscular atrophy
G. Riboldi, S. Brajkovic, A. Govoni, M. Ranieri, M. Nizzardo,
C. Simone, S. Salani, F. Rizzo, M. Ruggieri, I. Faravelli, C. Zanetta,
N. Bresolin, G.P. Comi, S. Corti (Milan, IT)
P937
The calcium binding proteins calneuron and NCS-1 interact
with the adenosine A2A and dopamine D2 receptor
heteromers
G. Navarro Brugal, M. Mykhaylova, J. Hradsky, V. Casado,
A. Cortes, J. Mallol, C. Lluis, E.I. Canela, M. Kreutz, P.J. McCormick
(Barcelona, ES; Magdeburg, DE)
P938
Increased tumor necrosis factor-alpha in the skin of
amyotrophic lateral sclerosis: an immunohistochemical study
S. Ono, H. Fukasawa, K. Higashida, T. Tsukie, Y. Oketa, H. Ishikawa,
K. Yasui, M. Nomura, H. Mikami, T. Watanabe, M. Suzuki (Ichihara, JP)
P939
Serum anti-neuronal antibodies in amyotrophic lateral sclerosis
R. Türkoglu, A. Çoban, C. Ulusoy, M. Giris, S. Turan, E. Tüzün,
H.A. Idrisoglu (Istanbul, TR)
11:30 – 12:30
Child neurology
Moderator:C. Angelini (Venice/Padua, IT)
P940
Use of valproate in children with stuttering
G. Natriashvili, D. Chkhartishvili (Tbilisi, GE)
133
Posters
Poster Session 4
Poster Session 4
P941
Subcortical band heterotopia or double cortex syndrome in
children
S.A. Nita, R. Teleanu, M. Sandu, D. Epure (Bucharest, RO)
P942
Lissencephaly and laminar heterotopia associated with
atypical epilepsy and normal development
I.R. Cardas, O. Tarta Arsene (Bucharest, RO)
P943
Epilepsy in inflammatory encephalopathies in children:
through clinical cases
C. Anghelescu, I. Acsinte, D. Bârca, C. Iliescu (Bucharest, RO)
P944
Gait initiation impairments in Rett syndrome
M. Michi, I.U. Isaias, A. Marzegan, C.A. Frigo, J. Volkmann,
G. Zorzi, N. Nardocci, M.L. Rodocanachi Roidi (Milan, IT; Würzburg, DE)
P945
Early childhood is a critical period for gait disturbance in
hereditary spastic paraplegia
I. Pulido-Valdeolivas, D. Gómez-Andrés, A. Cinza-González,
I. Rodríguez, J.A. Martín-Gonzalo, J. López-López,
I. Pascual-Pascual (Madrid, ES)
P946
Computer support of medical and rehabilitation process in
children with sensorineural hearing loss
S.Y.U. Lavrick, S.V. Domitrak, V.V. Shprakh, L.V. Kolesova (Irkutsk, RU)
P947
Algorithm of differential diagnostics of minimal brain
dysfunction and epilepsy in children of preschool and early
school age
S.Y.U. Lavrick, S.V. Domitrak, V.V. Shprakh, L.V. Kolesova (Irkutsk, RU)
P948
Horizontal gaze palsy and progressive scoliosis. association
or epiphenomenon?
S. Machado, S. Pina, C. Conceição, M.J. Santos, C. Costa
(Amadora, PT)
P949
Neurological comorbidities in children and adolescents with
migraine headache
A. Potic, D. Momcilovic-Kostadinovic, D. Stupar, J. Vujovic,
G. Tricomi (Belgrade, RS; Bologna, IT)
P950
Cognitive impairment of males with Duchenne muscular
dystrophy
D. Vojinovic, V. Milic Rasic (Belgrade, RS)
P951
Neurological evolution in antiphosphoripidic syndrome with
venous sinus thrombosis
G. Moisa, O. Tarta Arsene, C. Anghelescu (Bucharest, RO)
134
Poster Session 4
Demyelinating clinically isolated syndrome mimicking acute
brainstem ischaemia in an eight year old child with patent
foramen ovale
L. Ferrè, L. Moiola, M. Radaelli, V. Barcella, F. Sangalli, C. Baldoli,
F. Triulzi, V. Martinelli, G. Comi (Milan, IT)
11:30 – 12:30
Neuro-epidemiology
P953
Who gets admitted to neurology beds? Experience from a
tertiary referral centre in Egypt
S. El Tawil, T. Emara, N. Kasim, A. Abdelhak (Cairo, EG)
P954
Demographic and clinical characteristics of multiple sclerosis
patients in the Upper Silesia region of Poland: preliminary
study
M. Adamczyk-Sowa, K. Pierzchala, K. Kubicka, P. Sowa (Zabrze, PL)
P955
Predictors of disability extremes in patients with multiple
sclerosis treated with interferon-beta using the Swedish
multiple sclerosis registry
K. Fink, A. Glaser, A. Fogdell-Hahn, J. Hillert (Stockholm, SE)
P956
The prevalence of multiple sclerosis and dietary factors: an
ecological study using data from the Food and Agriculture
Organisation
K. Lauer (Griesheim, DE)
P957
The global epidemiology of hereditary ataxias and spastic
paraplegias: a systematic review of prevalence studies
L. Ruano, C. Melo, M.C. Silva, P. Coutinho (Santa Maria da Feira,
Famalicao, Porto, PT)
Posters
P952
135
List of Chairpersons
Symposia, Teaching Courses, Workshops, Oral Sessions, Satellite Symposia and Poster Highlight Session
Moderators
NamePage
Agosta, F.
64
Angelini, C.
28, 41, 131
Annunziata, P.
38
Antonaci, F.
23
Argov, Z.
28, 29, 36, 60
Bassetti, C.L.
Bates, D.
Berlit, P.
Bhatia, K.
Birklein, F.
Blanc, N.
Boon, P.
Brainin, M.
Brandt, T.
Bronstein, A.M.
Burlina, A.
25
33
26
22, 35
36
33
44, 67
35, 62
75
23, 84
31
Carreño, M.
44, 55
Chamorro, A.
57
Ciccarelli, O.
58
Cock, H.
22, 34, 55, 129
Comi, G.
30, 40, 58
Deecke, L.
Dengler, R.
Dichgans, M.
Dieterich, M.
Dietz, V.
21
51, 113
69
23, 53
24
Falup-Pecurariu, C.
110
Fazekas, F.
24, 57
Fernández, O.
32, 122
Ferro, J.M.
62, 108
Filippi, M.
24, 43, 55
Fink, K.
72
Fonseca, A.C.
26, 69
Galimberti, D.
Gamez, J.
Geurts, J.
136
102
130
43
NamePage
NamePage
Gold, R.
Grabli, D.
Graus, F.
Grobusch, M.
Gutowski, N.
29
37
45, 52
44
38
Paulus, W.
Peretz, I.
Peric, S.
Plecko, B.
Pohl, D.
Hardy, J.
Hartung, H.-P.
Houlden, H.
43
63, 90
47
Ickenstein, G.
Illa, I.
Iyadurai, S.
66
60
126
Reichmann, H.
Richardson, M.
Rieckmann, P.
Rocca, M.A.
Rohrer, J.D.
Rothwell, J.
Rovira, A.
Ruzicka, E.
Kappos, L.
Klopstock, T.
Kobeleva, X.
Krarup, C.
Kuhn Natriashvili, S.
48
27
31
26, 49
50
Laureys, S.
Liguori, R.
Llewelyn, G.
Lochmüller, H.
27, 66
20
25
28
Macerollo, A.
Maquet, P.
Marion, M.H.
Martino, D.
Mawet, J.
Milonas, I.
Montalban, X.
31, 95
61
20
32
101
63
29, 33, 36,
39, 41, 48
Nappi, R.
Noirhomme, Q.
23
27
Oreja-Guevara, C.
53
Pareyson, D.
Patankar, R.
Paterson, R.
27, 47
22
86
80
21
99
19, 56
56
22, 28, 29
67
21
20, 82
40, 42
24
21, 55
37
Santamaria, J.
61, 78
Sastre-Garriga, J.
106
Scarpini, E.
59, 118
Schestatsky, P.
45, 116
Schmutzhard, E.
41, 44
Sellner, J.
37, 51, 124
Silani, V.
30, 43, 51
Siva, A.
19
Soelberg Sørensen, P.
32
Soffietti, R.
45, 52
Sommer, C.
25, 45, 50
Steck, A.
65
Stoll, G.
35, 37, 65
Tolosa, E.
Toyka, K.V.
Valls-Solé, J.
Varga, E.
Verdelho, A.
Vidailhet, M.
Vincent, A.
Waldemar, G.
Winston, G.
68
51
26, 49
112
42, 59, 93
32
22, 68
64
97
Aasly, J.
P582
Abbruzzese, G.
O355
Abdel Jaber, M. O335, P429
Abdelhak, A.
P953
Abdelnour Ruiz, C.
P809
Abdollahi, I.
P555
Abdullah, J.M.
P490
Abella, G.
P662
Abete, M.
P804
AbouAl-Shar, H.
P832
Abram, M.
O283
Abramenko, Y.
P812
Absinta, M.
O280, O281,
O323, P475
Aburakawa, Y.
P892
Abutalebi, J.
P767
Acedo, C.
P821
Acler, M.
P470
Acsinte, I.
P943
Adamczyk-Sowa, M.
P954
Adamec, I.
P784, P789
Adams, M.
O341, O345
Adatia, S.
O291, O320
Afazel, S.
P367
Agapaki, O.M.
P592
Agarwal, S.
P391, P556
Agashivala, N.
P544
Aggelopoulou, C.
P756
Aghdami, N.
P554
Agosta, F.
48, 99, O251,
O300, O329, O331, O332,
O354, P474, P477, P478,
P591, P731, P896, P929
Agrawal, C.S.
P482, P835
Agrawal, Y.
P786
Aguennouz, M. O307, P904
Agüera, L.
P662
Aguiar de Sousa, D.
O319
Aguilar-Amat, M.J.P414, P549
Aguilar-Pérez, M.
O290
Ahmad, F.
O261
Ahmed, I.
P417
Ahmed, S.
P366
Aita, K.
P721
Ajanovic, Z.
P587
AK, F.
P623
Akbarfahimi, M.
P695
Akcali, A.
P797
Akgün, H. P481, P765, P808
Akgün, Ö.M.
P481
Akman-Demir, G.
P513
Al Drees, A.
O221
Al Hashel, J.Y.
P366, P650
Al Hindi, H.
O222
Al Sayed, Y.
O222
Al Sherooqi, I.
P365
Al Tassan, N.
P832
Al Yahya, M.
O222
Al-Jomaa, L.
P832
Al-Kawi, M.
P365
Al-Owain, M.
O221
Alajbegovic, A.
P587
Alay, S.
P481, P765, P808
Albach, F.N.
O322
Albanese, M.
O315
Albert-Weissenberger, C. P525,
P526
Albiol, S.
P454
Albu, S.
O240
Alcañiz, M.
P455, P456
Alcântara, J.
P416
Alcolea, D.
P672, P675
Aldape, K.D.
O259
Alejbegovic, A.
P404
Alemanno, F.
P767
Alexiou, E.
P875
Alexiou, G.A.
P679
Alhomoud, I.
O222
Alias, M.
O357, P740
Alipour, F.
P686
Alkan, O.
P466
Alkhairallah, T.
P832
Alkhalidi, H.
O221
Allaf, B.
P761
Allart, E.
O359
Allibert, R.
P718
Allocca, R.
P739
Almeida, A.
O356
Almeida, C.G.
P590
Almekhlafi, M. O291, O320
AlMuhaizea, M.
O222
Aloia, M.
O311
Alonso, A.
P855
Alonso Modino, D.
P902
Alp, R.
P627
Alpaslan, L.
P678
Alroughani, R.
P365, P366
Alsoub, H.
P880
Altamura, A.C.
O329
Altenmüller, E.
17, 44
Altieri, A. P927, P930, P931,
P932
Altinayar, S.
P794
Altinkaya, A.
O304, P558,
P559, P816
Alvarez, M.
P634
Alvarez-Linera, J. P495, P703
Alves, J.E.
O250
Alzaidan, H.
O221
Amadeo, R.
P688
Amadore, G.
P839
Amann, M.
O276
Amano, T.
P732
Amaral, M.
P515
Amaral-Silva, A.
P416
Amaro, S.
O364
Amato, M.P.
P475
Ambrosi, B.
O308
Ameridis, E.
P489
Amico, E.
P448
Amin, H.
P922
Aminian, A.
P889
Amor, S.
P850
Anarat, R.
P797
Anastasopoulos, D.
P592
Andelova, M.
O276
Anderseck, B.
P556
Ando, H.
O255
Ando, T.
P407
Andrade, C.
P680
Andreadou, E.
P371
Andronas, N.
P822
Anfossi, M.
O329
Angelini, C.
76, 177, P907,
P908
Anghelescu, C.
P943, P951
Anglada, E.
P548
Annunziata, P.
150, P390
Antalfy, B.
P523
Antik, A.
P658
Antoce, M.
P630
Antochi, F.
P717, P877
Antón-Aguirre, S.S.
P672
Antonaci, F.
8, 33
Antonenko, K.
P577
Antonutti, L.
P462
Aparicio, J.
P752
Apetauerova, D. O357, P600,
P727, P740
Apoil, M.
P565, P718
Arab, A.M.
P555
Arab, L.
P554
Arai, M.
P801
Araki, N.
P732
Araque, J.
O338
Arcaro, C.
O273
Archelos, J.J.
O297
Ardolino, G.
P579
Aref, H.
P365
Arenas, F.
P726
Arendt, T.
P676
Arenga, M.
P572, P614
Arevalo, M.J.
O231, P548
Argiolas, S.
P596
Argiriadou, V.
P677
Argiropoulou, O.
P779
Argov, Z.
79, 129, O252
Arias, E.
P701
Ariatti, A.
O309
Arighi, A. O329, P378, P670,
P818
Armstrong, D.
O286
Arnaldi, D.
P776
Arnason, B.
184
Arnold, D.L.
O227, O229,
O230, P388, P528, P531
Arnold, M.
O287
Arpa, J.
P497, P498, P501
Arpa-Gutiérrez, F.-J.
P499,
P500
Arrambide, G.
P548
Arrospide, A.
P824
Arroyo, R.
P531
Arshad, Q.
O265
Arvaniti, C.
P826
Arya, V.
P835
Ashhab, M.U.
O348, P609
Asil, T.
P652
Athanasopoulos, D.
P862
137
Chairs & Authors
Auger, C.
Auger, F.
Ávila, M.
Avila-Martín, G.
Aydeniz, A.
Aydin, A.
Ayllon, B.
Ayres Basto, M.
Aysen, A.
Ayuso, M.
Aziz, A. Azzedine, H.
Babu, C.
P548
O278
P662
O240
P797
O352
P805, P807
O353
P757
P804
P453
O221
P865, P866, P869,
P914
Bach, I.
P789
Badruddin, N.
P922
Badyal, R.
O225
Baetu, C.
P843
Bagnoli, S. O329, P665, P829
Bagul, M.
P761
Bahri, M.A.
P810
Bai, Q.
P522
Baier, B.
P487, P491
Bajenaru, O.
P411, P717,
P877, P900, P912
Balasubramaniam, H.C. P447
Balat, A.
P797
Balcer, L.
O227
Baldoli, C.
P952
Balnyte, R.
P705
Balvanovich, D.
P530
Banica, M.
P462
Bar, M.
P660, P661
Bar-Or, A.
O229
Baracchi, F. P598, P714, P915
Barbato, L.M.
P543, P544,
P545, P546
Bârca, D.
P943
Barca, E.
O307, P904
Barcala, M.
O258
Barcella, V.
P392, P952
Barcelon, E.
P669
Barhof, F.
18
Barinagarrementeria, F. O319
Barker, R.
O333
Barkhof, F. 18, O268, O325,
P380, P539
Barlafante, G.
P647
Barón, J. P649, P718, P804,
P805, P806, P807
Baron, P.
P681
Barone, P.
P579, P739
Barraza-Sandoval, G.
P636,
P637, P638
Barros, P.
P608, P680, P887
Barroso, C.
O330
Barsic, I.
P507
Bartholy, J.
P413
Bartlett, P.A.
O270
Bartosik-Psujek, H.
P868
Bartova, P.
P661
Barusic, A.K.
P789
138
Baruzzi, A.
O335
Bashardes, S.
O298
Basilico, P.
P681
Basílio, C.
P574
Bassa, D.
O261
Bassetti, C.L.
1, 56, P424,
P428, P435, P438, P441,
P442, P598, P714, P915
Bassi, M.T.
P474
Basta, I.
O310, P894
Bastin, C.
P810
Bastos Lima, A.
P586
Bataille, M.
P565
Bataller, L.
O337
Batla, A.
P743
Battaglia, M.A.
P688
Battista, P.
P767
Bauermann, T.
O275
Baumann, C.R. P418, P419,
P420, P421, P422, P423,
P428, P444
Bautista, L.
P807
Baxter, P.
94
Bayas, A.
P382
Baybas, S.
O352
Bäzner, H.
O290
Beaucamp, F.
O359
Bebek, N.
P757
Beck, G.
P735, P928
Beck, R.
P496
Becker, J.
P642, P643
Beerhorst, K.
P603
Behdani, F.
P400
Bèhin, A.
O223
Behr, C.
O270
Behrem, N.
O304, P816
Beisteiner, R.
16
Belachew, S.
P369, P372
Belfiore, M.
P462
Belluzzo, M.
P762
Belmonte-de-Abreu, P. P766
Beltrán, E.
O293
Ben Hur, T.
O252
Ben Simon, E.
P449
Ben-Menachem, E.P759, P760
Benavente, L.
P923
Bencsik, K.
P691, P696
Benedetti, S.
P474
Benes, H.
O316
Benítez, D.
P710
Benna, P.
P612
Benti, R.
O224
Benuzzi, F.
O309
Benz, N.
P813, P814, P815
Berankova, D.
P660, P661
Berardelli, A.
P783
Beratis, I.
P822
Berber, N.
O223
Béres-Molnár, K.A.
P413
Beretta, E.
O281
Bergami, A.
O300
Bergvall, N. P540, P541, P542
Berkö, S.
P374
Berlit, P.
59
Bernard, C.
P451
Bernsen, S.
P514
Berti, V.
P828
Bertolasi, L.
P579, P581
Bertolotto, A.
P839
Bertotti, A.C.
P658
Besalduch, N.
P516
Bessi, V.
O329, P665, P666
Best, C.
P487, P491
Bettecken, T.
P848
Beyer, C.
P850
Bhargava, M.
P835
Bhatia, K.
3, 32,128, P425,
P743
Bianchi, E.
P688
Bianco, M.
O234, O238
Biczó, D.
P413
Bieri, O.
O276
Bigaud, M.
P846
Biglioli, F.
P781
Bignamini, V.
P470
Billich, A.
P846
Binaghi, D.
P626
Bingöl, A.
P558, P559
Birklein, F.
131
Bisecco, A.
P485
Bitterlich, M.
O316
Bjelakovic, B.
O351
Blanco-Vicente, E.
O321,
O362, P414
Blauwblomme, T.
O283
Blesa, R.
P672
Bliwise, D.
P775
Bloomgren, G.
O228, P379
Blum, R.
P517
Bob, P.
P431
Boeru, G.
P383
Bogatz, L.
O344
Bogousslavsky, J.
P578
Bogovazova, L.R.
P917
Bohlega, S.
O222, P365
Boholega, S.
P832
Bollbuck, B.
P846
Bologna, M.
P783
Bonakis, A.
P817
Bonanni, L.
P911
Bonati, M.T.
P930
Bonato, S.
P509
Bonavita, S.
P485
Boniface, D.
P704
Bonifati, D.M.
P470
Bonsi, R.
O329
Bonuccelli, U.
O355, P584,
P595, P733, P741, P883
Boon, P.
83, 205
Bordet, R.
O278
Bordoni, A.
P906
Borellini, L.
P509, P681
Borislavova, V.
P493
Borisov, A.
P530
Borisova, N.A.
P917
Borreani, C.
O328, P688
Borrelli, S.
P485
Børvik, M.T.
P712
Boscoe, A.
P531
Bosley, T.
O221
Bostantjopoulou, S.
P589
Botta, A.
O306
Bougea, A.
P799
Bouktsi, M.
P373
Bouly, S.
P653
Bountziouka, C.
P875
Bourgeois, M.
O283
Bousser, M.-G.
O319
Boyero, S.
O249
Boyko, A.
O227
Bozic, C.
P379
Bracco, L.
P665, P666
Braemswig, T.B.
O322
Brajkovic, S. P907, P935, P936
Brambilla, E.
P521
Brandt, T.
O302, P786
Branera, J.
P796
Bravo Esteban, E.
O240
Bremova, T
O236, P786
Bresolin, N. P509, P681, P906,
P907, P935, P936
Brettschneider, J.
P707
Breuer, H.
P413
Brinkman, M.
P629
Brinkmann, V.
P846
Brodie, M.
P761
Brodowski, M.
P823
Broeg-Morvay, A.
O287
Bronstein, A.M.
39, O264,
O265, O358, P486
Brooks, D.
47
Brothwell, M.R.S.
P607
Brown, M.M.
123
Brozova, H.
P588
Brugger, F.
P593
Brum, M.
P685, P872
Brunecker, P.
O322
Bruni, A.C.
O329
Bruni, O.
P425
Bruno, G.
O329
Bruno, M.-A.
O267, P451
Brunori, P.
P933
Bublak, P.
P854
Buchner, H.
O292
Buck, D.
P848
Buckanie, N.
P800
Buckle, G.
P370
Budrewicz, S.
P512
Buechner, S.
P873
Buffa, D.
O242
Bugiardini, E.
O306, O308
Buraga, I.
P630, P843
Burch, J.G.
P543
Burdett, J.L.
O270
Bürger, K.
O302
Burkot, J.
O318
Burston, A.
O266
Burton, E.A.
P522
Busan, P.
P462
Bussmeyer, M.
Butzkueven, H.
Buzzi, M.G.
O292
P372
36
Cabib, C.
P781
Cabrera Valdivia, F.
P809
Cagnin, A.
O329
Cairola, P.
P510
Calabek, B.
P678
Calabresi, P.O227, O325, P387
Calay, P.
P557
Calini, D.
P927
Calleja, S.
P859, P923
Calvi, A.
P378, P670, P818
Calvo, A.
O251, P929
Calzolaro, S.
P899
Camacaro, M.
P700
Camacho, Ó.
P680
Caminal, L.
P859
Campagnolo, D.
O228
Campello, C.
P653
Campos Estela, B.
P502
Cañas, J.M.
P662
Canavan, M.
O288
Canbaz Kabay, S.
P550
Canela, E.I.
P937
Canhão, P.
O319
Cannas, A.
P596
Canneti, B.
O231
Cannone, G.
P899
Canovas, D.
P796
Cantisani, T.A..
P933
Cantó, E.
P847
Canu, E. O251, O300, P474,
P477, P478, P929
Capa, R.
P810
Caparros-Lefebvre, D. O278
Capela, C.
P844
Capo, I.
P611
Caporro, M. P438, P441, P442
Capote Díez, M.
P547
Cappa, S. O311, O329, O332,
P477, P478, P767
Capra, R.
O346
Caprioli, M.G.
P612
Caputo, D.
O280
Cardani, R.
O306
Cardas, I.R.
P942
Cardoso, M.J.
O270
Caride, A.
P658
Carlino, M.
P701
Carmona-Iragui, M.P672,P675
Carneiro, G.
P795
Carnero, E.
P510
Carod-Artal, F.J.
P648
Carpio, C.
P791
Carra-Vélez, A.M.
P672
Carreño, M.
206
Carrieri, P.
P706
Carrilho, A.M.
P872
Carrión, J.
P805, P807
Carson, A.
219
Carvajal, A.
O248
Carvalho, A.
P887
Carvalho, M.
O235
Casado, V.
P725, P937
Casanova, B.
O293
Casanova, J.
O258
Casanova-Molla, J.
O239,
P636, P637, P638
Cascais, M.
P844
Cascione, M.
P546
Cash, S.S.
O233
Caso, F.
O331, P591, P731,
P896
Cason, E.
P734
Casset-Semanaz, F.
O232
Castania, J.A.
P621
Castellano, A.
O311
Castellote, JM.
P782
Castelnovo, G.
P653
Castelo-Branco, M.
O269
Castillo, J. O231, P548, P847
Castillo-Hernández, C. P637
Castronovo, V.
O311
Catalan, M.
P462
Cattaneo, E.
P521
Cavaco, S.
O356, P586
Cavaleiro, I.
P845
Cavaletti, G.
P494
Cavaliere, M.
P803
Çavus, F.
P513
Cazzagon, M.
O281
Ceafalan, L.
P900
Cebrian, M.C.
P804
Çelik, Y.
P652
Celius, E.G.
P374
Celli, L.F.S.
P643
Celorrio, M. P805, P806, P807
Cenacchi, G.
P908
Centeno, M.
O347
Cerami, C.
O329
Ceravolo, R.P584, P595, P733,
P741, P883
Cereda, C.
P441
Cerqueira, L.
P793
Cerritelli, F.
P647
Cervera, A.
O364
Cetin, H.
P646
Cevik, M.
P633
Ceylan Has, A.
P623
Chaina, V.
P371
Chalimoniuk, M.
P857
Chamadoira, C.
O353
Chamberlain, F.
O265
Chamorro, A.
O364
Chamorro, B.
P495
Chamorro Hernández, B. P547
Chamova, T.
P825, P830
Champod, A.S.
O344
Chan, A.
P375
Chan, Y.M.
P785
Chang, H.-M.
P427
Chang, R.
O233
Charland-Verville, V.
O267
Chasalevris, I.
P371
139
Chairs & Authors
Chatelle, C. P448, P450, P451
Chaves, C.M.M.B.S.
P590
Cheema, S.
O265
Chen, L.-Y.
P427
Cheong, P.W.T.
P785
Cherninkova, S. P493, P692
Chiaki, K.
P708
Chiarini, A.
P933
Chieffo, R.O234, O238, P767,
P768, P770
Chiganer, E.
P510
Chin, P.
P540, P541, P542
Chinetti-Gbaguidi, G.
P845
Chiò, A.
O251, P929
Chitsazian, F.
P836
Chkhartishvili, D.
P940
Chlebicka, M.
O349
Cho, J.H.
P635, P898
Choi, J.C.
P924
Chojdak-Lukasiewicz, J. P570
Chooi, W.-T.
P922
Choon, C. P453
Chouette, I.
P761
Chrast, R.
O221
Chrastina, M.
P737
Christakos, C.N.
P592
Christodoulou, C.
O298
Chrousos, G.
P799
Chui, H.C.
O299
Ciammola, A.
P930
Ciano, C.
P624
Ciccarelli, O.
200
Ciceri, F.
P529
Cilia, R.
P733
Cilia, S.
P688
Cimbiz, A.
P527
Cinza-González, A.O285,P945
Cioara, G.
P864
Ciocca, M.
P579
Cioni, C.
P390
Cippa, M.
P428
Cipullo, F.
P901
Ciranni, A.
O307, P904
Cirillo, M.
P485, P901
Cîrstoiu, C.
P900
Cismariu, K.
P457
Civelli, V.
P681
Clerici, F.
O329
Clodomiro, A.
O329
Clover, L.
O248
Cmejla, R.
P583, P599
Çoban, A.
P513, P939
Cobzaru, A.-M.
P912
Cock, H. 4, P607, P619, P913
Coclitu, C.
P912
Coelho, M.
O330
Cogez, J.
P565
Cogiamanian, F.
P579
Cohen, J. O230, O325, P380,
P528, P531, P539
Colak, M.
P816
Cole, A.J.
O233
Coles, A.J. O230, P528, P531
140
Collette, F.
P810
Collins, L.
O333
Colombo, B.
O241, O282,
P392, P551, P655, P656,
P768, P778, P851
Colombo, I.
O305
Colomer, C.
P456
Colosimo, C.
P783
Comabella, M. O231, P548,
P847
Comi, G. 168, O234, O238,
O241, O251, O277, O279,
O282, O300, O323, O329,
O331, O332, O346, P378,
P380, P392, P474, P475,
P477, P478, P521, P529,
P532, P537, P538, P539,
P551, P655, P656, P698,
P702, P767, P768, P770,
P778, P842, P851, P852,
P906, P907, P929, P935,
P936, P952
Comola, M.
P529
Compston, D.A.S.O230, P528,
P531
Conceição, C.
P948
Confaloni, A.
O329
Confalonieri, P. O328, P688
Confavreux, C. O230, P528,
P531, P532
Conrad, J.
P487
Consolo, F.
O242
Constantinides, V.
P817
Conte, A.
P783
Conte, D.
P899
Conti, G.
P509
Cook, E.F.
O233
Copetti, M.O280, O346, P474,
P852, P929
Coppi, E.
O238, P768
Corbetta, S.
O308
Corcea, G.
P774
Cordeiro, I.
P574
Corelli, F.
P390
Coret, F.
O293
Corral Seijas, J.
P502
Corral-Juan, M.
P502
Correia, F.
O356
Correia, J.
O247
Correia, P.
P482, P835
Cortelli, P.
O335
Cortes, A.
P725, P937
Corti, P.
P670
Corti, S.
P906, P907, P935,
P936
Cortijo, E.
P806
Cosgrove, J.
P616, P728
Costa, C.
O296, P948
Costa, E.
O308
Costa, J.
O235, P787
Cottone, S.
P538
Cousins, R.
O255
Cousins, S.
O264
Coutinho, P.
P957
Cozzolino, V.
P647
Craciun, L.
P912
Craemer, E.
O261, P453
Craemer, U.
O261
Crayton, H.
P544
Cremascoli, R.
P776
Crespi, J.
P582
Crow, C.
P658
Cruz, S.
P563, P564
Cruz-Herranz, A. P397, P549
Cuadrado, M.L. O243, P798
Cucca, A.
P462
Culea, V.
O297
Cullup, T.
O305
Cummins, G.
O333
Cunha, G.
O269
Cunningham, K.
O266
Cuny, M.-L.
O283
Cupidi, C.
O329
Cupler, E.
O222
Curt, A.
P460
Cutfield, N.
O264
Cutter, G. P540, P541, P542
Cyran, C.
P560
Czajka-Belz, A.
O349
D. Celikozlu, S.
D´Onofrio, H.M.
D’Alessandro, R.
D’amelio, M.
D’Suoza, A.
Dababo, M.
Dabrowska-Bouta, B.
Daey Ouwens, I.M.
P527
P658
P687
O242
P880
O222
P857
O245,
O301
Dahdaleh, M.
P365
Dahlgren, L.
P693
Dahlke, F.
P537
Dahmen, N.O314, P434, P435
Dalla Costa, G.
P551
Dalla Libera, D. O238, O300,
P551, P655, P656, P768,
P852
Dalmau, J. O249, O263, O334
Damas-Hermoso, F.
P594
Damásio, J.
O356
Damjanovic, D.
P841
Damodaran, D. P865, P866,
P869, P914
Danek, A.
P560
Daniel, D.B.
P873
Danquah-Boateng, D. P619
Darviri, C.
P799
Daskalov, M.
P401
Dastgheib, S.
P618
Datieva, V.
P597
Datta, S.
P379
Daury, N.
P810
Dauvilliers, Y.
P425
Davari, M.
P400
Daveluy, W.
O359
Davies, B.M.
P910
Dawson, K.T.
O229, P388,
P389
De Carli, F.
P776
De Federicis, S.
P819
de Felipe, A.
O249
De Feo, D.
P521
de Jong, B.
P391
de la Cruz, C.
P649, P804,
P805, P807
De la Sayette, V.
P565
de León Hernández, J.C. P902
de Melo, R.A.
P885
de Mendonça, A.
O330
De Reuck, J.
O278
De Riz, M.
P378, P670
De Robertis, F.
P383
De Santi, L.
P390
De Simone, R.
P802, P803
Debette, S.
78
Defebvre, L.
O278
Deguchi, K.
O286, P523
Dehghani, F.
P412
Dei Cas, P.
P811
Deinsberger, W.
P503
Del Bo, R.
O329, P907
Del Carro, U.
O234, P778
Del Felice, A.
O273
Del Gamba, C.
P733, P883
Del Prete, E.
P584
Delanty, N.
O263
Deleu, D.
P880
Delgado, M.G. P578, P859,
P923
Delhay, J.-L.
P532
Deligianni, C.
P371
Dell’Osso, B.
O329
Delmont, E.
P631
Delrue, G.
P557
DeLuca, J.
P698
Delvaux, V.
P557
Demaerel, P.
179
Demarin, V.
P467
Demchuk, A.
O291, O320
Deme, S.M.
P408
Demertzi, A.
P451
Demirci, N.O.
P508
Demirkaya, S.
P481, P765,
P808
Demirturk, O.
P466
Dengler, R.
62, 167
Deppe, R.
P854
Depper, L.
O345
Deramecourt, V.
O278
Deretzi, G. P488, P876, P890
Derudas, B.
P845
Desnuelle, C.
P631
Devonshire, V.
110
Deykin, A.
O227, P387
Di Fonzo, A.
P509, P906
Di Giacomo, D.
P819
Di Giannantonio, M.
P911
Di Iorio, G.
P901
Di Maggio, G. O234, O238,
P551, P768, P778
Di Pace, J.L.
P510
Di Rocco, F.
O283
Diaconu, N.
P406
Dias, C.
P608
Dias, M.
P684
Dias, S.
P684, P793
Díaz-de-Terán, F.-J. P499, P500
Díaz-Manera, J.
O338
Dichgans, M.
58, O302
Diener, H.-C.
122, P800
Dieterich, M. 38, 144, O302,
P487, P491
Dietz, V.
42
Díez-Tejedor, E. O289, O321,
O362, P397, P414, P549,
P569, P716, P821
DiGioia, B.
O315
Dinca, L.
P377
Ding, M.
O257
Ding, Y.
P473
Dini, E.
P733
Dirican, A.
O352
Djelilovic-Vranic, J. P404, P587
Djokovic, S.R.
P403
Döhler, N.
P747
Dolgan, A.
P512
Domingos, J.
O247, O356,
P849
Domínguez, E.
O243
Domínguez-Melcón, F.-J. P497,
P498
Domitrak, S.V.
P946, P947
Donadio, V. O335, P429, P734
Donelli, C.
P670, P818
Dong-Si, T.
P379
Doretti, A.
P931, P932
Dornmair, K.
O293
Dorobat, B.
P717
Dowds, E.
P820
Drago, N.
P370
Drosselmeyer, J.
P463
Drulovic, J.
P841
Du Plessis, D.
P914
Duarte, C.
O269
Duarte, J.M.
P658
Duboc, D.
O223
Dubovik, B.
P746
Dubuc, L.
P565
Duggal, N.
P417
Duncan, J.S.
O270, O347
Dunkel, J.
P503, P504
Dupont, S.
P761
Durani, N.
O261
Durieux, N.
O278
Dusek, P.
P588
Duyckaerts, C.
O330
Dvorský, F.
P729
Economou, A.
P822
Edalatmanesh, M. P520, P553,
P686
Edlinger, G.
O343
Edwards, K.
P543
Edwards, M.J.
P425
Egri, M.
P792
Ehrensperger, M. P813, P815
Eickhoff, S.B.
O275
Eikelboom, J.W.
O288
Eiris, J.
P752
Ejma, M.
P512
El Tawil, S.
P953
El-seidy, E.
P838
Elahi, E.
P836
Elena, P.
P907
Elger, C.
P759, P760
Elkins, J.
O326
Ellis, C.
P628
Ellis, R.
P910
Elmalik, S.
O221
Eltoft, A.
P712
Emara, T.
P953
Emin, M.
P876
Ene, A.
P900
Eng, J.
P468, P469
Engler, J.
O302
Enk, K. P453
Enzinger, C.O297, O324, P566
Epure, D.
P480, P941
Eraksoy, M.
P513
Erdeljic, V.
P507
Erdelyi, B.
P747
Eren, F.
P651
Erimaki, S.
P592
Erro, R.
P739
Ertem, D.H.
O352
Eskandari, A.
O287
Eskes, G.A.
O344
Esnaashari, N.
P601
Esnault, E.
O283
Espak, M.
O270
Espallargues, M.
P710
Espejo, C.
O296
Espinos, C.
O337
Espinosa, A.
O343, P446
Esposito, F.
P485
Estela, J.
P796
Estévez, M.
P634
Estrada, M.D.
P710
Evangelopoulos, M.E.
P371
Evans, N.
P461
Evliyaoglu, O.
P633
Evstigneev, V.
P746
Eymard, B.
O223
Ezpeleta, D.
P804
Fabbrini, G.
Fadel, W.
Fagerlund, M.
Fagioli, G.
Faglioni, P.
Fairley, J.
Falcao, L.F.M.
P783
P838
P641
P734
O309
P775
P870, P885
141
Chairs & Authors
Falini, A. O241, O251, O277,
O279, O281, O282, O300,
O311, O323, O331, O332,
P474, P477, P478, P655,
P851, P852, P929
Falk, E.
P374
Faller, T.
P846
Fang, J.
O288
Fanin, M.
P908
Faouzi, M.
O287
Faravelli, I.
P935, P936
Farham, B.
P836
Faria, R.
O246
Farina, L.
O224
Farina, O.
P901
Fassone, E.
P906
Fazan, V.P.S.
P621
Fazekas, F.
45, 145, 197,
O268, O297, O324, P566
Fedorova, N.V.
P585
Fedulov, A.
P530
Feiss, J.
P854
Feki, I.
P365
Felbecker, A.
P393, P747
Felgueiras, H.
P887
Fenoglio, C.O329, P670, P818
Ferbert, A.
P503, P504
Ferini-Strambi, L. O311, P437,
P438, P439
Fernandez, E.
P594
Fernández, M.
P662
Fernández, O. 20, 117, O230,
P855
Fernandez, V.
P855
Fernandez Pardal, M.
P626
Fernández-Lobera, M. O342,
P771
Fernandez-Ruiz, J.
P820
Fernandez-Travieso, J.
P716
Ferrão, C.
O246, O247
Ferrarese, C.
P494
Ferrari, F.
P767
Ferrari, L. O238, P768, P778
Ferrari, M.
P474
Ferrè, L.
P392, P529, P952
Ferreira, C.
P918
Ferreira, P.
P887
Ferreira Carvalho, J.N. P572
Ferrero, P.
O329
Ferret-Sena, V.
P844, P845
Ferri, J.
P455
Ferri, R.
P437
Ferro, J.M.
O268, O319
Ferro, M.T.
P906
Ferrucci, R.
P579
Feyers, D.
P810
Fiaschi, A.
O273
Fichera, M.
O238, P768
Fidani, L.
P589
Fiebach, J.B.
O322
Fighera, M.R.
P524, P590
Filgueiras-Rama, D.
O289
Filipenko, M.
P840
142
Filippi, M.
2, 46, 101, 198,
O241, O251, O277, O279,
O280, O281, O282, O300,
O323, O329, O331, O332,
O346, O354, P474, P475,
P477, P478, P551, P591,
P655, P698, P731, P841,
P842, P851, P852, P896,
P929
Filla, L.
P886
Filosto, M.
P906
Fink, K.
P955
Finotti, E.
P425
Fiolet, A.T.L.
O245
Fiorino, A.
P475
Fischer, M.
P854
Fischer, U.
O287
Fleysher, L.
P706
Florio, I.
P873
Flügel, D.
P747
Fogdell-Hahn, A.
P955
Folyovich, A.
P413
Fonseca, A.C.
57
Fonseca Samões, R.
O246
Fook-Chong, S.
P785
Formica, A.
P783
Forssell, H.
P772
Fortea, J.
P672, P675
Fortin, K.
P385
Fortunato, F.
P907
Foschi, N.
P647
Fox, E.J. O230, P528, P531,
P543
Fox, R.J. O229, O327, P388,
P389
Frade, M.J.
P515
Frades, B.
P662
Franceschi, M. O329, O332,
P477
Franceschini, C.
P425
Francia, A.
P538, P761
Francis, G.
O325
Franco, G.
P509, P681
Frank García, A.
P821
Fratiglioni, L.
175
Freedman, M.S.
108, P532
Fregni, F.
P766
Fricska-Nagy, Z. P691, P696
Frigo, C.A.
P944
Frigo, M.
P494
Frigola, G.
P726
Fris, Y.
P711
Fromm, A.
P410
Fronczewska-Wieniawska, K.
P926
Frosini, D.
P595, P883
Fuchs, C.
O302
Fuchs, S. O297, O324, P374
Fuentes, B.O289, O321, O362,
P397, P414, P569, P716
Fuentes Gimeno, B.
P821
Fuhr, P.
P813, P814, P815
Fujihara, K.
P708
Fujimura, H.
P567, P928
Fukasawa, H.
P938
Fulda, S.
P438, P441, P442
Fulda, U.
P382
Fülöp, A.
P413
Fumagalli, G.
O329, P378,
P670, P818
Furlan, R.
O300, P551
Furuno, Y.
P721
Furuya, T.
P732
Fusco, M.L.
P494
Fuvesi, J.
P691, P696
Fuzii, H.
P870
Gabelic, T.
P784, P789
Gaber, T.
P464
Gaebler, J.
P391
Gal, C.
P457
Galan, I.
O231, P548
Galán Arriero, I.
O240
Galán Sánches-Seco, V. P809
Galantucci, S.
O331, O332,
P477, P929
Galassi, G.
O309
Galati, S.
P598
Galbiati, A.
P437, P439
Galimberti, D.174, 196, O329,
O331, P378, P670, P818
Gallano, P.
P905
Gallardo, E.
O338
Gallardo, M.
P700
Gallo, A.
P485
Galovic, M.
P393, P747
Gamazo, C.
P804
Gantenbein, A.R.
O314
Gao, B.
P915
Garavaglia, B.
P741
Garbacenkaite, R.
O341
Garcia, A.
P820
Garcia, G.
P752
Garcia, N.
P516
Garcia Carreira, M.C.
P796
García-Albea Ristol, E. P809
García-Chiclano, A.
P568
Garcia-Moreno, J.M.
P594
García-Soldevilla, M.A. P809
García-Talavera, P.
P804
Gardinetti, M.
P494
Garrett, C.
P680
Gass, A.
P376
Gattringer, T.
P566
Gavrilov, YV
P422
Geber, C.
P487
Gelenli Dolanbay, E.
P527
Gelpi, E.
O313
Georgoulas, G.
P775
Geraldes, T.
P884
Geurts, J.
199
Ghabeli Jouybari, A.
P399
Ghanaati, H.
P713
Ghandehari, K. P396, P399,
P400
Ghaus, C.
P386
Gherghiceanu, M.
P900
Ghezzi, A.
O323, P475
Ghezzi, L.
174, P378,
P670, P818
Giannoccaro, M.P. O335, P734
Giannopoulos, S.
P606
Giarolli, L.
P439
Giavasi, C.
P826
Gil-Gómez, J.-A.
P454
Gil-Nagel, A.
P759, P760
Giladi, N.
P449
Ginevri, L.
P647
Giordana, M.T.
O329
Giordano, A.
O328, P687,
P688
Giordano, G.
O242
Giovagnoli, A.
O224
Giovannoni, G.
134, O295,
O326, O327
Giris, M.
P939
Girotti, F.
P930
Giuntini, M.
P584, P595
Giuntoli, M.
P688
Giza, E.
P589
Gkagkanaki, K.
P875
Glasauer, S.
O236, O264
Glaser, A.
P955
Göb, E.
P517, P518
Gobbi, C.
P842
Godek, M.
O349
Goebel, K.
P525
Goel, A.
P820
Gogu, A.
P405
Gökçil, Z.
P753
Goksel, B.
P466
Gold, R.
86, O229, O326,
O327, P388, P389, P537
Golding, J.F.
O264, O265
Golubovic, S.
P561
Gomes, I. P590, P642, P643
Gomes, J.
O353
Gomez, F.
P448
Gómez-Andrés, D.
O285,
P499, P500, P549, P945
Gómez-Ansón, B.
P672
Gómez-Soriano, J.
O240
Gonçalves, A.
P586
Gondim, F.A.A.
P919
González, P.
P634
González-Gutiérrez, J.L. P798
Gonzalez-Rosa, J. O234, P770
González-Suárez, I.P549, P569
Gorian, A.
P462
Gorji, A.
P618
Gosseries, O.O267, P450,P451
Gossery, S.
P811
Gothelf, Y.
O252
Gotkine, M.
O252
Goto, K.
P471, P476
Goto, Y.-I.
P407, P523
Gotoh, L.
P523
Govind, P.
O256
Govindarajan, R.
P506
Govoni, A. P907, P935, P936
Gözbatik-Celik, G.
P511
Grabli, D.
149
Gradaus, R.
P503
Granell, E.
P672
Granella, F.
O328
Granieri, F.
P839
Gräßel, E.
P458
Grasso, M.G.
P688
Gratii, C.
P406
Grau, O.
O334
Graus, F.
216, O249, O334
Greco, R.
P529
Greenberg, S.M.
O299
Gresty, M.
O264, O265
Griesbach, S.H.
P919
Griffiths, J.
O262
Grisold, W.
P678, P867
Gritti, A.
O298
Grobusch, M.
211
Gronier, S.
P631
Grosu, A.
P406
Grosu, O.
P774
Gruberger, M.
P449
Gruschka, H.
P676
Grzeda, M.
P687
Gschwandtner, U. P813, P814,
P815
Gubanova, E.N.
P585
Guclu, I.
P558
Gudev, A.
P401
Guergueltcheva, V. P825, P830
Guerini, D.
P846
Guerreiro, R.
P685
Guerrero, A.L.
O243, P648,
P649, P798, P804, P805,
P806, P807
Guerrero, M.
P855
Guerrieri, S.
P778
Guger, C.
O343, P446
Guimarães, J.
P680
Gül, G.
P651
Gündogan, F.Ç.
P481
Gunduz, O.
P652
Gungor Hatipoglu, M. P550
Günther, L.
P496
Guranski, K.
P570
Gursoy, S.
P797
Gustavsson, A.
P534
Gutiérrez, A.
O296
Gutiérrez, J.
P634
Gutowski, N.J.
151, P671
Guttmann, S.
P552
Guzeva, V.
P613
Haas, C.T.
Habbal, D.
Habek, M.
Haering, D.
Hagelberg, N.
Hägele-Link, S.
Hakman, P.
Halac, E.
P463
P448
P784, P789
O325
P772
P593
P747
P701
Hamizah, R.N.
P490
Hamzeloo, A.
P554
Hanafi, Z. P453
Handzic, J.
P789
Hankeln, T.M.A.
P689
Hardiman, O.
100, O254
Hardmeier, M.
P815
Hardy, J.
201
Harigaya, Y.
P834
Harirchian, M.H. P713, P889
Harrer, A.
P367
Hartung, H.-P. 77, 112, O230,
P380, P528, P531, P539
Haschke-Becher, E.
P367
Hashimoto, J.
P732
Hashimoto, S.
P708
Hashmonay, R.
P545
Hassan, H.
O221
Hatipoglu, H.
P550
Hatz, F.
P813, P814, P815
Hauser, S.
P422, P444
Havranková, P.
O226
Havrdova, E.
O230, O326,
P389, P528, P531, P709
Hawkes, C.H
P704
Hayashi, Y.
P667
Heesen, C.
P376
Heibesen, S.
O272, P758
Heidari, M.
P695
Heide, W.
P874
Heidel, J.
P853
Heikkilä, H.
P641
Heine, L.
O267
Heldner, M.
O287
Heliopoulos, I.
P756
Helmchen, C.
40
Hemmer, B.
P848
Hendler, T.
P449
Henigsberg, N.
P507
Henkes, H.
O290
Hennig, N.
P526
Hennings, J.
P571
Herbert, J.
P706
Hernández, M.
O243
Hernández-Díaz, S.
P798
Herrero, S. O243, P648, P649,
P805, P806, P807
Hidalgo, H.O314, P434, P435,
P436
Hideyama, T.
O253
Hietala, J.
P772
Higashida, K.
P938
Hilbrich, I.
P676
Hillert, J.
P955
Hirunagi, T.
P407
Hishida, R.
P801
Hodor, A. P418, P419, P915
Hoffmann, F.
P560, P854
Hoffmann, R.
P375
Hofstadt-van Oy, U.
P736
Höftberger, R.
O249
Hohlfeld, R.
O293
Höhn, D.
P571
143
Chairs & Authors
Holle, D.
Holley, J.E.
Holtkamp, M.
Holuschova, L.
Holzer, M.
Homayoon, N.
Horakova, D.
Horno, R.
Horvath-Mechtler, B.
P800
P671
114
P660
P676
P566
P709
O231
P678,
P867
Hoskovcova, M.
P588
Hothorn, T.
P460
Houdayer, E.
O238, P767,
P768, P770
Houlden, H.
29
Howard, J.
P706
Hradsky, J.
P937
Hrelja, A.
P587
Hreniuc, C.N.
P408
Hryb, J.P.
P510
Huber, R.
P421
Hudgens, S.
P556
Huffman, C.
P544
Hughes, B.L.
P546
Hughes, K.E.
O244
Hughes, R.
O361
Humphrey, L.
P556
Hung, S.
O227, P387
Hunter, S.F.
P544
Hussey-Andersen, L.K. O244
Hustinx, R.
P451
Huszka, H.
P691
Hutchinson, M.
O229
Hwang, S.K.
O284
Iakovlev, N.
P812
Iannaccone, S.
O251, P929
Ibrahim, A.-S.
P880
Idbaih, A.
214
Idris, E.
O261
Idrisoglu, H.A.
P827, P939
Ignea, A.
P405
Ikeda, Y. O363, P471, P476
Ikeguchi, R.
P708
Ikeuchi, T.
P834
Ilic, A.
P764
Iliescu, C.
P943
Ilieva, P.
P401
Illa, I.
O338
Illán-Gala, I. P397, P499, P500
Ilsen, H. P453
Ilves, A.
P856
Imai, K.
P720
Imamura, E.
P398
Imbach, L.L. P419, P420, P421
Improta, I.
P739
Incensi, A.
O335, P734
Inglese, M.
P706
Ingravallo, F.
P425
Inoue, K. O286, P523, P567
Inoue, N.
P523
Inuggi, A. O251, O354, P591
Inzitari, D.
O268
144
Ioncu, D.S.
Iranzo, A.
Irazoqui, P.P.
Isaias, I.U.
Ishida, Y.
Ishikawa, H.
Isidro, G.
Ising, M.
Issard, D.
Ito, Y.
Iwata, M.
Iyadurai, S.
Izquierdo, G.
Izzi, F.
P408
O313, P432
P763
P944
P667
P938
O243
P848
O232
P720
P888
75
P377
O315
Jääskeläinen, S.K.
63, P772
Jaberi, E.
P836
Jacini, F.
P670, P818
JacobiO261
Jacobi, C. P453
Jacobs, B.
51
Jafaar, I. P453
Jafari Javid, M.
P889
Jagtap, S.
O256
Jahn, K.
O237, O302, P625
Jakubiak-Mazur, B.
P790
Jaman, C.
P811
James, E.
P445
Jamieson, S.
P728
Jamroz-Wisniewska, A. P868
Jamrozik, Z.
P724
Janik, P.
P724
Janout, V.
P729
Janovik, N.
P766
Januska, R.
P696
Jardel, C.
O223
Jaworski, J.
P868
Jeandel, P.-Y.
P631
Jech, R.
10, P588, P782
Jedidi, H.
P810
Jeffery, D.
P542
Jeon, H.W.
P861, P871
Jeong, Y.C.
P657
Jianu, D.C.
P408
Jiménez, J.
P745
Jobst, R.
P488
Johansen1, K.
P582
John, S.T.
P602
Johnsen, S.H.
P712
Johnson, J.
P556
Johnson-Long, A.
P775
Jones, M.
P461
Jordanova, A.
P825
Jost, V. P453
Jovic, N.
O351
Jugas, P.
P729
Jumah, M.
P365
Jungbluth, H.
O305
Kabiraj, M.
Kachan, T.
Kadastik-Eerme, L.
O221
P530
P580
Kafi, H.
P715
Kägi, G.
P593
Kagiava, A.
O298
Kahn, A.-K.
O239, O336
Kaiserova, M.
P729
Kajikawa, H.
P398
Kalaria, R.N.
O299
Kalfakis, N.
P817
Kalinderi, K.
P589
Kalla, R.
P711
Kallmann, B.
P375, P382
Kallweit, U.O314, P434, P435,
P436
Kamchatnov, P.
P711
Kamel, N. P490, P748, P777,
P922
Kamisli, O.
P794
Kamisli, S.
P794
Kampman, M.T.
P712
Kanellopoulos, D.
P875
Kang, J.-H.
P924
Kang, S.-Y.
P924
Kanovsky, P.
P729
Kantor, D.
P663, P916
Kapaki, E.
P799
Kaplan, Y.
P794
Kappos, L. 11, O232, O276,
O325, P372, P380, P389,
P532, P537, P539
Kapral, M.K.
O288
Karabudak, R.
P534
Karaca, S.
P769
Karacsony, M.
P691
Karadag, H.
P652
Karagianni, M.
P779
Karagöz Sakalli, N.O304, P816
Karakis, I.
O233
Karaliute, M.
P712
Karampampa, K.
P534
Kararizou, E.
P799
Karli Oguz, K.
P623
Karni, A.
P457
Karussis, D.
O252
Kasim, N.
P953
Kaski, D. O264, O358, P486
Kassis, I.
O252
Kassubek, J.
P492
Kaszás, N.
P413
Katayeva, G.
P856
Kato, S.
P928
Katona, I.
O221
Katsarava, Z.
P800
Katsarou, Z.
P589
Katsavos, S.
P878
Katz-Sand, I.
P706
Kaufmann, J.
P853
Kaupmann, K.
P846
Kaveh Moghadam, K. P424,
P425, P426, P430
Kawabe, T.
P721
Kay, C.S.K.
P886
Kekovic, G.
P611
Kentab, A.
O221
Kopchak, O.
P673, P674
Korczyn, A.
P921
Korman, M.
P457
Kornyeyeva, E.
P380, P539
Korobko, D.
P840
Koroleva, N.
P613
Koros, C.
P878
Kory-Calomfirescu, S.
P408
Kosmidis, M.
P822
Kostic, V.S. O354, P591, P731,
P896
Koszewicz, M.
P512
Koufali, M.
P394
Kourtesi, G.
P589
Kousaka, M.
P567
Koussa, S.
P365
Koutsouraki, E.
P779
Kovacicek, M.
P467
Kovalská, P.
P431
Kovarova, I.
P709
Kozlowski, O.
P811
Kral, V.
P709
Krarup, C.
61, 120
Krasulova, E.
P709
Kraus, J.
P367
Krbot Skoric, M. P784, P789
Krdžic, I.M.
P403
Kreitner, L.
P491
Kremmyda, O.
P786
Kresojevic, N.
O354, P731
Kress, B. P453
Kress, M.
O261
Kreutz, M.
P937
Krivoschekov, S.G.
P773
Krommyda, M.
P489
Krsa, J.
P729
Kruer, M.
O249
Krulova, P.
P660, P661
Krupinska-Dulemba, A. P570
Kubicka, K.
P954
Kubo, K.
O286
Kugler, G.
O302
Kuhle, J.
O232
Kuhn, C.
O341
Kuhn Natriashvili, S.
34
Kulisevsky, J.
P726
Kulisevsky Bojarski, J.
P502
Kulla, A.
P383
Kuloglu Pazarci, N.
P879
Kümpfel, T.
P576
Kumru, H.
P738
Kunkel, A.
P854
Kuroda, K.
P892
Kurre, W.
O290
Kurt, E.
P558, P559
Kurteva, T.
P401
Kurth, S.
P421
Kürtüncü, M.
P513
Kurukulasuriya, N.C.
O327
Kuruma, H.
P471
Kuruvilla, A.
O256
Kuscu, D.
P559
Kushitani, S.
P398
Kuzma-Kozakiewicz, M. P926
Kwak, S.
O253
Kwast-Rabben, O.
P641
Kwen, H.
P924
Kwon, S.H.
O284
Kwon, Y.B.
P657
Kyritsis, A.
P606, P679
Kyrozis, A.
P817, P878
la Fougere, C.
O302, P496
Lachmann, I.
P676
Laforet, P.
O223
LaGanke, C.
P545
Lahti, A.
P772
Lake, S.L. O230, P528, P531
Lalor, E.
O254
Lalosevic, D.
P611
Lambrou, D.
O287
Lamusuo, S.
P772
Lanfranconi, S.
P509, P681
Langane, É.
P696
Langdon, D.
109
Langfort, J.
P857
Langhauser, F.
P517, P518
Langkammer, C. O297, O324
Lansbury, A.
P616
Lanuza, M.A.
P516
Lanza, M.
P485
Laplaud, D.
P391
Larkin, A.M.
P381
Larrosa, D.
P923
Larsen, T.
P459
Laterza, C.
P521
Lauda, F.
P492
Lauer, K.
P956
Laureys, S.
69, 143, O267,
P446, P448, P450, P451
Lauria, G.
218
Lavorgna, L.
P485
Lavrick, S.Y.U.
P946, P947
Lavrnic, D.
O310, P894
Lavrnic, S.
O310
Layegh, P.
P618
Lazarou, M.
P788
Le Floch, A.
P653
Leavitt, V.M.
P690, P698
LeBourgeois, M.
P421
LeDoux, M.
P742
Lee, D.-H.
P689
Lee, J.-H.
P639
Lee, L.
P385
Lee, S.
O228, P575, P924
Lee, W.T.
P447
Lee, Y.H.
P615
Legros, L.
P631
Lehnen, N.
O235, P787
Leis, A.A.
O339
Leite, M.
O248
Leite, M.I.
P849
Lencses, G.
P691, P696
Leocani, L. O234, O238, P551,
P656, P767, P768, P770,
P778
145
Chairs & Authors
Keren, O.
P457
Kerkhoff, G.
O341, O345
Kersten, S.
P463
Kerszberg, M.
P701
Kesper, K.
P744
Kewenig, S.
O239
Khajedaluei, M.R. P399, P400
Khalil, D.
P832
Khalil, M.
O297, O324
Khan, A.
O221
Khan, U.A.
P607
Khatami, R.
P433
Khatri, B.
P380, P539
Khatua, S.
O257
Khedekar, D.
O350
Khodakov, A.
P858
Khosla, S.
P417
Khoury-Abdallah, R.
O257
Kieseier, B.
88, 134, 161,
O227, P376
Kiferle, L.
P584, P741
Kilidireas, C.
P371
Kilidireas, K.
O294
Kilinc, F.
P633
Kim, E.
P543, P546
Kim, S.H. P615, P754, P861,
P871, P898
Kim, W.-K.
P639
Kim, W.J.
P615
Kimiskidis, V.
P779
Kimura, T.
P892
Kincaid, J.C.
P763
Kincses, Z.T.
P691
Kinova, E.
P401
Kiourtidis, D. P488, P489, P890
Kipp, M.
P850
Kirbas, D. O304, P558, P559,
P816
Kirkova, V.
O303
Kistsen, V.
P746
Kitamura, K.
P407
Kittel-Schneider, S.
O239
Kleinschnitz, C. P517, P518,
P525, P526
Klempír, J.
O226, P599
Klempírová, O.
O226
Kleopa, K.A.
O298
Klopstock, T.
66
Klotz, L.
P533
Kmetska, K.
P383
Knake, S.
P800
Kobayashi, H.
P801
Koedijk, F.D.H.
O301
Koehler, P.J.
O245, O301
Koenig, M.
O221
Koepp, M.J.
O347
Kohlbecher, S.
O302
Köhler, W.
P854
Köktürk, S.
P527
Kolesova, L.V.
P946, P947
Kolev, P.
O271
Kon, S.
P891
Kontaxis, T.
P817
Leon, A.
P855
León, B.
P662
León, R.
P700
Leon Cejas, L.V.
P626
León Ruiz, M.
P809
Leonhardt, E.
O341
Leproust, S.
P761
Lerario, A.
P930
Lesenfants, D.
P448
Lessa, C.
P510
Lete, V.
P429
Levin, O.
P597
Levy, Y.
O252
Lewandowski, Z.
P790
Ley, M.
P745
Li, H.
P532, P906
Li, T.
P420
Liantinioti, C.
P826
Liao, W.-C.
P427
Libonati, R.
P870
Liebetrau, U.
P514
Liguori, C.
O315
Liguori, R.
13, O335, P429,
P734
Lim, D.-S.
P575
Lim, J.H.
P861
Lim, S.C.
P615, P754
Lima, J.
O353
Limmroth, V.
P514, P536
Lin, L.
P425, P430
Lin, W.
P906
Lindeck-Pozza, E.
P678
Lindholm, P.
P772
Lindner, K.
P867
Linhares, P.
O353
Linker, R.A.
P689
Linnebank, M.
87
Linsalata, G.
P741
Lipatova, L.
P605
Littlechild, J.
P671
Liu, C.
P906
Liu, H.M
P473
Liu, S.
O227, P387
Lizrova Preiningerova, J. P709
Llado, A.
O313
Lleó, A.
P672, P675
Llewelyn, G.
50
Lloréns, R. P454, P455, P456
Lluis, C.
P725, P937
Lo, Y.L.
P785
Lo Re, M.
P368
Lo Re, V.
P368
Lobato, M.I.
P766
Lochmüller, H.
74, P886
Lodi, R.
P430
Lohse, P.
P576
Loisidou, A.
P822
Lombardo, A.
P521
Lombes, A.
O223
Lomeña, F.
O313
Lommers, E.
P557
Longoni, G.
P851
Loparic, M.
P934
146
Lopatkiewicz, A.M.
P730
Lopes, L.
P688
López, J.
P662
Lopez, M.V.
P594
López Toledano, E.
P502
López-López, A.
P798
López-López, J. O285, P945
López-Mesonero, L.
P649,
P807
Lorenzoni, P.J.
P886
Losonczi, E.
P696
Loster-Niewinska, A.
P570
Loureiro, R.
O250
Lourenço, E.
P795
Lozza, A.
P781
Lu, E.
P693
Lubina-Dabrowska, N. P857
Lucae, S.
P848
Lucas, M.
P377
Lucidi, G. P666, P828, P829
Ludolph, A.C.
98, P492
Luedke, A.
P820
Lugaresi, A.
O328, P688
Lugo, Z.
P448
Luis, L.
O235, P787
Lukic, S.
O351
Luppi, P.-H.
53
Lushnikov, O.N.
P773
Luzeiro, I.
P614
M. Carrilho, A.
P685
Macdonell, R.
P391
Macerollo, A.
P743
Machado, Á.
P918
Machado, S.
P515, P948
Machtoub, G.
P395
Machtoub, L.
P934
MacKinnon, A.
P913
Maderna, L.
P931
Madinier, A.
O317
Madureira, S.
O268
Maeder, P.
O287
Maestri, M.
P438
Maeurer, M.
P376
Magalhães, M.
O356, P849
Maggi, L.
O305
Maggioni, G.
P776
Maggiore, C.
O295
Magistris, M.R.
130
Magnani, G.
O300, O329,
O331, O332, P477, P478
Magrashi, A.
P832
Magri, F.
P906, P907
Magzhanov, R.V.
P917
Mahadeva Iyer, P.
O254
Mai, F.-D.
P427
Maia e Silva, A.
P845
Maida, S.
P702
Maimone, D.
P538
Majerova, V.
P599
Malaguti, M.C.
P470
Malfatti, E.
O223
Malhotra, P.
P486
Malik, A.S. P447, P490, P748,
P777, P922
Malkova, N.
P840
Mallol, J.
P725, P937
Maltese, V.
P378
Manconi, M.P438, P441, P442
Mancuso, M.
94
Mandel, J.
O260, P683
Mañé, A.
O258
Manfredi, V.
O224
Manganotti, P.
O273
Mangas-Guijarro, M.A. O321,
O362, P414
Manikas, A.
P373
Manni, R.
P776
Mano, K.
P407
Manole, E.
P900
Manzur, A.
O305
Maquet, P.
54, P810
Mar, J.
P824
Marchese, M.
P802, P803
Marciani, M.G.
O315
Marcone, A.
O329
Marelli, S. O311, P437, P438,
P439
Marés, R.
O258
Margolin, D.H. O230, P528,
P531
Marhardt, K.
P381, P382
Mariangela, B.
P778
Mariani, C.
O329
Marini, S. P665, P666, P828,
P829
Marinkovic, I.
P562
Marion, M.H.
9
Marjanovic, I.
O310, P894
Markeljevic, J.
P507
Markoula, S.
P606
Markov, M.
O271
Marotta, G.
O224
Marques, M.
P572
Marrosu, F.
P596
Marrosu, G.
P538
Martac, L.
P611
Marti, P.
P905
Martín, F.
P662
Martin, J.
O295
Martin, M.I.
O231
Martin, R.E.
P843
Martin de Pablos, A.
P594
Martín-Gonzalo, J.A. O285,
P945
Martin-Montes, A.
O321,
O362, P414, P569, P821
Martinelli, P.
P734
Martinelli, V.
O234, O323,
O328, P392, P529, P551,
P702, P778, P842, P852,
P952
Martínez, P.
P662
Martínez Bugallo, F.
P902
Martínez Corral, M.
P502
Martinez-Lage, P.
P824
Martínez-Sáez, E.
O296
Martínez-Sánchez, P. O289,
O321, O362, P397, P414,
P569, P716
Martinka, I.
P505
Martinkova, J.
P737
Martino, D.
107
Martino, G.
P521, P688
Martinotti, G.
P911
Martins Silva, A. O246, O250,
P699
Marzegan, A.
P944
Marziniak, M.
P384
Mas, J.L.
P718
Mason, S.
O333
Masoudinezhad, S.
P399
Masri, A. P453
Massa, R.
O315
Massano, J.
O353
Masuda, M.
P708
Mathis, J.
P442
Matilla-Dueñas, A.
P502
Matos, C.
P684
Matos, R.
P872
Matsi, S.
P817
Matsuda, T.
P471, P476
Matsumoto, M.
P398
Mattarozzi, K.
P687
Mattia, D.
71
Mattioli, F.
O346
Maurage, C.-A.
O278
Mayer, G.
O316, P744
Mayordomo, F.
P905
Mazanec, R.
O340
Mazzola, M.A.
P368
Mazzucchi, S.
P595
McCague, K.
P543, P544,
P545, P546
McCormick, P.J. P725, P937
McFarland, D.
72
McGrath, E.R.
O288
McIninch, J.
P379
McKee, D. P865, P866, P869,
P914
McNeill, M.
O326
Meani, A.
O277, O332
Medaglini, S.
O234, P778
Medcalf, R.
P556
Meder, J.-F.
P718
Medici, C. P636, P637, P638
Meergans, M.
P536
Mehicevic, A.
P587
Mehlich, K.
P459
Mehrpour, M.
P465
Melamed, E.
O252
Mele, A.
P899
Melikyan, G.
P880
Melo, C.
P957
Meltzer, L.
O327
Mendes, A.
P586, P608
Mendes Pereira, V.
O287
Mendez-Lucena, C.
P594
Mendoza, C.
P662
Menguy-Vacheron, F.
P533
Menon, B.
O291, O320
Menon, C.
O261
Menon, S. P453
Mensikova, K.
P729
Meola, G.
O306, O308
Mercier, F.
P535
Mercuri, N.B.
O315
Mercurio, M.
P670
Mergeani, A.C.
P717
Merlini, A.
P521
Merritt, V.C.
O244
Merwick, A.
O263
Mesaros, S.
P841
Mesraoua, B.
P880
Messi, G.
P647
Messina, R.O241, O282, P655,
P656
Messina, S.O251, P927, P929,
P931, P932
Messmer Uccelli, M.
O328
Mestre, S.
P574
Mesumeci, O.
P907
Meuli, R.
O287
Meuth, S.
P525
Meyding-Lamadé, U.
P453
Meyer, B.
O222
Mezzarobba, S.
P462
Miceli, P.
O309
Michael, S. P865, P866, P869,
P914
Michel, P.
O287
Michelson, R.
P417
Michi, M.
P944
Mignot, E.
P425, P430
Mijajlovic, M.
P611
Mikami, H.
P938
Mikulicova, L.
P729
Milanov, I.
P383
Mildner, C.
P867
Milea, O.
P630
Milic Rasic, V.
P950
Miller, A.
P532
Miller, D.H.
O229, P388
Miller, T.
O230, P528, P531
Mills, R.J.
P394
Milonas, I.
P373
Milosevic, Z.
O351
Miltenberger-Miltenyi, G.O330
Minar, M.
P737
Mîndruta, I.
P900, P912
Mineura, K.
P721
Minzer, M.
P530
Miranda, H.P.
O356
Mirsaev, T.R.
P917
Misci, P.
O279
Mitjana, R.
P548
Mitsui, T.
P882
Mitsuma, N.
P407
Miyatake, T.
P622
Mizushima, K.
P834
Moccia, M.
P739
Mochizuki, H.
P735, P928
Moeini, A.
P553
Moeller, J.C.
P598
Moggio, M.
P906, P907
Moghadasi, M.
P553, P686
Moglia, A.
P776
Mohammad, S.F.A.
P650
Mohring, A.
P676
Mohs, C. P453
Mohs, S.
O261
Moiola, L. O234, P392, P475,
P529, P778, P952
Moisa, G.
P951
Moldovanu, I.
P654, P774
Moleiro, C.
O268
Molina, C.
P432
Molina, O
P700
Molina Sánchez, M.
P809
Molinuevo, J.L.
173, O313,
O334
Möller, M.
P503, P504
Molnar, M.J.
102
Momcilovic-Kostadinovic, D.
P742, P949
Monaco, S.
P581
Monaldini, C.
P552
Mongini, T.
P907
Monies, D.
O222
Monsch, A.U.
P815
Montalban, X. 85, 133, O231,
O296, O326, P380, P539,
P548, P710, P847
Montalenti, E.
P612
Monteiro, A.
O353
Montella, S.
P802, P803
Monti, F.
P762
Monton Alvarez, F.I.
P902
Moonen, G.
1
Moore, F.
P385
Mora, M.
P907
Morais, H.
P887
Morales, M.
O342, O364,
P637, P638, P771
Morawska, M.
P418
Morbin, M.
P624
Moreira, I. O250, P586, P699
Moreira, S.
P897
Morelli, C. P927, P930, P931,
P932
Morelli, M.E.
P852
Morenas-Rodríguez, E. P675
Moreno, E.
P725
Moreno, M.
P847
Moreno-Delgado, D.
P725
Moreno-Izco, F.
P824
Moreno-Yangüela, M. P497,
P498
Morgadinho, A. P572, P614
Morgado, J.
P416
Morimura, T.
P523
Morino, P.
P688
Moroni, I.
P907
Morovic, S.
P467
Mossman, S.
O266
147
Chairs & Authors
Motuzova, Y.
P530, P839
Mourad, H.
P838
Mouratidis, A.
P876, P890
Mousavi, M.
P399, P713
Mouzak, A.M.
P875
Mpotsaris, A.
O292
Muelas, N.
O337, P905
Mueller-Myhsok, B.
P848
Mugnaini, C.
P390
Mulas, C.S.
P596
Mulazzani, M.
P452
Muldmaa, M.
P580
Mulero, P. O243, P649, P804,
P807
Müller, C.
P452
Müller, H.-P.
P492
Müller-Forell, W.
P487
Müller-Lenke, N.
O276
Mumcu, S.
P879
Mundwiller, E.
O221
Muñoz, E.
O235, P787
Muñoz, I. O243, P649, P798,
P805, P806
Muntoni, F.
O305
Murdin, L.
O265
Musetescu, M.-C.
P480
Muslumani, M.
P880
Musumeci, O.
O307, P904
Mykhaylova, M.
P937
Myta, I.
P826
Nabavi, S.M.
P554, P555,
P694, P695
Nacmias, B.O329, P665, P828,
P829
Nacu, A.
P410
Naegel, S.
P800
Naegelin, Y.
O276
Naess, H.
P410
Nagamine, S.
P834
Nagane, Y.
P708
Nagels, G.
P391
Nair, M.
O256
Nakai, N.
P720
Nakajima, K.
O286
Nakano, T.
P407
Nakase, T.
O363
Nakken, K.O.
P761
Nambiar, V.
O291, O320
Nandedkar, S.
154
Nappi, R.
35
Nardi, K.
P933
Nardocci, N.
P944
Nascimento, S.
P723
Nathan, J.
O350, P617
Natriashvili, G.
P940
Navarro, B.
O283
Navarro, G.
P377
Navarro Brugal, G.
P937
Navas, M.
O338
Nechrych, T.
P369
Necioglu Orken, D.
P879
Nedelka, T.
O340
148
Nelles, L.
O314
Németh, Á.
P413
Nessler, R.A.
P621
Neuzner, J.
P503
Neyal, A.
P797
Neyal, A.M.
P797
Nguyen, H.
P370
Nia, S.
96
Nicholas, R.
P391
Nickel, J.
P863
Nickels, K.
P751
Nicolae, H.
P864
Nicoletti, V.
P595, P741
Niederkorn, K.
P566
Niedhammer, M.
P391
Niehaus, L.
O290
Nieto González, P.
P809
Nigmatullina, Y.
P486
Nigro, V.
P907, P908
Nikfarjam, H.
P520
Nikkhah, K.
P749
Nikoevski, N.
P825
Nikolic, A.
O310, P894
Nilius, P.
P660, P661
Nilssen, H.
P712
Nisar, H.
P447
Nischwitz, S.
P848
Nishida, S.
P720
Nissim, A.
O295
Nita, S.A.
P941
Nitkunan, A.
P913
Nitta, O.
P476
Nixon, R.
P540
Nizheharodova, D.
P530
Nizzardo, M.
P935, P936
Noachtar, S.
O269
Noain, D.
P418, P419
Nobili, L.
P425, P442
Nóbrega, C.
P844
Noé, E.
P454, P455, P456
Nogales-Gadea, G.
O338
Noirhomme, Q.70, P446, P448
Nojima, S.
P801
Nojszewska, M. P724, P790
Nolte, C.H.
O322
Nomura, E.
P398
Nomura, M.
P938
Noone, M.L.
P602
Norouzpour, M.
P686
Nos, C.
P548
Nouraddin, A.
P399
Noval, S.
P495, P703
Noval Martin, S.
P547
Novas, M.
P389
Nowakowska-Kotas, M. P823
Ntaios, G.
O287
Nuara, A. O238, P767, P768,
P770
Numata, Y.
P523
Nunes, T.
P759, P760
Núñez, F.
P672
Nurtdinov, R.
P847
Nyka, W.M.
O274
Nytrova, P.
Nzwalo, H.
P709
P574
O Conghaile, A.
O288
O Donnell, M.J.
O288
O’Gorman, J.
O229
O’Neill, G.
O326
O’Sullivan, B.
O262
O’Connor, P.
P532
Obach, V.
O364
Obermann, M.
P800
Obermeier, B.
O293
Obis, T.
P516
Odintsova, G.
P613
Odobescu, S.
P774
Oertel, W.
P744
Oertle, P.
P934
Oesingmann, N.
P706
Offen, D.
O252
Ogura, A.
P720
Oh, S.-S.
P575
Oheda, T.
P567
Ohshita, T.
P398
Oikonomidi, K.
P779
Okanli, A.
P646
Oketa, Y.
P938
Olazarán, J.
P662
Oldani, A.
P437, P439
Oliva-Navarro, J. P497, P498
Olivares, A.
P634
Oliveira, A.
P723
Oliveira, F.S.
P621
Olsson, T.P.
P532
Omran, A.
O348, P609
Ono, S.
P938
Onofrj, M.
P911
Onorati, M.
P521
Oo, W.W.
P464
Opara, J.A.
P459
Oppenheim, C.
P718
Oppermann, K.
P367
Oran, M.
P627
Ordás, C.M.
P798
Oreja-Guevara, C. P495, P547,
P703
Orologas, A.
P415
Oros, M.
P505
Orrico, D.
P470
Ortega-Aznar, A.
O296
Ortiz, E.
O338
Ortiz, N.
P516
Ortner, R.
O343, P446
Osaka, H.
P523
Oschmann, P.
P736
Osman, D.M.A.
P490
Ossowska, A.
O274
Otero, M.F.
P658
Otero-Romero, S.
P710
Ott, A.
O245, O301
Ott, S.
P441, P442
Ouallet, J.-C.
P382
Ourselin, S.
O270
Ovecka, J.
P729
Owada, K.
P721
Oyama, Y.
P882, P891
Öz, O.
P481, P765, P808
Ozcan, C.
P794
Ozcan, E.
P559
Ozden, H.
P550
Ozerden, M.
P816
Ozisik Karaman, H.I.
P620,
P646
Oztekin, Z.N.
P623
Ozturk, M.
O352
Ozyazicioglu, N.
P646
Paal, S.G.
P736
Pace, A.
O228
Pace, M.
P598, P714
Padiglioni, S.
P665, P666
Padovani, A.
P579
Padua, L.
14
Paes, D.
P369
Pagani, E. O282, O331, P841,
P842, P851, P852
Pagliarani, S.
P906
Paiva Nunes, A.
P416
Pal, A.
O225
Palace, J.
116
Palamara, L.
P624
Palchykova, S.
P915
Palermo, G.
P584, P595
Palmiero, M.
P819
Palmisano, L.
P688
Panagopoulos, G.
P862
Panea, C.
P864
Panjwani, S.
P617
Pantano, P.
P783
Pantoni, L.
O268
Panzara, M.A.
O230, P528,
P531
Panzeri, M.
P579
Papacostas, S.
P788
Papadimitriou, A.
P415
Papadopoulou, A.
O276
Papageorgiou, S.G.
P817,
P822, P826
Papagiannopoulos, S.
P779
Papathanasiou, E. 192, P788
Papatriantafyllou, J.
P822
Pape, O.
P874
Papendieck, C.
O261
Papendieck, M. P453
Pappas, V.
P817
Paramo, M.D.
P377
Paranhos, A.P.
P886
Paraskeuopoulou, V.
P488
Pardina, O.
O258
Pardo, J.
P761
Pareja, J.
P649
Pareyson, D.
52, 68, O224,
P624
Parisi, L.
O346
Parkes, L.
P381
Parkkola, R.
P772
Parra Santiago, A.
P809
Parreira, E.
P563, P564
Parris, R.S.
P522
Partinen, M.O312, P425, P426
Pasch, E.
P517
Pasco, P.M.
P669
Pascual, J.
P923
Pascual, V.
O258
Pascual-Pascual, S.-I.
O285,
P497, P945
Pasmans, R.C.O.S.
P603
Pasquier, F.
O278
Pasquina, P.F.
O244
Pasquini, S.
P390
Passafiume, D.
P819
Passeri, E.
O308
Pasternak, Y.
P449
Patankar, R.
21
Patel, R.
O361
Pathmanathan, J.
O233
Patti, F.
P688
Paulus, W.
43
Pavan, G.
P656
Pavlic, G.
P406
Pavlovic, A.
P894
Pawlitzki, M.
P853
Paxton, J.
P690
Peccatori, J.
P529
Pedraza, M.I.
O243, P649,
P804, P805, P806, P807
Pedro, B.
P723
Pedrosa, R. P684, P793, P844,
P845
Pelayo, R.
P738
Pellegrin, A.
P470
Pellegrini, F.
P372
Pellegrini, L.
P462
Pelletier, J. O227, P380, P539
Pellise, A.
O258
Peltola, H.
P425, P426
Peña, J.L.
P377
Peñas, M.L.
P648
Peng, J.
O348, P609
Penner, I.-K.
P374
Penner, M.
P418, P419
Peral Pellicer, E.
P502
Perassolo, M.
P510
Perego, E.
P702
Pereira, L.
O360
Peretz, I.
15
Perez, S.
P377
Pérez Hernández, A.
P902
Perez-Garrigues, H.
O337
Pérez-Miralles, F.C.
O293
Peric, S.
O310, P893, P894,
P896
Perry, B.N.
O244
Pershyna, I.
P722
Perticoni, S.
P933
Pesonen, U.
P772
Pestreich, L.
P543, P546
Peterle, E.
P908
Petersen, D.
P874
Petracca, M.
P706
Petrakis, A.
P415
Petrou, P.
O252
Petrovic, I.
P591
Pettorruso, M.
P911
Petzold, A.
O297
Peverelli, L.
P906
Pfausler, B.
212
Phadke, R.
O305
Phan-Ba, R.
P557
Philip, J.
P379
Phillips, J.T. O327, P388, P389
Phillips, M. P865, P866, P869,
P914
Piaceri, I.
O329, P829
Piana, H.
O283
Piani Meier, D.
P380
Piattella, C.
P783
Pichler, A.
P566
Picmausova, J.
P599
Pierard, S.
P557
Pierzchala, K.
P954
Pietroboni, A.M. P378, P670,
P818
Pietrolongo, E.
P688
Pietroski, F.
P643
Pilz, G.
P367
Pimentel, J.
O330
Pina, S.
P948
Pinheiro, J.M.R.
P886
Pinho, J.
P795
Pinkhardt, E.H.
P492
Pinter, D.
O324
Pinto, A.N.
P515
Pinto Marques, J.
P872
Piolino, P.
O283
Piperidou, C.
P756
Pires, C.
O330
Pisarenco, I.
P441
Piscopo, P.
O329
Piscosquito, G.
P624
Pisonova, K.
P505
Pistarini, C.
P776
Pizza, F.
P424, P425, P429,
P430
Pizza, F.
P426
Pizzamiglio, C.
O306
Pizzolato, G.
P462, P762
Placidi, F.
O315
Plavina, T.
O228
Plazzi, G. P425, P426, P429,
P430
Plecko, B.
5
Podemski, R.P512, P570, P823
Podgorac, J.
P611
Poggesi, A.
O268
Pöhnl, R.
P678
Pokryszko-Dragan, A.
P823
Polat, N.
P827
Põldsepp, S.
P580
Pollanz, S.
P678, P867
Pomeroy, I.
P445
Ponzio, M.
P688
Popa, I.
P792
149
Chairs & Authors
Popescu, B.O.
P900
Popescu, D.
P717
Porta-Etessam, J.
P649
Portell, E.
P738
Porteous, C.
P910
Poryazova, R.
P428
Posevitz, V.
P533
Posevitz-Fejfar, A.
P533
Postigo, M.J.
P855
Potic, A.
P742, P949
Potts, J.
P391
Potulska-Chromik, A. P724,
P926
Pozzilli, C.
P391
Pradhan, C.
O237, P625
Prakhova, L.
P856
Prasad, R.
O225
Predtechenskaya, E.
P858
Prefasi, D. O289, P497, P498
Preziosa, P. P841, P842, P852
Priego, M.
P516
Priori, A.
P579
Prokhorov, T.
O355
Prosperetti, C.
P598
Puget, S.
O283
Pulido-Valdeolivas, I.
O285,
P499, P500, P549, P945
Pupi, A.
P828
Pyrzowski, J.
O274
Qidwai, U.
Quancard, J.
Quaresma, J.
Querol, L.
P748
P846
P870
O338
R. Lugo, Z.
P446
Rabey, J.
O355
Racila, V.
P406
Radaelli, M.P392, P529, P842,
P952
Radermacher, K.A.
P518
Radue, E.-W.
O326
Radue, E.W.
O276, O325
Raghupathi, K.
P389
Ragonese, P.
P368
Ragunathan, A.
O259
Rahimi, A.
P553
Raieli, V.
O242
Rainero, I.
O329
Rajda, C.
P696
Rakocevic Stojanovic, V. O310,
P893, P894
Rakocevic-Stojanovic, V. P896
Rallmann, K.
P580
Ramalho, J.
O247
Ramió-Torrentà, L.L.
P710
Ramón y Cajal, S.
O296
Ramos, H.
P614
Rana, J.
O326
Ranieri, A.
P802, P803
Ranieri, M. P906, P907, P935,
P936
150
Ranjan, R.
P482, P835
Rannikmäe, K.
O299
Raoli, V.
P579
Rashed, K.
P838
Rashidfard, S.
P553
Rasmussen, I.
P712
Rastenyte, D
P705
Rastyar, S.
P686
Ratti, A.
P927
Rausch, P.
P491
Rausell, E.
O285
Raycheva, M.
P830
Reale, C.
P741
Realmuto, S.
P368
Rehberg-Weber, K.
P384
Reich, E.
P701
Reichmann, H.
80, 127
Reijneveld, J.
215
Reilly, R.
O254
Reiners, K.
O239
Reinhart, S.
O341, O345
Reis, C.
O353
Reisin, R.
P626
Rejdak, K.
O349
Relova, J.
P752
Relvas, R.
P793
Rémi, J.
O269
Renna, L.V.
O306
Rentzos, M.
P878
Renzetti, C.
P647
Ress, S.
P517
Ressner, P.
P660, P661
Reyhani, A.
P652
Rezaali, S.
P465
Ribera, G.
P796
Riboldi, G. P907, P935, P936
Ricci, G.
P907
Riccitelli, G. P698, P842, P851
Richardson, M.P.
207
Richert, N.
P379
Richman, S.
O228, P379
Richter, J.
O298
Ridolfi, E.
P670, P818
Rieckmann, P.
P848
Riedlbauchová, L.
O340
Riedlbauer, B.
O297
Rio, J.
O231, P548
Rispo, A.
P739
Ristic, D.T.
P562
Ristic, S.T.
P562
Ritter, S.
P380, P539
Riva, N.
O251, P929
River, Y.
P719
Rizzo, F.
P935, P936
Rizzuti, M.
P906
Robb, S.
O305
Robberecht, W.
202
Robertson, M.
105
Rocamora, R.
113, P745
Rocca, M.A. 12, O241, O277,
O279, O280, O281, O282,
O323, O346, P475, P655,
P698, P841, P842, P851,
P852
Roceanu, A.
P717, P877
Rocha, H.
P608
Rocha, S.
O353, P918
Rodegher, M.
P392, P702,
P778, P851
Rodenbeck, A.
O316
Rodenburg, R.
O221
Rodocanachi Roidi, M.L. P944
Rodolico, C.
O307, P904
Rodrigues, F.S.
P524
Rodrigues, J.
P416
Rodrigues, M.
O360
Rodríguez, C.
P805, P806,
P807
Rodriguez, J.
P446
Rodríguez de Antonio, L.A.P549
Rodríguez-de-Rivera, F.-J. P497,
P498
Rodriguez-Ruiz, M.
P725
Rodríguez-Sanz, A.
O289
Rodríguez, I.
O285, P945
Rogaeva, E.
O329
Rogeau, C.
O359
Rohani, M.
P836
Rohrer, J.D.
172,195
Roig Arnall, C.
P502
Rojas-Farreras, S.
P383
Rojas-García, R.
O338
Rojo, E.
P807
Romeo, M.
P702
Romeo, S.
O307
Romigi, A.
O315
Ronchi, D.
P906, P907
Ronconi, L.
P579
Ropele, S.
O297, O324
Roque, F.
P723
Roque, R.
P844
Roquer, J.
P745
Roriz, J.
P897
Rosas, M.J.
O353
Rose, N.
O262
Rosenow, F.
P800
Ross, M.
O339
Rossi, C.
P733
Rossi, G.
O306
Rossi, I.
P688
Rossi, P.
P529
Roth, C.
P503, P504
Roth, J.
O226, P588, P599,
P782
Roth, V.
P814
Rothwell, J.
41
Rotondo, E.
P670
Roujeau, T.
O283
Rousseaux, M.
O359, P811
Rovira, À.
O231, P548
Royes, L.F.F.
P524, P590
Royo, A.
P495, P703
Ruano, L.
P957
Rubino, E.
O329
Rudilosso, S.
O364
Rudolf, J. P489, P876, P890
Rueegg, S.
P815
Ruffini, F.
P521
Ruggieri, M.
P935, P936
Ruggieri, S.
P538
Ruiz, L.
P648
Ruiz, M.
P649, P804, P805,
P806, P807
Ruiz-Ares, G.
P569, P716
Rus, M.
P377
Ruscher, K.
O317
Rusu, O.
P402
Rusz, J.
P583, P588, P599
Ruzicka, E. 146, P583, P588,
P599
Ruzickova, H.
P583, P599
Rye, D.
P775
Sá, F.
P574
Saadatnia, M.
P412
Sabanagic-Hajric, S.
P587
Sabater, L.
O249
Sabau, D.
P763
Sabau, M.
P792
Sabetay, S.
P719
Sacco, R.
P485
Sacher, Y.
P457
Sachova, L.
P729
Sadeghi, R.
P618
Sadovnick, A.D.
P693
Sáenz-Cuesta, M.
P847
Safouris, A.
P415
Saftoiu, R.
P864
Saglam, S.
P797
Sahraian, M.
P365
Saifee, T.A.
O358
Sailer, M.
P853, P854
Sainte-Rose, C.
O283
Saip, S.
P508, P511
Saiz, A. O249, O334, P710,
P859, P923
Sakoda, S.
P567, P928
Sakurai, H.
P407
Sala, A.
P839
Sala, S.
O277, O323, O332
Sala-Matavera, I.
P672
Salamero, M.
P432
Salamzadeh, J.
P715
Salanga, V.
P506
Salani, S.
P935, P936
Salanova, V.
P763
Salemi, G.
P368
Sales, F.
O269
Salgado, H.C.
P621
Salih, M.
O221
Salmon, E.
P810
Salsano, E.
O224, P624
Saltogiannis, G.
P371
Samões, R.
O250
Sampaolo, S.
P901
San Nicolás Fernández, H. P502
Sánchez, I.
P502
Sánchez-Saudinós, M.B. P672
Sanchez-Valle, R. O313, O334
Sandi, D.
P691
Sándor, P.
O314
Sandu, M.
P941
Sangalli, F. P392, P529, P952
Sangelaji, B.
P694
Sangll, J.
O320
Sangll, S.
O291
Sanmarti, F.
P752
Sansone, V.
O308
Santafè, M.
P516
Santamaria, J. 55, O313, P432
Santamarta, E.
P859
Santana, D.P.
P590
Santangelo, G.
O242, P739
Santangelo, R.
P778
Santo António, A.
P685
Santos, A.F.
P918
Santos, E. O246, O247, O250,
P699, P849
Santos, M.
P948
Santos, P.
P872
Santos, T.
P887
Sanz-Gallego, I. P497, P498,
P499, P500, P501
Sarac, H.
P507
Sarada, C.
O256
Sarasso, S.
P598
Sargiannidou, I.
O298
Sarro, L.
O354, P731, P896
Sasajima, H.
P721
Sasaki, M.
O363
Sasaki, T.
P732
Sastre-Garriga, J. 118, O231,
P548, P710
Savettieri, G.
P368
Savic, G.
P561
Sawada, H.
P567
Sawaya, R.
O257
Scaglione, C.
P734
Scala, S.
O357, P600, P727
Scalco, R.S. P524, P590, P642,
P643
Scarlato, M.
P474
Scarpini, E.
81,174, O329,
P378, P670, P818
Scelzo, E.
P579
Schaadt, A.-K.
O341, O345
Scharnagl, H.
O297
Scheltens, P.
O268
Schenk, T.
P689
Scherer, L.
P590
Schestatsky, P.217, P637, P766
Schestatsky, S.
P766
Schindler, C.
P813, P814
Schlain, B.
O228
Schlenker, J.
O340
Schlick, C.
148
Schmid, A.
O239
Schmid, E.
O290
Schmidt, H.H.H.W.
P518
Schmidt, L.
O341, O345
Schmidt, R.
O268, P458
Schmidt, T.
P850
Schmitt, F.A.
O299
Schmitz, B.
82
Schmutzhard, E.
178, 209
Schneider, A.
152
Schneider, E.
O235, O302,
P787
Schneider, M.
P492
Schniepp, R.
O237, P625
Schöberl, F.
O302
Schoenhuber, R.
P873
Schofield, L.
P544, P546
Schreglmann, S.R.
P418
Schreiber, K.
P374
Schreuder, T.
P629
Schroth, G.
121
Schuh, E.
P576
Schuh, K.
P536
Schumann-Späth, E.
P571
Schupp, W.
P458
Schwab, M.
P854
Schwark, C. P453
Sciacco, M.
P906
Scifo, P.
O311
Scola, E.
O241
Scola, R.H.
P886
Scoto, M
O305
Scutelnicu, D.
P405
Seddighzadeh, A. O227, P387
Sedel, F.
6, 97
Sedlakova, K.
P736
Seemungal, B.
O264, P486
Sekine, A.
P834
Sekulic, S.
P611
Selezneva, E.
P530
Sellner, J.
210
Selmaj, K. O230, O326, P388,
P389, P528, P531
Semedo, C.
P872
Sen, H.M.
P620
Sena, A.
P844, P845
Sendtner, M.
P517
Senel, M.
P707
Senoo, A.
P471, P476
Seo, H.E.
O284
Serban, V.
P640, P903
Serebryanaya, N.
P605
Seri, M.
P430
Serpente, M.
O329, P818
Serradell, M.
O313, P432
Serrano-Munuera, C.
P502
Serranová, T.
P782
Sertic, J.
P507
Sessa, M.
P474
Sevilla, T.
O337, P905
Sewry, C.
O305
Seyahi, E.
P508
Sfikas, N. O325, P540, P541,
P542
Sgubin, G.
P462
151
Chairs & Authors
Shahdaei, S.
P686
Shahidi, G.A.
P836
Shakir, M.
P748
Shaklai, S.
P457
Shams-Hosseini, N.S.
P465
Sharifi Razavi, A.
P399
Sharma, A.
P394
Sharma, B.
22
Sharon, H.
P449
Sheikh, S.I. O229, P388, P389
Shen, B.
P906
Shim, D.-S.
P575
Shimizu, Y.
P708, P888
Shin, J.
P639
Shin, S.
P635
Shinzawa, K.
P735
Shiong Shiu, L.
P669
Shiota, K.
P476
Shiozawa, P.
P766
Shiratani, T.
P476
Shivaprasad, S.
P682
Shkilnyuk, G.
P856
Shoeibi, A.
P618, P749
Shon, Y.-M.
P615, P754
Shopova, A.
P830
Shprakh, V.V.
P946, P947
Siamashka, V.
P746
Siccoli, M.M.
P428
Sicignano, S.
P803
Siciliano, G.
P907
Siedler, G.
O336
Sieger, T.
P782
Sieminski, M.
O274, O312
Sigatullina, M.
P752
Sijaric-Voloder, S.
P404
Silani, V.
204, O251, P927,
P929, P930, P931, P932
Silva, A.M.
O247, P391
Silva, M.C.
P957
Simitsi, A.M.
P826
Simó-Castelló, M.
O293
Simón Gozalbo, A.
P821
Simón-Martínez, C.
O240
Simone, A.
P687
Simone, C.
P935, P936
Sina, F.
P836
Singer, B.
185
Sinha, A.
P537, P538
Sinnreich, M.
176
Sirén, A.-L.
P525, P526
Sistanzad, M.
P715
Siva, A.
7, 169, P508, P511
Sivakova, N.
P605
Sivera, R.
O337
Sixt, G.J.
P873
Skrodeniene, E.
P705
Slawka, S.
P386
Slezak, A.
O287
Slonka, J.
P671
Slowik, A.
O318, P850
Slyusar, T.
P812
Smith, F.
O266
Smith, M.L.
P490
152
Soares-da-Silva, P. O272, P758,
P759, P760
Soelberg Sørensen, P. 89, 119,
170, P391
Soffietti, R.
153, 213
Sokolova, E.
P840
Sokolova, L.
P577
Solari, A.
171, O328, P687,
P688
Solla, P.
P596
Somleva, D.
P401
Sommer, C. 49, 220, O239,
O336
Sommerauer, M. P423, P444
Song, H.-K.
P639
Song, S.K.
P924
Sonka, K.
P431
Sorbi, S. O329, P665, P666,
P828, P829
Sosti, M.V.
P726
Sotelo, E.M.
O243
Soto, A.
P700
Soto, I.
P700
Soto, M.
P824
Sousa, A. P793, P844, P845
Sousa, C.
O353
Sousa, L.S.F.
P870, P885
Sousa, R.
P759, P760
Souza, M.A.
P524
Souza, V.
P885
Sowa, P.
P954
Soysal, A.
P558
Sozmen, V.
O352
Spagnolo, F.O238, P768, P770
Spalek, P.
P505
Spandideas, N.
P799
Spasic, M.
O351
Spasova, N.
P401
Sperling, B. O227, P386, P387
Spinelli, E.G.O300, P474, P478
Spitaleri, C.
O242
Sprenger, T.
O276
Srovnalova, H.
P660
Srovnalova-Zakopcanova, H.
P661
Stadler, E.
P853, P854
Staedler, C.
P598
Staels, B.
P845
Stam, J.
O319
Stamboulis, E.
P799, P878
Stamelou, M.
P743
Stankovic, I.
P591
Stapf, C.
60
Stazzone, L.
P370
Steeves, J.
P460
Stefan, H.
P761
Stefanescu, V.
P402
Stefani, M.
O309
Stefanis, L.
P826
Stefoski, D.
O326
Stelmasiak, Z.
O349, P868
Stepien, A.
P857
Stergiou, C.
O294
Stevanin, G.
O221
Stevic, Z.
O310, P894
Stippich, C.
O276
Stojakovic, T.
O297
Stojkovic, T.
O223
Stokic, D.
O339
Stoll, G.124, P517, P518, P525
Stolyarov, I.
P856
Storti, S.F.
O273
Stosic-Opincal, T.
P841
Straffi, L.
O238, P768
Stragapede, L.
P762
Straumann, D.
37
Strazzer, S.
O281
Streiff, M.
P846
Strong, M.
203
Stroubini, T.
P875
Strupp, M.
95, O236, P786
Stumpo, M.
P552
Stupar, D.
P949
Stylios, C.
P775
Suárez, E.
P859
Suárez, L.
P923
Suárez, M.
P923
Suarez-Calvet, M. P672, P675
Suárez-Calvet, X.
O338
Subasic, N.S.
P587
Subramanyam, M.
O228
Sudlow, C.L.M.
O299
Suki, D.
O257
Suljic, E.
P587
Sulkowski, G.
P857
Sumi-Akamaru, H. P735, P928
Sumowski, J.F.
P690, P698
Sun, J.
P374
Suszek, D.
P868
Sut, N.
P652
Sütlas, P.N.
O304, P816
Suzuki, A.
O363
Suzuki, M.
P888, P938
Suzuki, N.
P708
Suzuki, S.
P708
Suzuki, Y.
P892, P708
Svenningsson, A.
P374
Svetel, M.
O354, P731
Svirid, I.
P530
Sweetser, M.T.
P389
Symeonidou, E.-R. P418, P419
Symms, M.
O347
Synnes, A.
P693
Szacka, K.
P926
Szatmary, G.
O339
Szczygiel, J.
P459
Szewczyk, P.
P512
Sztajzel, R.
O287
Szydlo, M.
P823
Taba, P.
Taiminen, T.
Taipale, K.
Takada, H.
Takagi, K.
Takahashi, Y.
P580
P772
P384
P891
P801
P708
Tió, E.
P796
Tiric-Campara, M.
P404
Tiu, C.
P402, P411
Tocco, P.
P581
Todorov, T.
P830
Todorova, A.
P830
Toledano, M.
P804
Tolosa, E.
125, O313, P432
Tomàs, J.
P516
Tomàs, M.
P516
Tomelleri, G.
P907
Tomic, A.
O354, P731
Tomic, D. P380, P537, P538,
P540, P541, P542
Tomita, S.
P567
Tomlinson, M.
P383
Tondelli, M.
O309
Tonon, C.
P430
Toolabi, K.
P889
Topcular, B.O304, P558, P559,
P816
Toribio, E.
P648
Török, M.
P696
Torres, C.
P701
Torres, M.
O231
Tortora, R.
P739
Toscano, A. 73, O307, P904,
P907
Tournev, I.
P825, P830
Tousignant, G.
111
Touze, E.
P718
Toyooka, K.
P928
Trabajos-Garcia, O.
O321,
O362, P414, P499, P500
Traboulsee, A.
P693
Traykov, L.
O303
Treglia, G.
P734
Tremlett, H.
P693
Tremont-Lukats, I. O259, O260,
P682, P683
Trezzi, I.
P681
Tricarico, D.
P899
Tricomi, G.
P949
Trinka, E.
P367
Tripsianis, G.
P756
Triulzi, F.
P952
Trojano, M.
O328, P372
Trousson, C.
O283
Truffinet, P.
P532
Tsai, C.-H.
P427
Tsamis, K.
P679
Tsao, J.W.
O244
Tsatovidou, R.
P677
Tsiara, S.
P862
Tsiptsios, D.
P488, P489
Tsiptsios, I. P488, P489, P876,
P890
Tsironis, T. P488, P489, P890
Tsitsi, P.
P876, P890
Tsoukanelis, K.
P606
Tsuchiya, T.
P667
Tsujimoto, Y.
P735
Tsukie, T.
P938
Tumani, H.
P492, P707
Tummala, S.O260, P682, P683
Tupkovic, E.
P404
Tur, C.
O231, P548, P847
Turan, S.
P513, P939
Turc, G.
P718
Turconi, A.C.
O281
Turgut, B.
P627
Turgut, N.
P627
Turkmanovic, Z.
O310
Türkoglu, R.
P513, P939
Turrini, R.
P538
Tüzün, E.
P513, P939
Twyman, C.L.
O230, P528,
P531
Tyblova, M.
P709
Tychalas, A.
P876, P890
Tykalova, T.
P583, P599
Tzartos, J.S.
O294
Tzartos, S.
O294
Ubano, M.
P708
Uccelli, A.
84
Üçeyler, N.
O239, O336
Uchiyama, S.
P708, P888
Uggetti, C.
67
Ugurlu, S.
P508
Uhl, V.
O314, P436
Uitdehaag, B.
O232
Ulas, Ü.H.
P765, P808
Uluduz, D.
P511
Ulusoy, C.
P513, P939
Unal, A.
P627
Uncini, A.
P714
Unti, E.
P733, P883
Urbaneja, P.
P855
Urbonaviciute, I.
P705
Uribe, F.
O243
Urminska, I.
P505
Urra, X.
O364
Usnich, T.
O322
Ustrell, X.
O258
Utsugisawa, K.
P708
Utsumi, H.
P708
Utz, K.S.
O345, P689
Uyar, T.
P757
Uygunoglu, U.
P508, P511
Uysal, A.I.
P753
Uzar, E.
P633
Uziel, G.
O224
Vadasdi, K.
P413
Vafaei-Bagheri, F.
P520
Vaida, L.
P792
Vaitkus, A.
P705
Vaknin-Dembinsky, A. O252
Valadas, A.
O330, P872
Valaperta, R.
O308
Valavanis, A.
P415
Vale, J.
P845
Vale, O.C.
P919
Valentí, M.
P662
153
Chairs & Authors
Takeuchi, M.
P888
Talarico, G.
O329
Tallon-Barranco, A.
O321,
P414, P549, P569
Tam, A.
P820
Tamam, Y.
P633
Tan, H.
P472, P479
Tan, M.
P466
Tan, U.
P466
Tanadini, L.
P460
Tanel, R.
P470
Tanriverdi, G.
P620, P646
Tanriverdi, Z.
P879
Tarta Arsene, O. P942, P951
Tasdemir, S.
P481, P808
Taskiran Sag, A.
P623
Tasliinar, A.
P765
Tataru, A.
P718
Tatsuzawa, K.
P721
Taub, E.
P813
Tavernarakis, A.
P677
Tawil, B.
P832
Tay, A.
P633
Tay, L.B.
P468, P469
Taylor, J.
O240
Taylor, K.
O344
Tedde, A.
P829
Tedeschi, G.
P485
Tefertiller, C.
P461
Tegos, T.J.
P415
Tejera Martín, I.
P902
Teleanu, R.I.
P480, P941
Temucin, C.M.
P623
Tennant, A.
P445
Teodorescu, R.
P706
Teramoto, S.
O253
Terecoasa, E.
P402, P411
Terracciano, C.
O315
Terzaghi, M.
P776
Tesio, L.
P687
Tettenborn, B.
P393, P593,
P747
Teufel, J.
P786
Tevzadze, N.
P780
Thalheim, C.
186
Theeler, B.
O259
Theochari, E.
P628
Thibaut, A. O267, P450, P451
Thomaides, T.
O294, P799
Thomas, A.
P911
Thomas, F.P.
P919
Thomassen, L.
P410
Thömke, F.
P491
Thompson, A.G.B.
P607
Thompson, P.
O347
Thonnard, M.
P450, P451
Thussu, A.
P366
Ticho, B.
O228, P379
Ticozzi, N. P927, P931, P932
Tiloca, C.
P927, P931
Timer, E.
P879
Tinchon, A.
P678, P867
Tintoré, M. O231, P548, P710
Valentino, P.
P839
Valko, P.O. P420, P422, P423,
P444
Valkovic, P.
P737
Valldeoriola, F.
O313, P432
Valle, A.J.
O243
Valls-Solé, J. 64, 192, O235,
O342, O364, P636, P637,
P638, P771, P781, P782,
P787
Valsasina, P.
O277, O279,
O280, O281, O323,
O332, O346
Van Asch, P.
P556
Van Broeckhoven, C.
P825
Van den Broeck, M.
P825
Van den Wijngaard, C.C. O301
van der Kop, M.
P693
van der Sande, M.A.B. O301
van Hilten, J.J.
132
van Ommen, H.J.
O267
Vanacker, P.
O287
Vanadia, F.
O242
Vandi, S.
P425, P429
Vandroogenbroeck, M. P557
Vaneckova, M.
P709
Vanhaudenhuyse, A.
O267
Varanda, S.
P795
Varga, E.T.
103
Varga, V.
P413
Varona, R.
P533
Vartholomatos, E.
P679
Vas, A.
P865, P866, P869,
P914
Vasconcelos, C. O246, O247
Vasile, D.
P480
Vasishta, R.
O225
Vassileva, E.
P401
Vastik, M.
P729
Vaz, R.
O353
Vazquez, J.F.
O337
Vecsei, L.
P691, P696
Vega, J.
P859
Veggiotti, P.
O323, P475
Veletza, S.
P756
Velikova, S.
O238
Veloso, M.
P845
Ventura, N.
P600
Verde, F.
P931, P932
Verdelho, A. 193, O268, O330
Vergallo, A.
P883
Verhoeven, W.M.A.
O245,
O301
Verma, K.
P468, P469
Vermersch, P.
19, 160
Ververaki, S.
P677
Vezzulli, P.
P529
Viader, F.
P565
Vicente, M.J.
O231
Vickrey, B.G.
P385
Vidailhet, M.
104
Vidal-Jordana, Á. O231, P548
Vieira Dias, H.
P723
154
Viglietta, V. O229, P388, P389
Vignatelli, L.
P687
Vila-Chã, N.
P586
Vilas, D.
O313
Vilaseca, I.
O313, P432
Vilchaez Padilla, J.J.
P908
Vílchez, J.
P905
Vilchez, J.J.
O337
Villa, C.
O329
Villalobos, A.
P791
Vimercati, R.
P670
Viñas, J.
O258
Vincent, A.
31, O248
Vincent-Smith, L..
P628
Virtanen, A.
P772
Visvardi, A.
P875
Vita, G.
O307, P904
Vitale, C.
P739
Vitkauskiene, A.
P705
Vivanco, R.
P745
Vladimirova, Z.
P692
Vlaikidis, N.
P779
Vo, K.H.
P370
Vogrig, A.
P581
Voigt, K.
P854
Voiticovschi-Iosob, C.
P654
Vojinovic, D.
P950
Volkmann, J.
P944
Vollmar, C.
O347, P560
Vollmer, T.
134a
Volonté, M.A.
O238
Voloshyna, N.
P369
Volpini, M.
P552
Volpini Bertrán, V.
P502
Von Rosenstiel, P. O325, P380,
P537, P538, P539, P542
Vujnic, M.
P893
Vujovic, J.
P742, P949
Vural, B.
P513
Wagner, F.
P393, P747
Wagner, U.
P676
Wahbi, K.
O223
Waje-Andreassen, U.
P410
Wakabayashi, S.
P398
Wakil, S.
O222
Waldemar, G.
194
Waliszewska-Prosol, M. P512,
P570
Walter, H.L.
O317
Walter, U.
P375
Wandschneider, B.
O347
Ward, M.P.
P763
Warø, B.
P582
Waschbisch, A.
P689
Watanabe, T.
P938
Waters, P.
O248
Wazan, O.
O222
Weber, F.
P571, P848
Weber, J.
P393
Weber, W.
O292
Weckhuysen, S.
208
Weeks, S.R.
O244
Weerdesteyn, V.
147
Weiner, H. O230, P528, P531
Weis, J.
O221
Wenning, G.
126
Wenten, M.
P379
Werneck, L.C.
P886
Wernsdörfer, C. P375, P376,
P384
Werth, E. P420, P421, P422,
P423, P428, P444
Westgeest, A.C.
P638
Wettmarshausen, C.
P375,
P376
Wieloch, T.
O317
Wiendl, H. P372, P376, P533
Willemsen, M.
30
Williams, E.J.
O270
Williams, S.
P616, P728
Willis, H.
P381
Wing, A.C.
O231
Winkelmann, J.
P430
Winston, G.P.
O270
Wipfler, P.
P367
Wirrell, E.
P751
Wnuk, M.
O318
Wöber, C.
P452
Wolf, C.
P848
Wolf, M.
P424
Wolinsky, J.S.
P532
Wong, M.C.
P785
Wong-Kisiel, L.
P751
Wood, N.
65
Woodhall, M.
O248
Woodman, K.
P683
Worbe, Y.
106
Worth, R.M.
P763
Wu, R.
P484
Wu, U.-I.
P427
Wuehr, M.
P625
Wühr, M.
O237
Wynn, D.R.
P545
Xi, Z.
Xiao, Y.
Xiong, G.
Xiromerisiou, G.
O329
P484
O302
P489
Yahara, O.
P892
Yalcin Gursoy, M.H.
P620
Yamamoto, R.
P523
Yamashita, T.
O253
Yamazaki, K.
P801
Yamout, B.
P365
Yan, G.
P473
Yandim Kuscu, D.
P558
Yang, M.
O229, P388
Yannis, G.
P822
Yardimoglu, M.
P527
Yasar, H.
P765
Yasuda, T.
P720, P735
Yasui, K.
P938
Yazdani, S.
P399
Zafranskaya, M.
P530
Zago, S.
Zagrajek, M.
Zaharis, T.
Zahiri, N.
Zakrzewska-Pniewska, B.
P670
P570
P862
P555
P724,
P790
Zande, M.
P373
Zanetta, C.
P935, P936
Zangen, A. O238, P767, P768
Zani, J.
P600
Zaratin, P.
P688
Zardo, E.A.
P642
Zarubova, K.
P588
Zauner, M.
P796
Zavalko, I.
P441, P442
Zbornikova, P.
P709
Zeller, D.
O239, O336
Zerah, M.
O283
Zettl, U.
P854
Zettl, UK.
P848
Zeydan, B.
P508
Zhang, A.
O327, P372
Zhang, P.
P484
Zhang, R.
P388
Zhang, Z.
P433
Zhao, Y.
P693
Zhelyazkova, S.
P825
Zheng, H.Y.
P472, P479
Zheng, L.
P906
Zheng, W.B. P472, P473, P479
Zhu, F.
P693
Zhu, Y.
O227
Židovská, J.
O226
Ziegler, M.S.
P642
Ziemssen, T. 159, 187, P556
Zikou, A.
P606
Zilinska, Z.
P737
Zimmermann, R. P813, P814,
P815
Zingler, V.
P375, P376
Zisimopoulou, P.
O294
Zisimopoulou, V.
P677
Zlatareva, D.
P830
Zmarandescu, R.
P630
Zoabi, W.
P719
Zompola, C.
P826
Zorzi, G.
P944
Zouroudi, S.
P606
Zouvelou, V.
P878
Zsiros, V.
P691
zu Eulenburg, P. O275, P487,
P491
Zuberbuhler, P.
P626
Zucconi, M. P437, P438, P439
Zwergal, A.
O302, P496
Chairs & Authors
Yazdankhah, Z.
P399
Ye, B.
P484
Yeap, K.
P447
Yeni, S.N.
P511
Yeoh, Q.W.
P447
Yetisyigit, T.
P627
Yigiter, R.
P797
Yilmaz, M.
P797
Yimenicioglu, F.
P797
Yin, F.
O348, P609
Yokoo, H.
P834
Yokoyama, S.
P882
Yoon, B.A.
P871
Yoon, G.-J.
P860
Yoshida, K.
P892
You, X.
P369, P386
Young, C.A.
O255, O262,
P394, P445
Young, P.
O316
Yu, L.-H.
P523
Yuan, H.
P389
Yuan, Y.-C.
P906
Yücel, M. P481, P765, P808
Yuen, H.W.
P785
Yust-Katz, S.
P682
155
© drummond79 – Fotolia.com
Audiovisual
Equipment /
Speakers’
Service
Centre (SSC)
The Speakers‘ Service Centre (SSC) is located close to all lecture
halls (see floor plan p. 169). PowerPoint presentations must be
handed in via an USB compatible memory stick or via your own
laptop at the SSC at least one hour before the beginning
of the session.
Speakers will have the opportunity to check their presentations
on PCs available in the SSC.
Posters and
Guided
PosterHighlight
Sessions
Posters will be displayed for one half-day.
Moderated poster highlight sessions will take place in order
to enliven the poster display. Authors are kindly asked to be
present for the duration of the poster session in which their
posters are on display.
Poster highlight sessions require the use of headphones which
can be collected in the poster area. Each session is allocated
a channel and the channel number is displayed at the start of
each walk.
All authors are requested to mount and remove their posters
at the times mentioned on the next page. Posters still hanging
at the end of the removal time will be disposed of by the
organisers.
156
Poster
Poster No. Day of Poster Session
Session
Session
Time
Poster
Mounting
Poster
Removal
1
P365 – P527 Sunday, 9 June 2013
11:30 – 12:30 09:00 – 10:00 16:00 – 16:30
2
P528 – P685 Monday, 10 June 2013
11:30 – 12:30 09:00 – 10:00 13:00 – 13:30
3
P686 – P836 Monday, 10 June 2013
17:30 – 18:30 14:00 – 14:30 18:30 – 19:00
4
P838 – P957 Tuesday, 11 June 2013
11:30 – 12:30 09:00 – 10:00 13:30 – 14:00
Width: 160 cm
Height: 80 cm (horizontal presentation)
Poster Desk
The poster desk is located in the poster area (see floor plan
p. 169). Material to mount your poster will be available there.
Video
Presentation
Authors who have requested a video (DVD) to accompany their
poster will have equipment with monitor at their disposal.
Publication
All accepted abstracts will be published in the "Journal of
Neurology" which you will receive with your congress bag.
Abstract texts can be viewed on the congress website as from
the start of the conference: www.ensinfo.org
E-Posters
Posters can also be viewed as E-Posters at the indicated station
in the poster area.
The E-Posters will be presented in addition to the paper posters
to enable delegates to easily find and browse posters and to
download them as PDF.
The posters will be available on the ENS 2013 Website during,
and if permitted by the author, after the congress.
Chairs & Authors
Poster
Measurements
157
© MasterLu - Fotolia.com
General Information (in alphabetical order)
Application
for Mobile
Devices
The ENS App allows delegates to easily navigate through the
entire scientific programme from their mobile device. Scan the
QR code on the 2nd cover page to download the App or go to
your Appstore and search for "ENS 2013".
The ENS App is supported by Abstracts
All accepted abstracts are published as a supplement to the
Journal of Neurology, the official journal of the ENS. Abstract
texts are available online as from the beginning of the
conference at www.ensinfo.org
ATM / Cash
Machine
An ATM cash machine is located close to the Congress
Secretariat (see floor plan p. 169). VISA and MasterCard are
accepted.
Award
In memory of Prof. PK Thomas the ENS is pleased to announce
the PK Thomas Award for the best paper on peripheral
nerve disorders. Prof. PK Thomas graciously left an annual
sum of € 500.– for awarding the best paper on peripheral
nerve disorders. The papers will be evaluated during the ENS
meeting and the prize winner will be notified in writing after
the congress.
158
General Information
Badges
Access to scientific sessions will only be possible with your
personal badge which you will receive at the registration desk.
All participants are requested to wear their badge throughout
the congress.
For replacement of a lost badge € 30.– will be charged.
Badge
and Bag
Recycling
You can leave your badge in a recycling box when leaving the
conference. If you do not want to keep your congress bag,
please bring it back to the congress secretariat.
Business
Centre
Close to the conference centre is the Gran Via 2 mall.
Address: Avinguda Gran Via, 75 – 97
Opening times: Monday to Saturday 10:00 – 22:00
Certificates
Please refer to p. 7 for details.
Cloakroom
A cloakroom is available nearby the registration area and is
open during the secretariat opening hours. The cloakroom
service costs € 2.– per person per day.
ENS/EFNS
Society
Booth and
ENS Business
Meeting
Throughout the meeting, staff is available at the ENS/EFNS
booth to answer questions you may have.
Exhibition
The ENS 2013 exhibition will be open during the following
times:
ENS Business Meeting 2013 for all ENS members
Date and time: Tuesday, 11 June 2013; 11:00 – 12:00
Location: Room D
Saturday, 8 June 2013, 12:00 – 16:00
Sunday, 9 June 2013, 09:00 – 17:30
Monday,10 June 2013, 10:30 – 17:30
Tuesday, 11 June 2013, 10:30 – 16:00
The meeting organiser cannot accept liability for personal
injuries sustained, or for loss or damage of property, either
during, or as a result of the meeting. Please check the validity
of your insurance.
Internet
Corner
An internet corner is located in the exhibition area and is
available to all congress participants during the opening hours
of the exhibition. In this area also WiFi is available.
General Information
Insurance
159
General Information
Italian
Agency
AIM Group International – AIM Education Srl
Ms Raffaella Frigerio
Via Guiseppe Ripamonti, 129
20141 Milan / Italy
Tel: +39 02 56 60 12 88
Fax: +39 02 70 04 85 85
[email protected]
www.aimgroupinternational.com
Language
The official language of the congress is English. No simultaneous
translation is provided.
Lunch and
Coffee
Breaks
Lunch and coffee is included in the registration fee and will be
served in the exhibition area as per the times indicated in the
Programme Overview (pp. 10 – 17).
Message
Board
A message board is available close to the Congress Secretariat.
If you have a message for another delegate, you are welcome
to hang it on this board.
Posters and
E-Posters
Please refer to pp. 154 – 155 for detailed information.
Press
Registration
and Media
Centre
A Media Centre with wireless internet access is available to
registered journalists. Press representatives must register at
the secretariat showing their official press accreditation. The
Media Centre is located close to the lecture halls (see floor
plan on p. 169).
Social Media
Follow "ENS Congress" on Facebook, Twitter, LinkedIn and
Google+.
Speakers
Service
Centre (SSC)
The SSC is located close to all lecture halls (see floor plan
on p. 169). All speakers are kindly asked to hand in their
PowerPoint presentation at the SSC at least 1 hour
before the start of their session.
Shuttle
Buses
From 8 – 11 June 2013 a free shuttle bus service will be in
operation, driving between the "Europa Fira" train station and
the ENS Congress Venue (North Entrance; Hall 8). Please refer
to pp. 166 – 167 for further details.
Teaching
Course
Manuscripts
All teaching course manuscripts can be accessed online
after the congress. Please go to the congress website
www.congrex.ch/ens2013 (Scientific Programme), and log-in
with your email address and the password: ENS2013!
Transportation Tickets
Transportation tickets can be bought at the "Barcelona
Information Desk" close to the Congress Secretariat.
160
General Information
Travel
Agency
Congrex Travel Ltd.
Tel: +34 932 334 574 (onsite)
Fax: +34 932 344 300 (onsite)
Email [email protected]
Congrex Travel is present at a desk during the meeting close to
the Congress Secretariat. Staff can assist you with your hotel
and flight bookings.
The official Airline Carrier of the ENS is Star Alliance.
Venue
The 23rd ENS meeting takes place at the Fira de Barcelona –
Recinto Gran Via (www.firabcn.es). The venue is located
outside of Barcelona’s city centre, on the way towards
Barcelona Airport. The building is not accessible via metro,
but can be reached via an FGC train that leaves from "Plaza
Espanya" (L8). Refer to pp. 166 – 167 for more details.
Address during the conference:
ENS 2013
Fira de Barcelona – Recinto Gran Via
Pabellon 8 (North Entrance)
Av. Joan Carles I, 64
08908 L’Hospitalet de Llobregat
Barcelona / Spain
Tel:
+34 932 334 575 (onsite)
All foreign visitors must posess a passport valid for at least the
next six months. Please note that visa application procedures
can take up to two months and that it is not possible to obtain
a visa a the Barcelona Airport. For further information, please
have look at the website of the Ministry for Foreign Affairs:
www.maec.es
WiFi
WiFi is available free of charge in the exhibition area.
General Information
Visa
Requirements
161
© fazon - Fotolia.com
Registration Fee Scientific Programme
Up to
As from 21 March
As from
20 March 2013
to 25 April 2013
26 April 2013
Member ENS
€ 300.–
€ 375.–
€ 410.–
Non-member
€ 490.–
€ 565.–
€ 600.–
Junior member ENS
€ 235.–
€ 310.–
€ 345.–
Junior non-member*
€ 360.–
€ 435.–
€ 470.–
Junior non-member**
€ 265.–
€ 340.–
€ 375.–
Member Spanish
Neurological Society
€ 405.–
€ 465.–
€ 500.–
*Colleagues in training, born after 1 January 1978, including subscription to the Journal of
Neurology for one year (copy of valid passport obligatory)
**Colleagues in training, born after 1 January 1978, excluding subscription to the Journal of
Neurology (copy of valid passport obligatory)
Please note: the ENS Opening Ceremony (although free of charge) requires separate registration
as well as the ENS Farewell Networking Event (E 60.– per person.) Teaching Courses and
Workshops during the ENS Meeting are also subject to ENS Congress registration.
Registration Fee Teaching Courses
Member ENS
Non-member
Up to 20 March 2013
As from 21 March 2013
Half day
€ 20.–
€ 35.–
Half day
€ 35.–
€ 50.–
Full day
€ 35.–
€ 65.–
Full day
€ 65.–
€ 85.–
Please note that certificates for Teaching Course participation are only given out during the
respective courses and cannot be issued afterwards.
162
Workshops and Practical Sessions
Up to 20 March 2013
As from 21 March 2013
Member ENS
€ 15.–
€ 20.–
Non-member
€ 20.–
€ 25.–
Registration is limited and on a "first-come first-served" basis.
Subscription to the
Journal of
Neurology
Should the Meeting participant not be a member of the ENS,
he/she will receive a temporary subscription to the Journal of
Neurology. This free e-subscription is valid for all issues of 2013.
The electronic access codes will be emailed in August 2013.
Opening
Hours
Secretariat
and
Registration
The registration desk at the Congress Venue is open during the
following opening hours:
Saturday, 8 June 2013, 07:30 – 20:00
Sunday, 9 June 2013, 07:30 – 18:00
Monday,10 June 2013, 07:15 – 18:00
Tuesday, 11 June 2013, 07:15 – 17:30
All documents included in the registration fee (congress bag,
personal name badge, Journal of Neurology) will be handed
over to registered participants.
The participant acknowledges that he/she has no right
to lodge damage claims against the organisers, should
the holding of the congress be hindered or prevented by
unexpected political events or economic events or generally
by force majeure, or should the non-appearance of speakers
or other reasons necessitate programme changes. With
registration, the participant accepts this proviso.
Cancellation/
Refund Policy
Refund of fees, less 25 % administrative charges, can be
applied for in writing until 2 May 2013 to the Organising
Secretariat in Basel, Switzerland. After this date no refund will
be possible. For any change of names, a fee of € 30.– will be
charged. If she/he is not attending the conference and has
not respected the cancellation policy, the complete registration
costs have to be paid.
General Information
Responsibility
163
No mat ter where you’re travelling from, the
Star Alliance network of fers you a wide choice
of flights to Barcelona, Spain.
And with 21,900 flights a day to over 1,329
destinations across 194 countries, our 27 member
airlines ex tend the same choice to any future
conferences you’re planning to at tend.
You can also save money when you book your
flights. Simply quote the unique conventions code
and you and one companion travelling with you will
receive a special discount. Bet ter still, no mat ter
which Star Alliance member airline’s frequent
flyer programme you belong to, you can earn and
redeem miles across all 27 airlines.
For more information, or to join the airline
network that of fers you more choice wherever
your conferences take you, simply go to
staralliance.com/conventionsplus
www.staralliance.com
Information correct as at 11/2012
Networking Events
Opening Ceremony
19:30
The Opening Ceremony will take place right after the presidential symposium
to round off the first conference day at the Fira Gran Via. Here, participants
will have the opportunity to network with colleagues in a relaxed atmosphere!
Typical Spanish drinks and tapas will be served. The highlight of this Spanish
Evening will be the acrobatic act of building a so called "Castell" (human
tower), which is often seen during festivals at many locations within Catalonia.
All participants and exhibitors are invited to the reception. Please wear your
badge!
Location: Fira Gran Via (Hall 8); 2nd floor
ENS Farewell Networking Event
20:00
The ENS Farewell Networking Event (standing cocktail reception) will be held
at the spectacular Casa Batlló in the city centre of Barcelona and will replace
the ENS Banquet this year.
Casa Batlló is considered a masterpiece of Art Nouveau architecture. It was
built between 1904 and 1906 by the famous architect Antoni Gaudí for
Josep Batlló, a wealthy aristocrat. The local name for the building is Casa dels
ossos (House of Bones). Dragons, monsters and Venetian masks among others
are the elements that recall the sight of the façade. The interior of the house
consists of details made of mosaic tiles, wood and glass, offering a dream
world to its visitors.
The event will take place mainly on the roof top and in the lower levels of
the house, where cocktails and warm finger food will be served. A traditional
Rumba Group will entertain the audience. Later on, the magical surroundings
will transform into a bar and dance floor.
Ticket price: E 60.– per person
Way Description:
From "Europa Fira" FGC train station you will reach "Plaza Espanya". There you can take the
green line (L3) of the metro network, direction "Trinitat Nova" and get off at "Passeig de
Gràcia" metro station. Casa Batlló is right next to it.
Casa Batlló
Passeig de Gràcia, 43
08007 Barcelona
165
General Information
Onsite tickets: please ask at the Congress Secretariat whether there are still
tickets available. Access to the venue is only guaranteed if you have a ticket.
© MasterLu - Fotolia.com
Useful Information about Barcelona (in alphabetical order)
City of
Barcelona
Barcelona, the capital of the autonomous community of
Catalonia is a dynamic and welcoming city and one of
the leading drivers of the Mediterranean economy. The
creation of new transport networks along with its modern
hotel infrastructure has made Barcelona one of the most
international of European cities.
Greeks, Carthaginians, Romans, Visigoths and Moorish
have all left their marks on the city, its culture and customs.
A non exhaustive list of the possibilities that the Ciudad de
los Prodigios (The City of Wonders) may offer includes the
Gothic Quarter, the best preserved in Europe, the unique
modernistic architecture of Gaudí, Domènech i Montaner
and Puig i Cadafalch, the view from the Tibidabo Hill and the
indescribable flavours of both, new and traditional Catalan
cuisines. Those who still want to discover the city any further
can go for a stroll in Las Ramblas or for a swim on the beach
of the Barceloneta.
For further information please visit the following website:
www.barcelonaturisme.com
Barcelona
Information
Desk
166
City tours can be booked via the website of Barcelona Turisme
or at the Barcelona Information Desk, which is located close
to the Congress Secretariat onsite. Participants can also obtain
city maps and can buy transportation tickets for the public
transportation system.
Useful Information about Barcelona
Barcelona enjoys a Mediterranean climate with warm summers
and relatively low rainfall. In June the temperatures are very
pleasant at 24° Celsius (75° Fahrenheit) on average.
Currency
All official congress prices are indicated in Euros (€), which
is the official currency in Spain. All major credit cards are
accepted in most hotels, restaurants and shops.
Electricity
Spain uses the 220 volt 50 Hz system. Sockets follow the
European standard.
Emergency
Phone
Numbers
Fire Department
081
Ambulance Service 112
Police Department 091
Restaurants
In Spain, people normally have their meals later than in other
European countries. People sit down for lunch between 14:00
and 15:00 and for dinner between 21:00 and 23:00.
Safety
Barcelona is a safe city, with almost no violent crime, and
visitors can stroll around at ease. However, as in any big city,
some basic safety precautions should be observed. Congress
participants are advised to be vigilant of handbags and wallets,
especially in the metro.
Shopping
Normal trading hours are Monday to Saturday from 09:00 to
13:30 and 16:30 to 20:00.
Tipping
A general guideline is between 5 % and 10 % of the bill,
depending on the quality of the service.
Time Zone
Spain is on European Time, i.e. Greenwich Mean Time (GMT
+ 1 hour).
General Information
Climate
167
© nadirco - Fotolia.com
Arriving
by Plane
The Fira Gran Via is located outside of Barcelona’s city centre,
on the way towards Barcelona Airport. There is no direct metro
connection between the Congress Venue and the airport. The
easiest and quickest way to reach the Congress Venue from
the airport is by taxi.
Taxi Service
The travel time by taxi from the airport to the Fira Gran Via
(Hall 8) is approx. 15 minutes and the price should be around
€ 20.–
The taxi driver should drop you off at the North Entrance.
Radio Taxi 033: +34 933 033 033
Fono Taxi:
+34 933 001 100
Public Transportation
There is also no direct metro connection from the airport to
the city centre. However, city shuttle buses are leaving every
6 – 15 minutes in front of Terminal 1 and 2 and cost around
€ 5,75 for a single-way ticket and € 9,95 for a return ticket
(valid for 9 days).
To reach the Congress Venue by public transportation take the
aerobus and get off at "Plaza Espanya" (travel time approx.
25 minutes). From "Plaza Espanya" take FGC (train line) "L8"
to the station "Europa Fira" (3 stops; travel time approx.
6 minutes).
Outside of the "Europa Fira" station, ENS Conference shuttle
buses will bring passengers to the North Entrance of the Fira
Gran Via (Hall 8). The shuttle buses departure every 3 minutes
and the journey to the venue takes about 5 minutes.
168
Public Transportation
(cont.)
The conference shuttle buses are free of charge and are driving
between the "Europa Fira" train station and the venue from
8 – 11 June during the following times:
Saturday, 8 June 2013, 07:15 – 21:30
Sunday, 9 June 2013,07:15 – 20:00
Monday, 10 June 2013,07:00 – 20:00
Tuesday, 11 June 2013,07:00 – 17:30
© Fira Barcelona
General Barcelona transportation tickets can be bought at
the "Barcelona Information Desk" close to the Congress
Secretariat.
• Girona – Barcelona | AP-7, C-33, Ronda Litoral exit 17,
Gran Via M2
• Mataró – Barcelona | C-32, Ronda Litoral exit 17,
Gran Via M2
• Manresa – Barcelona | C-58, Ronda Litoral exit 17,
Gran Via M2
• Aeroport del Prat – Barcelona | C-31, Gran Via
• Tarragona – Barcelona | AP-7, A-2, Ronda Litoral exit
Barcelona Fires – Gran Via
• Igualada – Barcelona | A-2, Ronda Litoral exit Barcelona
Fires – Gran Via
• Lleida – Barcelona | AP-2, A-2, Ronda Litoral exit Barcelona
Fires – Gran Via
Delegates arriving by car can use parking F, in front of Hall 8.
Parking tickets ca be bought directly in this parking area for
€ 2,90 / hour.
169
General Information
Arriving
by Car
S a t e l l i t e
S y M P o S i u M
targeting the
Glutamate
aMPa receptor
a Novel approach in Clinical Practice
Sunday 9th June 2013
17.30 – 19.00
Room C
Dr Hannah Cock (London, UK) Chairperson
Professor Hans-Peter Hartung (Düsseldorf, Germany)
Dr Rodrigo Rocamora (Barcelona, Spain)
Professor Martin Holtkamp (Berlin, Germany)
This symposium is
sponsored by Eisai Europe Ltd
EpiGen-EU0019
Date of preparation: April 2013
23rd Meeting of the European
Neurological Society
8-11 June 2013, Barcelona, Spain
General Information
Room C
i
Meeting
Room 1
Poster
Desk
Speakers
Service
Centre
Main Entrance
Barcelona Information Desk
Secretariat / Registration
Main Entrance
@ Corner
Exhibition Area
Room D
Room A
Poster
Exhibition
e-Posters
Meeting
Room 4
ATM
Media
Centre
Room E
Meeting
Room 2
Room B
Cloakroom
Room F
Meeting Room 3
Meeting
Room 5
Plenary Hall
Meeting
Room 6
Venue Floor Plan
171
List of Exhibitors and Exhibition Floor Plan
G22
American Academy of Neurology (AAN), Minneapolis, MN / US
B13
Actelion Pharmaceuticals Ltd, Allschwil / CH
C12
Bayer HealthCare Pharmaceuticals, Montville,NJ / US
B32
Biogen Idec Intl. GmbH, Zug / CH
F24
Cadwell, Kennewick, WA / US
E23
Electrical Geodesics, Inc (EGI), Eugene, OR / US
G20
ENS / EFNS, Basel / CH, Vienna / AT
C23
Euroimmun AG, Luebeck / DE
B33
Genzyme Europe B.V., Naarden / NL
To/from
Lecture Halls
To/from
Lecture Halls
B32
B33
D32
A23
Catering
Aisle
Aisle
Aisle
A
C
B
B12
A14
A13
A12
A11
A10
D26
E25
D24
E23
C23
B24
Cat
Aisle
Aisle
D
E
E24
C12
B13
E24
Main
Entrance
172
B24
Grifols International S.A., Barcelona / ES
D26
Inomed Medizintechnik GmbH, Emmendingen / DE
B12
Merck Serono, Darmstadt / DE
D32
Novartis Pharma AG, Basel / CH
F26
Serono Symposia International Foundation, Geneva / CH
F28
SOMNOmedics GmbH, Randersacker / DE
E24
Wiley, Oxford / UK
A23
Wisepress Ltd., London / UK
F28
Catering
F26
Aisle
Aisle
E
F
E24
F25
To/from
Lecture Halls
Aisle
F24
G
G22
F22
G20
F23
F20
F21
173
Exhibition & Satellites
E24
Satellite Symposia
Refer to Scientific Programme for full session details
11:50 – 13:20
Room A
Emerging insights in multiple sclerosis: Re-evaluating the
treatment algorithm
(page 21)
Satellite Symposia
Sunday, 9 June 2013
12:00 – 13:30
Plenary Hall
Moving the treatment of MS forward
12:00 – 13:30
Room B
(page 29)
Amyotrophic lateral sclerosis: where do we stand?
12:00 – 13:30
Room D
(page 30)
From neurological anomalies to diagnosis of treatable
conditions: lessons from Niemann-Pick disease Type C
17:30 – 19:00
Plenary Hall
(page 31)
Supporting patient engagement for
optimized treatment management in MS
17:30 – 19:00
Room C
Targeting the glutamate AMPA receptor – a novel
approach in clinical practice
174
(page 33)
(page 34)
© Victoria Demidova - Fotolia.com
Satellite Symposia
11:45 – 13:15
Plenary Hall
Time matters: early and enduring treatment
options in MS
17:30 – 19:00
Room A
(page 36)
Current challenges of MS therapy: accepted
Satellite Symposia
(page 39)
25 years of partnership: working towards a
better future for patients with MS
(page 41)
175
Exhibition & Satellites
11:45 – 13:15
Room A
Our extentensive client base
includes national and international associations, governmental
We provide a tailored offering for organisations and corporations.
our clients’needs when organising meetings, events and
We believe the best part of our
conferences, and also deliver
work is the close relationship we
association management and
establish with our clients, which
travel & accommodation services. allows us to address their
challenges and deliver exciting
project.
Establised in 1982, we serve a
variety of industries from our
Let’s meet, visit
many ofices, utilising our
network of partners globally.
www.congrex.com
Congrex is the official organiser
of the ENS conference 2013.
www.JointCongressofEuropeanNeurology.org
JOINT CONGRESS ISTANBUL 2014
ISTANBUL, TURKEY, 31 MAY – 3 JUNE 2014
EUROPEAN FEDERATION OF NEUROLOGICAL SOCIETIES
EUROPEAN NEUROLOGICAL SOCIETY
We look forward to welcoming you
to Istanbul and this unique Congress!
Abstract submission deadline: 8 January 2014
12:00–13:30, Sunday 9 June 2013
Fira Barcelona, Convention Centre Gran Via (Room D), Barcelona, Spain
PROGRAMME
From neurological anomalies to diagnosis
of treatable conditions: lessons from
Niemann-Pick disease Type C
Chaired by Alessandro Burlina
(Bassano del Grappa, Italy)
Satellite Symposium at the 23rd Meeting of
the European Neurological Society (ENS) 2013
Supported by an educational grant
provided by Actelion Pharmaceuticals Ltd
Chair: Alessandro Burlina (Bassano del Grappa, Italy)
12:00 – 12:10
Welcome & introduction
Alessandro Burlina
12:10 – 12:25
Relevance of neurological manifestations in differential
diagnosis of ataxias
Michelangelo Mancuso (Pisa, Italy)
12:25 – 12:40
A clinical approach to differential diagnosis of central
ocular motor disorders
Michael Strupp (Munich, Germany)
12:40 – 12:55
From developmental delay to adult cognitive impairment:
differential diagnosis
Saba Nia (Vienna, Austria)
12:55 – 13:10
Treating neurological progression: disease-specific treatment for NP-C
Frédéric Sedel (Paris, France)
13:10 – 13:25
Q&A session
All
13:25 – 13:30
Summary & conclusions
Alessandro Burlina
13:30
Close
Actelion booth and
Symposium location
D
Poster Area
Visit us at our
Booth n° B13
Registration
Main
Entrance
ZAV_274_ENS2013_ADVERT_04.2013
Exhibition Area
Zavesca Symposium
(Room D)

Barcelona, Spain

Transcription

Similar documents

Scandinavian Music Festival Program

Charles Hayden Planetarium - Museum of Science, Boston

Untitled - Continental Tires

On Wednesdays, Adoration is followed by Novena to Our Lady of

Bloggers Favorite Things Gift Guide

Presentazione standard di PowerPoint

Presentazione di PowerPoint

COMENIUS

The Conference Program - North Atlantic University Union

campus map - Quest University Canada

dx 4 fx 4 gx 1 ax 2 bx 2 cx 4 ex 4 1 2 XY 1 2 XY FR Les

Tuesday Daily Newspaper - 2016 AGU Fall Meeting